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Abstract
The final irreversible step in the duplication and dissemination of 
genomes to daughter cells takes place at the metaphase to anaphase 
transition. Sister chromatid pairs that are aligned in metaphase split and 
separate in anaphase. This splitting is triggered by a specific protease called 
“separase”, conserved in all eukaryotes. Separase cleaves Scc1, the central 
subunit of the “cohesin” complex that is required for holding together the sister 
chromatids in metaphase.
In budding yeast, separase’ proteolytic activity is regulated in two ways: 
by its binding partner securin and through modification of the substrate Scc1. 
This thesis shows that securin supports separase localisation in the nucleus 
and ensures that separase gains full proteolytic activity by acting like a 
chaperone. It also shows that securin is a direct inhibitor of separase’ proteolytic 
activity. Securin prevents binding of separase to its substrates. It also hinders 
the separase N-terminus from interacting with and possibly inducing an 
activating conformational change at the protease active site at the proteins C- 
terminus.
During chromosome condensation in prophase, part of cohesin leaves 
chromatin and it is unclear how separase specifically finds and cleaves the 
fraction of the cohesin that is left on chromosomes in metaphase. An assay was 
established to compare the cleavage of chromatin-bound versus soluble 
cohesin. This revealed that Scc1 in chromatin-bound cohesin is significantly 
preferred by separase over Scc1 in soluble cohesin. This difference was not 
due to the chromatin environment and can be explained by preferential 
phosphorylation of chromatin-bound Scc1. Site directed mutagenesis of ten 
Polo kinase phosphorylation sites in Scc1 reduced the rate of cleavage of 
chromatin-bound cohesin, and hyperphosphorylation of soluble Scc1 by 
overexpression of Polo kinase accelerated its cleavage in vitro. 
Phosphorylation site mutant Scc1 slowed anaphase progression in vivo leading 
to an increase in chromosome loss.
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Chapter 1 
Introduction
!n order to divide a cell must double its mass and distribute its 
components equally between two daughter cells. Cell division can be triggered 
by different environmental signals. These signals are transmitted through signal 
cascades to the DNA and activate the transcription of cell division specific 
genes. The molecular processes of a cell division are subjected to a defined 
temporal order. Their coordinated regulation, also called cell cycle control, is 
essential for the survival of a healthy cell. Mistakes in the cell cycle control can 
lead to deregulated cell growth and chromosomal missegregation.
The molecular bases of the cell cycle regulation were discovered in the 
beginning of the seventies. Biochemical analysis performed on sea urchin and 
Xenopus laevis fertilised eggs led to important discoveries of cell cycle control 
mechanisms [1, 2]. These model organisms were albeit not suited for genetical 
analysis. The two fungi Saccharomyces cerevisiae and Schizosaccharomyces 
pombe are good organisms for genetic manipulation. Mutational analysis on 
these unicellular organisms led to the further identification and characterisation 
of genes involved in the control of the cell cycle [3, 4].
1.1 The mitotic cell cycle
The somatic cell cycle is defined as the period between two mitotic 
divisions. This period is subdivided into a G1-, S- and G2-phase. The two key 
control points in the cell cycle are in G1-phase and at the end of the G2-phase. 
During G1 a commitment is made to enter a replication cycle. This commitment 
is defined by the restriction point in animal cells, and the START in yeast cells. 
Once this decision has been taken, cells are committed to begin a replication- 
or S-phase. The end of G2 is marked by the decision to enter mitosis or M- 
phase. This in turn depends on a correctly completed S- and G2-phase.
11
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Mitosis is divided into five subsequent phases: prophase, prometaphase, 
metaphase, anaphase and telophase (Fig. 1.1).
prophase prometaphase metaphase anaphase telophase
Figure 1.1: Mitosis in the plant Tradescantia virginiana
During prophase and prometaphase chromosomes start to condense and appear as 
individual chromosomes. In metaphase the chromosomes align at the cell equator 
known as metaphase plate. Microtubules emanating from opposite spindle poles attach 
to the centromeres of each sister chromatid. As anaphase commences, sister 
chromatids split and are pulled to opposite poles of the cell. In telophase the DNA 
starts to decondense and two new daughter cells form.
During prophase, the replicated chromosomes undergo extensive 
condensation and the mitotic spindle begins to emanate from both spindle 
poles, located at opposite ends of the cell. In prometaphase the microtubules of 
the mitotic spindle begin to interact with the chromosomes, and chromosomes 
start to assemble at the metaphase plate with their centromeres situated in the 
middle of the mitotic spindle. The kinetochore, a proteinaceous structure, 
assembled at the surface of the centromere, acts as the site of spindle 
microtubule binding. Each kinetochore of the replicated chromosome is pointed 
toward one side of the spindle. The congression of chromosomes and the 
alignment of the centromeres on the metaphase plate is an essential 
prerequisite for the orderly separation of the replicated genome into two equal 
parts. In metaphase the alignment of the replicated chromosomes at the 
metaphase spindle is completed and the chromosomes decrease their 
movement significantly. Anaphase commences with the initial splitting of sister 
chromatids. The splitting depends on the targeted destruction of a protein 
complex that holds the chromatids together. The major mechanism for 
chromosome movement in anaphase is motor-powered kinetochore movement 
coupled to microtubule disassembly at the kinetochore. Each kinetochore is 
pulled towards the spindle pole by microtubule depolymerisation. Consequently,
12
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sister chromatids separate from each other, each moving away from the 
metaphase plate and toward one of the two spindle poles. In telophase, the 
chromosomes have moved close to the spindle pole regions, and the spindle 
midzone begins to clear.
1.2 Regulation of mitosis
1.2.1 Cyclin dependent kinases
A unifying feature in the cell cycles of yeast and animals is the existence 
of a cyclin dependent kinase (CDK) and a mitotic cyclin of either the A or the B 
class. The activity of CDK is controlled by the phosphorylation state of the 
catalytic subunit of the serine/threonine kinase and by the degradation of the 
cyclin component. By phosphorylating appropriate substrates, the kinase 
provides MPF (M-phase promoting factors) activity, which stimulates mitosis. A 
prominent substrate is histone H1 whose phosphorylation coincides with 
chromatin condensation, a prerequisite for proper chromosome segregation. 
Cdc28, the CDK of S.cerevisiae, associates with different sets of cyclins to 
control the cell cycle [5]. The START is triggered by the association of the 
kinase with G1 or A cyclins, whereas mitosis coincides with its association with 
B cyclins (Table 1.1). This mitotic CDK activity is responsible for sister 
chromatid separation during anaphase.
Entry into mitosis requires activation of Cdc28. For this to occur, 
inhibitory phosphates on Cdc28 must be removed by the phosphatase Mih1 
(Cdc25 in fission yeast). Proper timing is assured by the opposing effect of the 
kinase Swe1 (Wee1 in fission yeast) building a switch-like mechanism for 
Cdc28 activation [6, 7]. Various regulatory mechanisms converge on this 
kinase/phosphatase switch, shifting the balance towards Mih1 for mitotic entry 
or towards Swe1 to keep the cell in G2. The morphogenetic pathway, which 
ensures proper bud shaping shortly after bud emergence, as well as the correct 
positioning of the pre-mitotic spindle, is one of the key regulators of that switch.
13
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In S.cerevisiae cell cycle control is exerted through the interaction of different
cyclins (A-type CLN1-2, B-type CLB1-6) with a single CDK, the Cdc28 kinase 
(Cdc2 in S.pombe).
Cyclin Protein kinase process regulated
Cln1,Cln2,Cln3 Cdc28 Start (G1 to S)
Clb5,Clb6 Cdc28 S-phase
Clb3, Clb4 Cdc28 M-phase entry
Clb1, Clb2 Cdc28 M-phase progression
In humans:
Cyclin Protein kinase process regulated
Cyclin D1-3 Cdk4,6 G1-phase progression
Cyclin E Cdk2 G1 to S-phase
Cyclin A Cdk2 S-phase progression
Cyclin A Cdk1 S through G2
Cyclin B Cdk1 M-phase
Table 1.1: CDKs and cyclins in yeast and men
1.2.2 The anaphase promoting complex (APC)
The initiation and coordination of mitotic events are governed by 
ubiquitin-dependent proteolysis of key regulatory proteins, including mitotic 
cyclins [8-11]. A major step in this targeted protein destruction is catalysed by a 
multimeric ubiquitin ligase known as the anaphase-promoting complex (APC) or 
cyclosome. APC activity rises abruptly at metaphase, resulting in the 
destruction of proteins that inhibit sister-chromatid separation. APC-dependent 
destruction of B-cyclins initiates spindle disassembly, cytokinesis and the 
resetting of replication origins for the next cell cycle (Fig. 1.2)
The APC is an ubiquitin ligase, which collaborates with an ubiquitin- 
activating enzyme and an ubiquitin-conjugating enzyme to catalyse the transfer 
of ubiquitin molecules to lysine side chains on target proteins [12]. Target 
proteins are recognised by the APC through a destruction-box (D-box or KEN- 
box) [13]. The ubiquitylated proteins are subsequently degraded by the 26S 
proteasome.
14
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Figure 1.2: The cell cycle in somatic cells
Cyclin-dependent activation of Cdk not only leads to mitotic entry but also promotes 
activation of Cdc20-APC, which then triggers cyclin destruction and mitotic exit. Cdk 
inactivation in late mitosis results in the activation of Cdh1-APC, which maintains cyclin 
destruction (and so Cdk inactivity) throughout G1. The loss of Cdk activity causes 
Cdc20-APC inactivation, and cyclin can accumulate again. Phases of the cell cycle are 
S (‘synthesis’, in which DNA replication occurs) and M (nuclear division, or mitosis, 
followed by cell division, or cytokinesis). G1 is a gap’ phase in which growth takes 
place. (D.Morgan and J.Roberts, Nature, Volume 418, 1.8.2002)
The APC needs to be activated, in order to be able to ubiquitylate 
proteins. This activation is cell cycle regulated and depends on two proteins, 
Cdc20 and Hct1/Cdh1 [14, 15]. Cdc20 and Hct1/Cdh1 are thought to be 
substrate specific APC activators, such that Cdc20 stimulates the destruction of 
the anaphase inhibitor Pds1/securin, whereas Hct1/Cdh1 targets the major 
mitotic cyclin Clb2 for destruction, a prerequisite for cells to exit mitosis [14-17] 
(Fig. 1.2). The most striking difference between Cdc20 and Hct1/Cdh1 lays not 
so much in their substrate specificity but in their regulation. Whereas the Cdc20- 
APC appears to be stimulated by mitotic CDK activity, the Hct1/Cdh1-APC is 
inhibited by this activity. Cdc20 and several APC subunits undergo CDK- 
dependent mitotic phosphorylation, although biochemical evidence that this 
phosphorylation directly influences the activity of Cdc20 or the APC is still 
missing. In budding yeast, phosphorylation of Hct1/Cdh1 by Cdc28 blocks the 
ability of Hct1/Cdh1 to activate the APC [18]. Cdc28 thus blocks its own
15
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inactivation by the Hct1/Cdh1-APC, explaining the inverse correlation between 
the activities of Cdc28 and Hct1/Cdh1-APC during the cell cycle. (Fig.1.3)
CDK-cyclin *1 ■*—  Cdc5   |
O  Cdc,4
i
/
Cdc14
i N  . 1
anaphase inhibitors mitotic cyclins
•J- J_ spindle dissasembly
metaphase---------------- ► anaphase----------------- ► cytokinesis
DNA re-replication
Figure 1.3: A model of the regulatory network controlling the APC in mitosis 
In somatic cells, the Cdc20-APC is stimulated by mitotic CDK activity and is 
responsible for the destruction of anaphase inhibitors and cyclins. The dashed arrows 
indicate that the ability of CDK activity and Polo-like kinase (Cdc5) to stimulate the 
Cdc20-APC is poorly understood and perhaps indirect. Hct1-APC is inhibited by CDK 
activity, but late mitotic gene products like Cdc14 activate the Hct1-APC. This allows 
stable APC activation in G1. In budding yeast, Cdc20-APC may target some cyclins 
for destruction, but at least one cyclin type (Clb2) is targeted primarily by the 
Hct1-APC.
1.2.3 Regulation of late mitotic events
The switch-like features of CDK inactivation are enhanced by a similar 
antagonistic relationship between Cdc28 and Sic1, a protein that binds and 
inhibits Cdc28-cyclin complexes in late mitosis and G1. Phosphorylation of Sic1 
by Cdc28 destabilises S id , and phosphorylation of the transcription factor Swi5 
reduces SIC1 expression. Swi5 promotes exit from mitosis by inducing SIC1 
expression in telophase [19-21]. Because of these relationships, S id levels are
16
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low from S phase to early mitosis but rise abruptly as CDK activity declines in 
late mitosis. Favourable growth conditions then stimulate the production of G1 
cyclins, which are not Sic1 targets and therefore are able to turn off Cdh1 
induced APC-resistant CDK activity.
The phosphatase Cdc14 has been implicated in the direct control of 
cyclin destruction. Cdc14 catalyses dephosphorylation of Hct1 at the inhibitory 
CDK sites, contributing to Hct1-APC activation [18]. Cdc14 also removes CDK- 
dependent phosphates from Sic1 and Swi5, leading to S id  accumulation [22]. 
Cdc14 is thus positioned to be a key regulator of CDK inactivation in late 
mitosis. Cdc5 is a member of the highly conserved family of Polo-related protein 
kinases, which have been implicated in the control of mitosis in a wide range of 
eukaryotes [23]. Polo-like kinases in many species are required for mitotic exit. 
Like Cdc5 in budding yeast, the Polo-like kinases of fission yeast and 
Drosophila are required for cytokinesis but not for anaphase onset [24, 25].
The ordering of Cdc20 and Hct1/Cdh1 activation seems to be based on 
the ability of Cdc20 to promote the destruction of proteins that inhibit Hct1/Cdh1 
activation. In fact, the best-known Cdc20 target, the anaphase inhibitor 
Pds1 /securin, may also be an inhibitor of cyclin destruction: over-expression of 
a non-degradable mutant form of Pds1 blocks not only sister chromatids 
separation but also prevents cyclin destruction and cytokinesis [26, 27]. Cells 
carrying mutations in CDC20, arrest in metaphase with undegraded Pds1, 
whereas pds1 cells with mutations in CDC20 arrest after anaphase with stable 
Clb2 [16, 28]. Thus, Cdc20 is required for cyclin destruction even in the 
absence of Pds1, suggesting that Cdc20 must promote the destruction of some 
other inhibitor of Hct1/Cdh1-APC activation. As Hct1/Cdh1 is required for 
destruction of Clb2, Cdc20 may target other mitotic cyclins such as Clb3 and 
Clb5. The destruction of other cyclins by Cdc20 would partially lower CDK 
activity (despite Clb2 stability), causing partial dephosphorylation of Hct1/Cdh1 
and Sic1, and thereby triggering the switch that activates the Hct1/Cdh1-APC 
and causes Sic1 accumulation. (Fig.1.3)
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1.3 The key players of metaphase to anaphase transition: separase and 
securin
1.3.1 Securin
A key event in the completion of the mitotic decision, and therefore 
subject to tight regulation, represents the separation of sister chromatids at the 
onset of anaphase. The metaphase to anaphase transition coincides with the 
proteolytic degradation of securin. The initial characterisation of securin, Pds1 in 
budding yeast, uncovered two complementary roles. Although not essential, 
securin is required for efficient chromosome segregation in anaphase. At the 
same time securin is needed to prevent anaphase in response to spindle and 
DNA damage [28-31]. It became clear that securin is an inhibitor of sister 
chromatid separation that has to be degraded via ubiquitylation by the APC [26, 
32, 33]. While present in cells securin is bound to the cysteine protease 
Esp1/separase [31, 34]. Separase itself is necessary and sufficient for sister 
chromatid separation in anaphase [35, 36]. In crude in vitro systems securin 
prevents separase from cleaving Scc1 [37, 38].
In fission yeast, as well as in budding yeast, the C-terminus of securin is 
thought to interact with N-terminal regions of separase [30, 34]. A similar 
interaction has also been shown in Drosophila and humans [37, 39].
Securins are found in most organisms studied. Although they share very 
little primary sequence similarity, they all contain D-or KEN-boxes at their N- 
termini, which is the recognition sequence for ubiquitylation by the APC. Upon 
activation of the APC by Cdc20 in metaphase, securin is ubiquitylated and 
subsequently degraded. As a consequence separase is free to separate sister 
chromatids.
Several lines of evidence suggested that securin might have not only an 
inhibitory role on separase function but might also be needed to activate 
separase at the metaphase to anaphase transition. The fission yeast 
Cut1/securin is essential and thought to help localising separase to the mitotic 
spindle [40]. Studies in yeast that are discussed in this thesis in parallel with 
studies conducted in other laboratories showed that Pds1/securin is needed for
18
Chapter 1: Introduction
the nuclear localisation as well as for proper spindle association of 
Esp1/separase [34, 41]. Furthermore phosphorylation of securin by Cdc28 is 
required for efficient nuclear localisation of separase [42].
1.3.2 Separase
Separases have been first identified as Esp1 in budding yeast and Cut1 
in fission yeast [43-45]. Mutational defects in Esp1 have initially been shown to 
lead to a lethal state characterised by the accumulation of Extra Spindle Pole 
bodies (ESP) [45]. The lethality of esp1 mutants was then described to be a 
consequence of an aberrant behavior of the mitotic spindle, leading to a failure 
of a correct nuclear division and massive chromosome nondisjunction, with one 
daughter cell generally acquiring most of the DNA and both spindle poles. This 
cell then frequently proceeded to initiate a new cell cycle, leading to increases 
in both DNA content and the number of Spindle Pole Bodies (SPBs) [43]. Later 
studies showed that esp1 mutants failed to separate sister chromatids when 
shifted to non-permissive temperatures. It became clear that Esp1 was 
responsible for the sudden disappearance of cohesion between sister 
chromatids at the metaphase to anaphase transition [31]. Concomitantly, it 
turned out that sister chromatid separation at the anaphase onset is promoted 
by cleavage of the Scc1 subunit of the cohesin complex holding sister 
chromatids together [38] and that Esp1 was the protease responsible for this 
cleavage [35].
Separases are large (180 to 250kD) proteins with a highly conserved C- 
terminal domain. This domain contains the catalytic dyad of the protease 
common to caspases (CD-clan of proteins), which is composed of five parallel 
p-strands linked by helices. At the end of the two central strands lie the 
conserved histidine and cysteine residues that form the catalytic dyad [35] 
(Fig1.4).
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Figure 1.4: Esp1 and the CD Clan of Cysteine Proteases
(A) Sequence conservation between separases in the region of the proposed 
proteolytic catalytic site. Sequence alignment in the region of the strictly conserved His 
and Cys residues is shown together with the sequences of human caspase 1, the 
transamidase Gpi8, and gingipain. Key to sequences: separins from S. cerevisae Esp1 
(AAB03897), S. pombe Cut1 (A35694), two proteins from C. elegans (AAA83576 and 
the WormPep-Entry CE22098), E. nidulans BimB (P33144), D. melanogaster 
(conceptual translation of A C 0114811), H. sapiens (BAA11482), A. thaliana 
(CAA19812), human caspase 1 (P29466), human Gpi8 (CAA68871), and P. gingivalis 
gingipain (P95493). (B) The catalytic site of gingipain is shown as a model for that of 
separase. The histidine and cysteine catalytic residues are colored in yellow and red 
respectively, whereas hydrophobic parallel p-strands on the N-terminal side of these 
catalytic residues are shown in blue. The polypeptide chain between the two strands is 
in green. Residues within separases that are proposed to correspond to these 
structural motifs are marked with the same color scheme in the alignment in A. The 
figure was drawn with MOLSCRIPT. (F.Uhlmann et al., Cell, Vol 103, 27.10.2000)
Separase’s large N-terminal domain is unconserved on the primary 
sequence level. Nevertheless it is present in all eukaryotes studied, indicating 
an important role for this large N-terminal part. In fission yeast, N-terminal 
sequences are required for the function of separase and have been implicated 
in its nuclear localisation, and more central sequences in the possible 
cytoplasmic retention of the protein [40].
Tertiary structure predictions in dipteria revealed alpha-alpha 
superhelical folds in the N-terminal domains of separase. The compatibility of
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these folds with a wide range of primary sequences could explain the rapid 
divergence of N-terminal separase sequences as well as securins, which 
contact this region [46].
Like caspases, separases in vertebrate cells undergo auto cleavage 
upon their activation, following APC-mediated securin destruction. In flies, 
where separase appears to have split into two proteins - SSE containing the 
protease domain and Three Rows (THR) as the N-terminal part - the latter also 
undergoes cleavage upon activation of the protease. Cleavage of THR does not 
appear to be necessary for separase activity but instead may contribute to its 
inactivation during telophase [47]. Auto cleavage of separase in vertebrate cells 
may have a similar role.
1.4 Separase targets
1.4.1 Scc1
The main proteolytic target of separase is a protein complex, called 
cohesin complex, which mediates cohesion between sister chromatids after 
their replication in S-phase. The yeast cohesin complex contains an SMC 
heterodimer formed by the interaction between two different Smc proteins, 
called Smc1 and Smc3 [48]. These are bound to a third protein, Scc1, whose 
cleavage by separase triggers the pole ward movement of sisters at the 
metaphase-to-anaphase transition [38, 49] (Fig1.5). Separase and Scc1 
represent crucial players in the process of sister chromatid separation. This 
mechanism to initiate anaphase is indeed conserved in eukaryotes from 
budding yeast to human.
Scc1 binds a fourth cohesin subunit, Scc3, whose function is still unclear. 
Recent findings showed that the N- and C-terminal domains of Scc1 bind, 
respectively, to the Smc3 and Smc1 heads of the Smc1/3 heterodimer [48]. 
(Fig1.6) This suggested that cohesin forms a large proteinaceous ring within 
which the DNA strands could be trapped. The hypothesis that sister chromatids 
are connected via a topological rather than a chemical bound would fit with the
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observation that cohesin does not bind very strongly to DNA [50, 51] and could 
explain how it can very quickly be released from chromosomes after cleavage 
of its Scc1 subunit [38].
/KXKCA Cohesin 
Smc3
Figure 1.5: Chromosome segregation in mitotic cells
In late G1 phase, the cohesin complex is loaded on chromosomes and holds sister 
chromatids together after the DNA has been replicated. At the beginning of mitosis, 
microtubules attaching to the centromeric region of each sister chromatid exert a pulling 
force towards opposite spindle poles. This force is counteracted by the cohesin complex 
that is released from chromosomes in anaphase through the proteolytic cleavage of Scc1 
by separase.
One of the still unsolved questions is how cohesin is loaded onto DNA 
before replication and how sister chromatid cohesion is established after 
replication. Studies in budding yeast suggest that cohesin binding to chromatin 
is accomplished by an ATP hydrolysis-dependent transport of DNA into the 
cohesin ring [52]. These studies also present evidence that the two Smc 
subunits of cohesin by themselves form a ring, closed at interacting ATPase 
head domains. In addition to an intact cohesin ring structure, functional ATPase 
heads are indispensable for DNA binding, suggesting that ATP hydrolysis may 
be coupled to DNA transport into the cohesin ring. Parallel studies suggest that
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ATP hydrolysis drives the temporary disconnection of Scc1 from Smc heads 
that are needed for DNA entrapment and that this process is promoted by 
Scc2/4 [53]. Scc2 and Scc4 are required to load cohesin on chromosomes. 
DNA is released in anaphase when separase cleaves cohesin’s Scc1 subunit. A 
cleavage fragment of Scc1 could disrupt the interaction between the two Smc 
heads, thereby opening the ring (Fig.1.6) [52].
A
ATP
Smc1Smc3
B
ADP+Pj
Separase
Scc3
Sect
Figure 1.6: ATP Hydrolysis-Dependent DNA Transport into the Cohesin Ring
(A) The cohesin Smc dimer forms a ring. ATP binding by Smc1 is required for 
association of Scc1 when it is synthesized at the G1/S transition. DNA might then 
induce ATP hydrolysis and its own active transport into the ring. During this process 
Smc heads separate but remain connected by Scc1. (B) During DNA replication two 
sister strands become entrapped in the cohesin ring. At anaphase onset Scc1 is 
cleaved by separase. The C-terminal cleavage product, bound to Smc1, prevents the 
Smc heads from interacting, allowing release of sister strands from the open ring. 
(S.Weitzeret al., Current Biology, Volume 13, 11.11.2003)
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I.4 .2  Rec8
During meiosis I, cohesion between sister chromatid arms is essential for 
holding homologs together after their recombination to produce chiasmata. In 
yeast, this cohesion is destroyed by separase-mediated cleavage of a meiosis 
specific variant of Scc1 called Rec8 [54]. Cleavage of Rec8 along chromosome 
arms occurs at the onset of anaphase I, but Rec8 in the vicinity of centromeres 
is cleaved only at the onset of anaphase II. The persistence of centromeric 
cohesion during meiosis I is essential for chromatid segregation during meiosis
II.
In Drosophila, the protein Mei-S332 has been implicated in the retention 
of centromeric cohesion until onset of meiosis II. Mei-S332 is concentrated at 
pericentric chromosome regions from metaphase I to metaphase II in meiotic 
cells as well as during metaphase of mitotic cells [55, 56]. In flies carrying mei- 
S332 mutations, a high frequency of sister centromeres are separated already 
by late anaphase I [57], and this phenomenon is associated with a high 
frequency of nondisjunction, lagging chromosomes, and chromosome loss 
during meiosis II [58].
A protein with analogous function and distantly related structure to Mei- 
S332 in Drosophila has been discovered in fission yeast. Recent studies in 
fission yeast revealed that the pericentric protein Sgo1 protects centromeric 
Rec8 from cleavage during meiosis I, probably by shielding Rec8 from separase 
action [59, 60]. A genome-wide screen in S.cerevisiae identified three mutants, 
iml3, chl4, and sgol,  whose chromosome segregation pattern predicts an 
involvement in the maintenance of centromeric cohesion during meiosis I [61]. 
All three proteins are, to different extents, required to retain cohesin around 
centromeres during anaphase I and localise to centromeric regions. The finding 
that Sgo1, like Mei-S332, is a coiled-coil protein and dissociates from 
centromeric regions at the onset of anaphase during mitosis and the onset of 
anaphase II during meiosis [55, 62, 63] further raises the possibility that SG01  
is the functional homolog of MEI-S332 in S. cerevisiae.
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1.4.3 Slk19
The third known proteolytic separase target, besides Scc1 and Rec8, is 
Slk19 [64]. The kinetochore and spindle-associated protein Slk19 is cleaved by 
separase during anaphase. Unlike Scc1, whose C-terminal cleavage product is 
rapidly degraded via the N-end rule, the Slk19 cleavage product is stable [65- 
67]. According to the N-end rule pathway, a set of molecular components 
recognise and degrade proteins bearing N-degrons, a destabilising N-terminal 
residue of a protein [65]. The escape of the Slk19 cleavage product from 
degradation is important to allow cleaved Slk19 to stabilise the anaphase 
spindle. Accumulation of uncleaved Slk19 is incompatible with high-fidelity 
chromosome segregation. This demonstrates that separase cleavage can, not 
only destroy proteins, like the cohesins, but that cleavage can also generate 
new protein species with altered properties.
Furthermore, and independently of its cleavage, the localisation of Slk19 
to the spindle midzone in anaphase depends on separase. Another protein at 
the spindle midzone, Ase1, is also mislocalised in the absence of separase. The 
spindle midzone is thought to be the region where microtubule plus ends from 
opposite spindle pole bodies overlap [68], and Slk19 and Ase1 might be 
involved in protecting the plus ends from shrinkage, thereby stabilising the 
anaphase spindle. A normal spindle midzone fails to form during anaphase in 
the absence of separase [35], showing that separase and Slk19 might act in the 
same pathway to stabilise the spindle [64].
1.4.4 Separase cleavage sites
All three known budding yeast separase substrates, Scc1, Rec8 and 
Slk19, are cleaved at one or two conserved peptide motifs, about eight amino 
acid in length (Fig1.7) [38, 54, 64], and related motifs are found at separase 
cleavage sites in other organisms [36, 47, 69-71].
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I
Sccl 173 DTSLEVGRRFSPDE 186 
261 DNSVEQGRRLGESI 274 
Rec8 424 FSSVERGRKRAHSL 437 
446 TRSHEYGRKSFRNN 459 
.pSh-.GRp...S.
Slkl9 70 DRSIDYGRSSALNN 83
Figure 1.7: Separases' cleavage targets
Sequence alignment of the known separase cleavage sites in Scc1 and Rec8 (p, polar 
(CDEHKNQRST); h, hydrophobic (ACFGHILMVWY); minus, negatively charged (DE); 
s, small (ADGNPSTV)). The consensus was used to screen the Saccharom yces  
c e r e v i s i a e  proteom e with the IS R EC  pattern finder (w w w .isrec.isb- 
sib.ch/software/PATFND_form.html). (M.Sullivan et al, Nature Cell Biology, Volume 3, 
9.2001)
Separase always cleaves downstream of a conserved arginine residue. 
Mutation of the arginine to a negatively charged amino acid largely abolishes 
cleavage. The exact sequence requirements for recognition of the cleavage site 
motif have been characterised. A systematic mutational analysis of the major 
separase cleavage site in Scc1 showed that a core {DE}XXR element within the 
cleavage site motif bears most weight for recognition by separase in 
Saccharomyces cerevisiae [72]. In higher eukaryotes, an EXXR motif appears 
to be the main conserved feature at separase cleavage sites [36, 47, 69, 70]. 
This suggests that cleavage site recognition by separase follows a 
fundamentally similar principle in all organisms.
1.5 Surveying the metaphase to anaphase transition
1.5.1 The spindle checkpoint
All eukaryotic cells possess elaborate mechanisms that regulate the 
timing of separase activation and prevent it from occurring in the presence of 
incomplete DNA replication and of chromatid pairs that have not yet bi-oriented. 
At metaphase of mitosis, sister kinetochores must be bi-oriented and attached 
to microtubules emanating from opposite spindle poles. This ‘amphitelic’ 
attachment is dependent on cohesion between sister chromatids which
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counteracts the pulling force exerted by the microtubules, and is promoted by 
the Ipl1/Aurora B kinase [73, 74]. In budding yeast, most chromosomes start off 
after replication with both sister kinetochores attached to the same spindle pole. 
Aurora B kinase is required to correct this monopolar or syntelic attachment into 
the requisite bipolar or amphitelic attachment at metaphase [73]. This implies 
that aurora B dissolves non-productive kinetochore-microtubule interactions 
until bipolar tension is reached. Consistent with this idea, interference with 
aurora B kinase activity in tissue culture cells leads to chromosome alignment 
defects [75-77]. Once bipolar tension at kinetochores has been established, 
aurora B must stop dissolving attachments.
A surveillance mechanism, known as the spindle checkpoint, detects 
unattached chromosomes, syntelically attached chromosomes and possibly 
also chromosomes that have attached to only one pole, known as monotelic 
attached chromosomes. Unattached or misattached chromosomes or treatment 
with spindle depolymerising drugs like nocodazole trigger the production of a 
complex containing the Mad1/Mad2, BubR1 (Mad3), and Bub3 proteins. This 
complex binds to the APC’s activator protein Cdc20, preventing its interaction 
with the APC, [78] and thereby blocks ubiquitylation of both securin and cyclin B 
[79] (Fig.1.8). The persistence of cyclin B keeps Cdc28 active, which maintains 
cells in a mitotic state in which chromosomes remain condensed, whereas the 
persistence of securin prevents cleavage of Scc1 through separase.
1.5.2 The DNA-damage checkpoint
Another surveillance mechanism that regulates the timing of separase 
activation is the DNA-damage checkpoint. In response to DNA damage, cells 
are arrested in metaphase through the activation of Rad53 and Chk1. The role 
of Rad53 in the DNA damage checkpoint is to maintain CDK activity high [80, 
81]. Chk1 targets the anaphase inhibitor securin [81, 82], which is 
phosphorylated and stabilised during the DNA-damage arrest in a Chk1- 
dependent manner [26, 28, 81] (Fig.1.9). The fact that cells lacking Chk1 or 
Pds1 exhibit a partial DNA-damage induced metaphase arrest, whereas cells 
lacking both Chk1 and Rad53, Pds1 and Rad53 show no metaphase arrest,
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suggests that there is a Rad53 target in addition to securin regulating 
establishment of the arrest [81-83],
unattached or monopolar 
kinetochores
Figure 1.8: Spindle checkpoint induced metaphase arrest
Unattached or misattached chromosomes as well as microtubule damage cause the 
production of a Mad/Bub complex that sequesters the APC activator Cdc20. This prevents 
the proteolysis of securin by inhibiting APC activity.
Figure 1.9: DNA-damage induced metaphase arrest
DNA-damage causes a metaphase arrest through the phosphorylation of securin by 
Chk1.
microtubule damage
Metaphase-
arrest
S-phase Metaphase-
arrest
DNA-damage 
DNA-replication block
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1.6 Separase and the exit from mitosis
In addition to its role in controlling sister chromatid separation, separase 
is also involved in the exit from mitosis and interestingly this function is 
independent of its protease activity. In budding yeast, exit from mitosis depends 
at least in part on the movement of one spindle pole body into the bud [84, 85]. 
The cell monitors the position and successful segregation of the inherited 
spindle pole through the GTP binding protein, Tem1. Tem1 binds GDP while in 
the mother cell, but binds GTP when brought into contact with its GDP/GTP 
exchange factor (GEF) Lte1, which is confined to the daughter cell [84, 86]. Lte1 
is itself activated through phosphorylation by the Polo kinase Cdc5 [87].
1.6.1 Polo-like kinase
As in other eukaryotes, the budding yeast polo kinase homologue, Cdc5, 
plays multiple key roles in the coordination of mitosis, including the G2/M 
transition, chromosome separation and cytokinesis. Cdc5 accumulates in the 
nuclei of G2 and early M-phase cells and disappears from cells as they 
complete mitosis [88]. Cdc5 is required to activate Hct1/Cdh1-dependent 
ubiquitylation of late mitotic substrates such as Clb2, whose degradation is 
important for exit from mitosis. Cdc5 is like Cdc20 itself a substrate of the APC 
and is degraded in G1 by an Hct1/Cdh1-APC dependent mechanism [17, 80]. 
Degradation of Cdc5 in G1 might provide a feedback mechanism by which the 
APC destroys its activator at the onset of the next cell cycle.
Cdc5 localises to centrosomes early in mitosis, then accumulates on the 
central region of the spindle and persist at the midbody through cytokinesis, in 
addition to locating at kinetochores [89-91].
1.6.2 The mitotic exit network (MEN)
Besides Cdc5 and Tem1, the protein kinases Cdc15 and Dbf2, Dbf20, 
the Mob1 protein, in complex with Dbf2, and the Cdc14 protein phosphatase are
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needed for cells to exit mitosis. These proteins contribute to the so called 
‘mitotic exit network’ (MEN) (Fig. 1.10). All the components of the network are 
essential for the B cyclin removal by the Hct1/Cdh1-APC and for Sic1- 
dependent CDK inactivation after anaphase [85, 92, 93]. The MEN is thought to 
work in the following order: GTP-bound Tem1 binds to the kinase Cdc15 [94], 
which in turn activates through phosphorylation the Dbf2 kinase. Dbf2 must be 
complexed with Mob1 to undergo proper activation by Cdc15 [95]. The activated 
Dbf2/Mob1 complex and Cdc5 then trigger the release of the Cdc14 
phosphatase from the nucleolus by dissociation from its sequestering factor 
Net1 [87, 95-98]. As a consequence, Cdc14 is free to dephosphorylate its 
targets and promote mitotic exit.
Figure 1.10: Comparison of early and late anaphase control of Cdc14 release
Separase has been shown to play a role in Cdc14 release from the nucleolus, in 
addition to its previously characterised role in chromatid separation. At least one of the 
separase targets is the kinetochore protein Slk19, but other targets (signified by “?") 
are suggested, based on the esp1 mitotic exit phenotype. Together with Cdc5, these 
proteins make up the FEAR network. The early anaphase release of Cdc14 may be 
confined to the nucleus. In contrast, the MEN functions to maintain Cdc14 release at 
later stages of spindle elongation. This pathway works through previously 
characterised components, many functioning at the spindle poles, and may promote 
Cdc14 release to the cytoplasm (W.S.Saunders, Molecular Cell, Volume 9, 2.2002)
Dbf2/Nob 1
FEAR MEN
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1.6.3 The FEAR pathway (CDC Fourteen Early Anaphase Release)
Although the total and maintained release of Cdc14 in late anaphase, 
crucial for mitotic exit, depends on the MEN pathway, a partial release of Cdc14 
from the nucleolus happens already in early anaphase [99, 100]. Such early 
release of Cdc14 depends on the FEAR network. So far the proteins 
separase/Esp1, Slk19, Spo12, and Cdc5 constitute the first members of the 
FEAR network (Fig.1.10). Unlike Spo12 mutants, that were blocked primarily in 
the early release of Cdc14, Cdc5 mutants were blocked both in the early and 
late Cdc14 release. Separase mutants show a delay in the early anaphase 
release of Cdc14 [100] and separase activation at the onset of anaphase is 
sufficient to promote release from the nucleolus and activation of Cdc14 [101]. 
At least one of the separase targets, the kinetochore protein Slk19, acts 
downstream of separase in the FEAR pathway, as the early release of Cdc14 is 
significantly reduced when Slk19 is deleted [100] and mitotic exit is delayed. 
Interestingly, the ability of separase to activate Cdc14 is independent of its 
protease function but may involve promoting phosphorylation of the Cdc14 
inhibitor Net1 [101]. This non-proteolytic separase function is co-regulated with 
its proteolytic activity by the separase inhibitor securin. This could explain the 
coupling of anaphase and mitotic exit - after securin degradation at anaphase 
onset, separase cleaves cohesin to trigger chromosome segregation and 
concurrently uses a non-proteolytic mechanism to initiate mitotic exit [101].
1.7 Regulation of cohesin cleavage
1.7.1 Scc1 phosphorylation
Securin destruction by the APC is essential for anaphase onset and 
stabilisation of securin in response to spindle or DNA damage is an efficient 
way to prevent anaphase [26, 32, 33]. Mutant cells that lack securin still block 
cyclin B destruction in the presence of spindle poisons, but fail to block 
cleavage of Scc1 by separase, which results in loss of sister chromatid
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cohesion [27, 28]. However, yeast securin mutants are viable at low 
temperatures (23°C) and Scc1 cleavage continues to be cell cycle regulated in 
these mutants. This suggested another, securin independent control 
mechanism of separase activation at the metaphase to anaphase transition. 
Phosphorylation of Scc1 by Polo-like kinase is required for Scc1 cleavage in 
vitro and mutation of two key phosphorylation sites in Scc1 are synthetically 
lethal in the absence of securin [102]. Polo could therefore be a securin 
independent regulator of cohesin cleavage.
1.7.2 Separase phosphorylation
The securin gene can also be deleted in human tissue culture cells [103] 
and even in mouse embryos without causing lethality [104, 105]. In contrast to 
yeast cells, mammalian cells that lack securin are still capable of blocking the 
loss of sister chromatid cohesion when treated with spindle poisons. This could 
be due to the existence of several securin genes in mammalian cells or these 
cells could block separase activation by a securin-independent mechanism. In 
accordance with the latter, high levels of cyclin B/CDK levels in Xenopus 
extracts can prevent separase activation despite securin destruction [37]. It 
turned out that in human cells phosphorylation of separase at Ser1126 is 
necessary for separase inactivation. When this residue was mutated to alanine, 
separase failed to be inactivated by high levels of CDK activity but could 
nevertheless be inhibited by securin. Ser1126 is quantitatively phosphorylated 
during metaphase and becomes at least partly dephosphorylated upon 
anaphase onset [37].
1.7.3 Separase auto-cleavage
Yet another level of separase regulation has been revealed in human 
cells and Drosophila embryos. After its activation at anaphase onset, separase 
cleaves itself [37, 47, 106]. The large human separase protein is thus split into 
two halves. These fragments stay associated with each other, and separase
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activity initially does not seem to be diminished by this cleavage [69, 70]. The 
carboxy-terminal half of the protein becomes unstable, however, and 
disappears during the following G1 phase [106]. As this part of separase 
contains the protease active site, this ultimately leads to a downregulation of 
separase activity. In Drosophila, separase is composed of two smaller 
polypeptides, called Three Rows and separase [39], which may be the result of 
a primordial separase gene having split on the evolutionary lineage leading to 
Drosophila. The Three Rows polypeptide is cleaved in anaphase, and its 
carboxy-terminal fragment is destabilised and disappears from cells. Even 
though this fragment does not contain the protease active site, a separase 
complex without it is inactive [47]. Three Rows cleavage thus causes 
inactivation of separase after anaphase onset.
1.8 Regulation of cohesin cleavage
1.8.1 Centromeric versus arm cohesion
Cohesin establishes sister chromatid connections during replication at 
both centromeres and discrete sites along chromosome arms, but appears to 
be enriched in the vicinity of centromeres [107-111]. Studies in S. pombe 
indicate that the enrichment of cohesin at centromeres results from the intrinsic 
ability of centromeric heterochromatin to recruit high levels of cohesin. The 
heterochromatin protein 1 (HP-1), Swi6, is specifically required for cohesion 
between sister centromeres but not along chromosome arms [49,112].
Recent findings in S.cerevisiae report that the RSC (remodels the structure of 
chromatin), an ATP-dependent chromatin remodeler [113, 114], instead is 
necessary for cohesin’s association with chromosomal arms but not with 
centromeric binding sites [115]. RSC’s association with chromosomal arms 
precedes the arrival of the core cohesin subunit Scc1 in late G1/S phase about 
15 min suggesting a role for RSC in the early stages of the multistep process of 
sister chromatid cohesion, including cohesion loading on chromosomes. 
Indeed, Scc1 fails to associate specifically with cohesin binding sites on
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chromosomal arms, but remains associated with centromeres in rsc mutants. 
Thus, unlike the Scc2/Scc4 loading factors, required for cohesin loading on both 
chromosomal arms and centromeres [50], or the heterochromatin proteins HP- 
1/Swi6, which recruits cohesin at centromeres but not arms [116, 117], RSC 
might be specifically needed for cohesin loading at chromosomal arms.
1.8.2 The prophase pathway
In higher eukaryotes, the bulk of cohesin dissociates from chromosomes 
during prophase, when chromosomes start to condense, and prometaphase, 
when they bi-orient on the mitotic spindle. This dissociation occurs at the 
chromosome arms and is thought to be independent of separase [51, 118] as it 
happens before separase activation, but appears to depend on the mitotic 
kinase Polo. Phosphorylation of arm cohesin by Polo facilitates its removal from 
chromosomes [119]. At the same time, a related complex, called condensin, 
binds to the axes of both chromatids and contributes to the mitosis specific 
chromosome compaction [49]. The fraction of cohesin that persists mainly on 
the centromeres of chromosomes until metaphase [106, 120] is responsible for 
holding sisters together while they bi-orient during prometaphase. This fraction 
is then targeted by separase whose cleavage of the cohesin complex triggers 
anaphase [35, 36].
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Chapter 2
The dual mechanism of separase regulation by securin
2.1 Securin is needed for a nuciear localisation as well as a full proteolytic 
activity of separase
Securin was initially characterised as a separase inhibitor that has to be 
degraded by the anaphase promoting complex to allow sister chromatids to 
separate in anaphase [26, 32, 33]. The inhibition of separase by securin could 
suggest that in cells lacking securin, separase is overly active, but this is not the 
case. Budding yeast and human cells lacking securin show compromised 
separase function [31, 103], and in fission yeast and Drosophila securin is 
essential for sister chromatid separation and therefore apparently for separase 
activity. The supportive role of securin for separase activity could be explained 
in two ways. Securin might be required in a chaperone-like function to ensure 
that separase adopts proteolytic activity [103]. Securin might also be required 
for a correct subcellular localisation of separase [34, 40].
2.1.1 Separase accumulates in the nucleus from G1 - t o  anaphase
To study the subcellular distribution of separase during the cell cycle in 
S.cerevisiae, I synchronised cells in G1 using alpha-factor and released cells 
synchronously in one cell cycle. Separase that has been endogenously tagged 
with the myc epitope tag showed a nuclear concentration in 50% of the cells in 
G1 (Fig.2.1). As soon as cells were released into S-phase the amount of cells 
with a positive nuclear separase signal increased to 80%. Approximately 60 
minutes after the release, cells had reached metaphase and had a nuclear 
concentration of separase in nearly 90% of the cells.
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Figure 2.1: Securin is required for separase nuclear accumulation
(A) Wild-type cells, Y455 (MATa, ESP1-myc18, PDS1-HA3, TetOs::URA3, TetR-GFP), 
and cells deleted for securin, Y291 (MATa, pdslA, ESP1-myc18, TetOs::URA3, TetR- 
G FP), were arrested in G1 by mating pheromone a-factor and released into a 
synchronous cycle. Cells were fixed and processed for in situ immunofluorescense 
against the myc epitope on separase using monoclonal antibody 9E10 and against the 
HA epitope on securin using monoclonal antibody 16B12 (Babco). DNA was visualised 
by staining with 4',6-diamidino-2-phenylindole (dapi). Cells at characteristic cell cycle 
stages are shown. (B) Quantification of the nuclear separase signal shown in A.
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The nuclear separase signal was strongest in metaphase and anaphase. 
Nuclear separase concentrations remained high until anaphase and slowly 
dropped when cells exited mitosis and went into the next cell cycle. Although a 
dotlike signal of separase was also visible in the cytoplasm throughout the cell 
cycle there is a clear nuclear concentration of separase that increased gradually 
from G1/S- to anaphase. This makes sense as separase is needed in anaphase 
to cleave the Scc1 subunit of the cohesin complex to release sister chromatids, 
allowing the cells to go into the next cell cycle.
2.1.2 The nuclear concentration of separase depends on securin
Securin inhibits the cleavage of the Scc1 subunit of the cohesin complex 
until anaphase onset where it is targeted for degradation by the APC. 
Interestingly, the promoter regions of securin and Scc1 are under the same 
control so that there is no substrate Scc1 produced without the appearance of 
the inhibitor securin. Securin is entirely nuclear right after its synthesis in S- 
phase until its destruction in metaphase. Hence there is no cell cycle 
accumulation like in the case of separase albeit high nuclear securin levels 
coincide with high nuclear separase levels.
To investigate if one possible positive function of securin on separase 
activity is to help separase to localise to its site of action, I followed the 
subcellular distribution of separase in cells that have been deleted for securin. 
Interestingly, these cells never showed a nuclear concentration of separase 
throughout the cell cycle. Instead the cytoplasm now appeared brighter, 
indicating a higher concentration of separase in this compartment (Fig.2.1 -A). 
Securin deleted cells appear bigger and sometimes misshaped compared to 
wild-type cells and they take approximately 20 minutes longer to go through one 
cell cycle. In order to have a better resolution of the nuclear region in cells 
deleted for securin, I performed a confocal microscopy analysis on wild-type 
cells and cells that have been deleted for securin. This confirmed a broad 
exclusion of separase from the nucleus (Fig.2.2) in securin deleted cells.
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Figure 2.2: Confocal analysis of separase in wild-type cells and cells deleted for 
securin
Wild-type cells, Y292 {MATa, ESP1-myc18, TetOs::URA3, TetR-GFP), and cells 
deleted for securin, Y291 {MATa, pdslA, ESP1-myc18, TetOs::URA3, TetR-GFP) were 
treated as described in Figure 1. Confocal microscopy was performed on a laser 
scanning confocal microscope LSM510 (Zeiss Co.)
These results strongly suggest that securin is indeed needed for the 
nuclear concentration of separase during the cell cycle. Although securin 
disappeared in anaphase and is absent in wild-type G1 cells, separase is still 
concentrated in the nuclei of some of these cells. It could be that separase 
leaves the nucleus rather slowly after securin is destroyed. In fact separase is 
active cleaving the cohesin complex from anaphase until next G1.
The cohesin subunit Scc1 is cleaved on time in budding yeast cells 
lacking securin [102], suggesting that a certain level of separase, sufficient to 
cleave Scc1, can reach the nucleus even in the absence of securin. To address 
this directly, I observed separase on chromatin spreads in which cytoplasmatic 
components of the cell are washed away [121, 122]. Separase was seen 
associated with metaphase chromatin in wild-type cells, and to a lesser but still 
significant extent, it was seen on spreads from metaphase cells lacking securin 
(Fig.2.3). Separase was no longer chromatin associated in anaphase. Instead, 
and as reported previously [31, 34], separase was visible at spindle poles and, 
in wild-type cells, also at the anaphase spindle. The association of a low level of 
separase with chromatin in the absence of securin indicates that separase can 
indeed enter the nucleus independently of securin.
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Figure 2.3: Separase associates at low levels to chromatin in securin deleted  
cells
Chromosome spreads of wild-type cells, Y292 (MATa, ESP1-myc18, TetOs::URA3, 
T e tR -G F P ), and cells deleted for securin, Y291 (MATa, pdslA, ESP1-myc18, 
TetOs::URA3, TetR-GFP), in metaphase and anaphase from a cell cycle experiment. 
Cells were arrested in G1 by mating pheromone a-factor and released into a 
synchronous cycle. Cells were fixed and processed for in situ immunofluorescense 
against the myc epitope on separase using monoclonal antibody 9E10. The cell cycle 
stage of individual chromosome spreads was confirmed by visualising sister 
chromatids close to centromere V by GFP.
2.1.3 Securin promotes separase nuclear accumulation independent of the cell 
cycle
Securin binds and inactivates separase at the end of G1-phase, but 
separase gradually accumulates in nuclei throughout G2, reaching maximum 
levels only in mitosis. This could mean that cell cycle-dependent events other 
than the presence of securin contribute to the nuclear accumulation of 
separase. To see if the replication phase was mandatory for separases’ nuclear 
accumulation, cells were arrested in S-phase using the replication inhibitor 
hydroxyurea. However, the nuclear concentration of separase was unchanged 
when DNA replication was blocked, compared to cells that had reached 
metaphase (Fig.2.4).
To investigate if high mitotic cyclin levels are needed for a proper nuclear 
concentration of separase, I used cells that are temperature sensitive for the 
mitotic cylins clb1-4 (clb1,3,4del, clb2ts) [123], arrested them in metaphase 
using the spindle depolymerising drug nocodazole and shifted them to 37°C to 
inactivate the cyclins. Separase nuclear accumulation was not altered after
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inactivating the mitotic cyclins compared to wild-type cells treated in the same 
way (Fig.2.5). Therefore cell cycle stages do not seem to have a major 
influence in the nuclear accumulation of separase.
HU-arrest noc-arrest
dapi
Esp1-myc
Figure 2.4: Separase accumulates in the nucleus independently of a completed  
replication cycle
Wild-type cells, Y292 {MATa, ESP1-myc18, TetOs::URA3, TetR-GFP), and cells 
deleted for securin, Y291 {MATa, pdslA, ESP1-myc18, TetOs::URA3, TetR-GFP), 
were arrested in S-phase using the replication inhibitor hydroxyurea and in M-phase 
using the microtubule depolymerising drug nocodazole. Cells were fixed and processed 
for in situ immunofluorescense against the myc epitope on separase using monoclonal 
antibody 9E10. DNA was visualised by staining with 4',6-diamidino-2-phenylindole 
(dapi). S- and M-phase arrested cells are shown.
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Figure 2.5: Separase accumulates in the nucleus independently of mitotic cyclins
Wild-type cells, Y292 {MATa, ESP1-myc18, TetOs::URA3, TetR-GFP) and cells that 
are temperature sensitive for the mitotic cyclins clb1-4, Y456 {MATa, ESP1-myc18, 
clb1A, clb3A, clb4A, c lb 2-ts) were arrested in metaphase using the spindle 
depolymerising drug nocodazole, then shifted to 37°C. Cells were fixed and processed 
for in situ immunofluorescense against the myc epitope on separase using monoclonal 
antibody 9E10. DNA was visualised by staining with 4',6-diamidino-2-phenylindole 
(dapi).
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Alternatively, the presence of securin might be sufficient to cause nuclear 
accumulation of separase, but it might be a relatively slow process or require an 
excess of securin over separase. In this case, even G1 cells should accumulate 
nuclear separase if securin is ectopically expressed. To test this, I arrested cells 
lacking securin stably in G1 by pheromone treatment and then induced 
expression of securin from the galactose-inducible GAL1 promoter (Fig.2.6) 
[26].
dapi Pds1 Esp1-myc
0 10 20 30 40 50 60 
time (min)
Figure 2.6: Securin is sufficient to cause nuclear accumulation of separase
Cells deleted for securin, Y576 {MATa, pdslA , ESP1-myc18, GAL1-PDS1mdb), were 
arrested in G1 using a-factor and expression of securin from the GAL1 promoter was 
induced by addition of 2% galactose to the culture. Complete arrest in G1 before and 
throughout the experiment was confirmed by FACS analysis. Securin was detected 
using antibody sc-9076 (Santa Cruz Biotech). Examples of cells before and 30 min 
after galactose addition are shown.
As soon as securin appeared in the nucleus, separase had redistributed 
and was also concentrated in the nucleus, reminiscent of cells in mitosis. This 
demonstrates that expression of securin in G1 is sufficient to cause nuclear 
accumulation of separase. Because levels of securin after expression from the 
GAL1 promoter were about 10-fold higher than endogenous levels in 
metaphase, an excess of securin might be sufficient to promote fast nuclear 
separase accumulation.
41
Chapter 2: Separase regulation by securin
2.1.4 Securin might concentrate separase in the nucleus by preventing 
separases’ nuclear export
Together, this suggests that separase can enter the nucleus 
independently of securin, but that the presence of securin is required and 
sufficient to cause nuclear concentration of separase.
One possible mechanism to explain this observation is that separase is in 
equilibrium of import and export from the nucleus. Securin, once present in the 
nucleus, could act to prevent nuclear export of separase thereby concentrating 
the protease in the nucleus. A search in the amino acid sequence of separase 
revealed a putative bipartite nuclear localisation sequence (NLS) 
RKAQNLALSLLKKKNK at amino acids 798-813 as well as several possible 
nuclear export sequences, Lx1-3Lx2-3LxL, for the major nuclear export receptor 
Crm1/Xpo1. The NLS was mutated at the lysins K809N, K810N and K811N to 
destroy the nuclear localisation signal. Separase mutated in these three lysins 
was still functional as it was able to cleave its substrate Scc1. The proteolytic 
activity of this separase mutant was measured incubating extract containing 
overexpressed mutant separase with chromatin-bound Scc1 [38].
NLS-mutated and wild-type separase were expressed from the inducible GAL1 
promoter in wild-type cells for 20 minutes and the nuclear separase signal was 
scored. No significant decrease in the nuclear concentration of the NLS mutated 
separase compared to wild-type separase was observed, indicating that the 
mutation of the putative NLS did not interfere with nuclear localisation of 
separase.
To investigate if securin achieves nuclear concentration of separase by 
blocking separases’ nuclear export through the Crm1/Xpo1 receptor, wild-type 
cells and cells deleted for securin were treated with leptomycin B, a drug that 
efficiently blocks nuclear export through the Crm1/Xpo1-receptor [124]. Cells 
deleted for securin did not show any nuclear concentration of separase after 
leptomycin B treatment (Fig.2.7).
I then used a temperature sensitive mutation of the Crm1/Xpo1 -receptor [124] 
and compared separases’ nuclear concentration in G1 arrested cells at the 
permissive (25°C) and the restrictive temperature (37°C). Inactivation of the 
Crm1/Xpo1 -receptor at 37°C, however, did not show any increase in the nuclear
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localisation of separase (data not shown). Therefore, securin causes nuclear 
concentration of separase by a mechanism different from preventing 
Crm1/Xpo1 -mediated nuclear export.
-LMB +LMB (15’) +LMB(30’) -LMB +LMB(15’) +LMB(30’)
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Figure 2.7: Nuclear retention of separase does not depend on the nuclear export 
receptor Crm1/Xpo1
Wild-type cells, Y292 {MATa, ESP1-myc18, TetOs::URA3, TetR-GFP), and cells 
deleted for securin, Y291 {MATa, pdslA, ESP1-myc18, TetOs::URA3, TetR-GFP), 
were treated with leptomycin B for 15 min and 30 min. Cells were fixed and processed 
for in situ immunofluorescense against the myc epitope on separase using monoclonal 
antibody 9E10. DNA was visualised by staining with 4',6-diamidino-2-phenylindole 
(dapi).
2.1.5 Securin supports full proteolytic activity of separase
In addition to its role in separase localisation securin might act in a 
chaperone-like function, possibly facilitating proper folding of the large separase 
polypeptide. This has been suggested for separase isolated from human cells 
lacking securin [103]. To address this directly in budding yeast, I measured the 
proteolytic activity of separase in wild-type and securin deleted cells that were 
both arrested in G1 by alpha factor treatment (Fig.2.8).
At this stage securin is absent from both cell types as it is degraded in 
anaphase and does not re-accumulate before the next S-phase. In contrast to 
securin deleted cells, separase in wild-type cells was previously bound to 
securin. I prepared extracts from both cells that contained comparable levels of 
separase. I then measured the protease activity of separase in both extracts by 
incubating them with saturating levels of Scc1 on a metaphase chromatin
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preparation [35]. Separase in wild-type cell extracts was at least two-fold more 
active in cleaving Scc1 as compared to separase from securin deleted cells.
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Figure 2.8: Securin helps separase to acquire its full proteolytic activity
Separase activity in wild-type, Y189 (MATa, ESP1-myc18), and securin deleted, Y543 
(MATa, pdslA, ESP1-myc18), cells was measured. Cells were arrested in metaphase 
(noc) or G1 (a-factor), extracts were prepared, and Scc1 cleavage activity was 
measured using chromatin from metaphase cells as a substrate.
This suggests that the initial binding to securin helps separase to acquire 
activity after securin is destroyed. The two-fold difference in separase activity is 
likely an underestimate. Western blotting revealed residual low levels of securin 
in the wild-type cell extract that may have partly inhibited separase and that 
might stem from minor impurities of non-G1 cells in the preparation.
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2.2 Mechanisms of separase inhibition through securin
While present in cells, securin is bound to separase [31, 34] and in crude 
in vitro systems this prevents separase from cleaving Scc1 [37, 38]. Whether 
securin is itself sufficient to inhibit separase, and by which mechanism securin 
prevents separase from attacking Scc1, was unknown. In particular, it was 
unclear how binding of securin to the separase N-terminus could influence the 
activity of the protease domain that is located at the protein's very C-terminus.
2.2.1 Securin is a protease inhibitor of separase
I therefore addressed the mechanism by which securin, while bound to 
separase, inhibits it from cleaving Scc1. Securin could directly inhibit the 
protease activity of separase, or other proteins might cooperate with securin in 
rendering or maintaining separase inactive. The laboratory had previously 
established the use of virtually pure separase and Scc1 for an in vitro assay to 
measure separases' proteolytic activity [38]. Separase was overexpressed in 
yeast and purified via a chitin binding domain on chitin beads. Scc1 was purified 
form baculovirus infected insect cells as well via a chitin binding domain on 
chitin beads. To see whether securin was sufficient to inhibit separase, I added 
purified securin to this reaction. The C-terminal half of securin is expected to 
bind to separase [30], so a fragment was designed spanning a C-terminal 
domain (amino acids 256-359) of securin/Pds1 fused to GST. This fragment 
was expressed in bacteria and purified by P.Knowles in collaboration with 
N.McDonald in the structural biology laboratory at Cancer Research UK 
(Fig.2.9-A). When this recombinant securin fragment was added to the 
separase assay, Scc1 cleavage was efficiently inhibited (Fig.2.9-B). In a control 
reaction GST alone did not inhibit separase (data not shown). This 
demonstrates that securin is indeed a protease inhibitor for separase.
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Figure 2.9: Securin inhibits separase proteolytic activity
(A) Preparation of the securin fragment (amino acids 256-359) used for the experiment. 
The fragment, fused to GST, was purified on glutathione sepharose. Numerous 
breakdown products of the fragment are present in the preparation. (B) Inhibition of 
separase cleavage of Scc1. For the cleavage assay separase was purified on chitin 
beads, and recombinant Scc1 was added as described [35], This reaction was 
performed with or without addition of the securin fragment.
Securin is thought to bind to the N-terminus of separase [30, 34] while 
the protease active site is situated close to its C-terminus [35]. Securin might 
therefore cause an allosteric change within separase that inactivates the 
protease active site or it might prevent substrates from binding to separase. To 
test the latter, I measured the binding of recombinant Scc1 to separase that was 
immobilised via a chitin binding domain-tag on chitin beads. I used a separase 
variant carrying an active site point mutation (H1531A, [35]) to prevent Scc1 
from being cleaved after binding. Figure 2.10 shows that Scc1 binding to 
separase was readily detected in this assay. When the inactivating securin 
fragment was incubated with the separase beads before adding Scc1, securin 
bound to separase and the binding of Scc1 was prevented. When separase was 
incubated with Scc1 first to allow binding, and then securin was added, Scc1 
was displaced by securin from separase (Fig.2.10). This indicates that securin 
binding to separase prevents the interaction of separase with its substrate, and 
that the interaction of securin with separase is likely to be stronger, or more 
stable than, the interaction with Scc1.
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Figure 2.10: Securin inhibits binding of Scc1 to separase
The catalytically inactive separase variant, H1505A, was purified from strain Y364 
(MATa, pep4A, GAL1-flag-ESP1 (H 1505A)-CBD ) on chitin beads and binding of 
recombinant Scc1 was analysed. Securin was added either before (1), or after (2), the 
incubation with Scc1.
I then analysed if securin had any effect on the binding of the protease 
inhibitor Bio-SVEQGR-amk to separase [35]. This inhibitor is a short biotinylated 
peptide spanning an Scc1-derived cleavage site motif linked to a reactive 
acyloxomethylketone (amk) group that covalently binds to and inhibits the 
separase active site cysteine residue. If securin prevents Scc1 binding to 
separase by occupying a substrate binding site at the separase N-terminus, the 
small peptide inhibitor might still gain access to the active site at the C-terminus. 
Separase was purified again on chitin beads, incubated with or without securin, 
and Bio-SVEQGR-amk was added (Fig.2.11-A). The inhibitor bound to 
separase, as detected by Western blotting against its biotin moiety, but binding 
was prevented by preincubation of separase with securin.
This indicates that securin does not only hinder access of the substrate 
protein Scc1, but also of a reactive cleavage site peptide. Peptide binding could 
be blocked if securin binds tightly into the separase active site groove. 
However, when the protease active site was occupied by Bio-SVEQGR-amk 
this did not perturb the subsequent interaction of securin with separase (Fig. 
2.11 -B). Indeed securin makes only a weak contact with the separase C- 
terminus (see below). Therefore securin might prevent binding of the cleavage 
site peptide to separase by an alternative mechanism, maybe by causing an 
allosteric change that distorts the active site.
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Figure 2.11: Securin inhibits the reaction of separase with a cleavage site 
binding peptide
(A) Separase was purified from strain Y334 (MATa, GAL1 -flag-ESP1 -CBD), and the 
binding of the peptide inhibitor Bio-SVEQGR-amk (amk) was measured with or without 
addition of securin. (B) Same as (A), but the binding of securin was measured after the 
addition of the peptide inhibitor Bio-SVEQGR-amk (amk).
2.2.2 Separases’ peptide recognition site is not essential for substrate binding
To better understand how separase recognises its cleavage substrates, I 
investigated whether the cleavage site motif is the only determinant that 
mediates interaction with separase. I made again use of the Bio-SVEQGR-amk 
peptide inhibitor of separase and asked whether separase in which the 
cleavage peptide recognition pocket was occupied with Bio-SVEQGR-amk was 
still able to interact with Scc1. As a comparison, the interaction of free separase 
with Scc1 was analysed. To prevent cleavage of Scc1 during binding to free
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separase, a catalytic inactive separase (C1531 A, [35]), in which the active site 
cysteine was mutated to alanine, was used (Fig. 1.12).
Both wild-type and C1531A separase were isolated after overexpression in 
yeast by chitin affinity purification. Wild-type separase was incubated with Bio- 
SVEQGR-amk, then recombinant Scc1 was added to test binding to the two 
different separase preparations. Proteolytically inactive C1531A separase 
without peptide inhibitor interacted with Scc1, as has been seen before [35]. 
Wild-type separase that had been incubated with the cleavage site peptide 
inhibitor bound Scc1 with indistinguishable efficiency. This suggests that 
separase makes contact with Scc1 that are independent of cleavage site 
peptide recognition. I confirmed that the peptide inhibitor was indeed bound to 
separase by Western blotting against the biotin moiety attached to the inhibitor 
N-terminus. No Scc1 cleavage was detectable after the incubation, which 
further confirmed that all wild-type separase was bound and inhibited by the 
peptide. I also added Scc1 to wild-type separase that had not been treated with 
the peptide inhibitor. As expected Scc1 was cleaved in this reaction, but now 
the C-terminal cleavage fragment interacted with separase. Since this fragment 
does not contain a cleavage site motif, this provides further evidence that 
contacts between separase and Scc1 exist that lie outside the cleavage site 
motif (Fig.2.12).
Together these results indicate that the catalytic dyad of separase, 
although essential for Scc1 cleavage, is not necessary for binding of the 
substrate to the protease.
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Figure 2.12: Interaction of separase with Scc1 occurs independently of cleavage 
site recognition
Wild-type or catalytically inactive (C1531A) separase, fused to a flag epitope and chitin 
binding domain (CBD), were purified after overexpression under the inducible GAL- 
promoter. Wild-type separase was incubated with or without the peptide inhibitor Bio- 
SVEQGR-amk. After the incubation, binding of recombinant Scc1, marked with an HA 
epitope tag, to the different separase preparations was analysed. A control binding 
reaction of Scc1 to beads after a mock purification is included. Scc1 bound to free 
catalytically inactive separase and to peptide-inhibited wild-type separase with 
comparable efficiency. A C-terminal cleavage product of Scc1, produced after 
incubation with uninhibited wild-type separase, also associated with separase.
2.2.3 Securin interacts with separase N-and C-termini
Because the protease active site is located at the separase C-terminus, I 
wanted to see which parts of separase directly interact with securin and thereby 
confer the inhibition. I constructed different N-terminal deletion mutants of 
separase that were overexpressed in yeast and purified on chitin beads as 
above (Fig.2.13). One of the constructs lacked only the first 155 amino acids 
from the N-terminus (156C), another construct comprised the conserved 
separase domain (1196C), a third construct only included the C-terminal half of
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the separase domain that is predicted to fold into the protease domain (1390C). 
When the inhibiting GST-securin fragment was added, it bound efficiently to full- 
length separase, but significantly less well to any of the deletion mutants 
(Fig.2.14-A). Thus, the very N-terminus of separase contributes to the inhibitory 
interaction with securin.
Because only a C-terminal part of securin was used in this binding assay, 
one could not exclude the possibility of additional contacts between securin and 
separase. I therefore co-expressed full-length securin and the different 
separase constructs in yeast and isolated complexes by binding of separase to 
chitin beads (Fig.2.14-B). Again, only full-length separase interacted efficiently 
with securin. But a weaker interaction of securin with separase was evident 
after the N-terminus was deleted. The efficiency of this interaction was similar 
when separase lacked only 155 N-terminal amino acids or when only the short 
C-terminal protease domain was expressed (Fig.2.14-B). This shows that while 
the separase N-terminus is necessary for securin binding, securin also makes 
contact with the C-terminal protease domain in separase.
HC * *
flag - Separase -CBD
1 1630
156'-------- --------------------- 1i 156C
1196i-----------------11196C
1390'---------11390C
Figure 2.13: Scheme of the separase N-terminal deletion mutants
The separase domain that shows conservation between all species is shaded. The 
residues histidine, H, and cysteine, C, that are predicted to form the catalytic dyad are 
marked with asterisks. The scheme is drawn to scale.
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Figure 2.14: Securin interacts with the N-terminus of separase
(A) The strains that expressed these deletion mutants were Y373 (MATa, GAL1-flag- 
ESP1 (156C)-CBD), Y367 (MATa, GAL1-flag-ESP1 (1196C)-CBD), and Y336 (M ATa, 
GAL1-flag-ESP1 (1390C)-CBD). Separase and the deletion mutants were purified on 
chitin beads, and binding of the securin fragment was analysed. (B) Separase and the 
deletion mutants together with full-length securin were co-overexpressed in yeast and 
their association was analysed after binding separase to chitin beads. Securin was 
detected using antibody sc-9076.
2.2.4 The separase N-terminus is required for protease activity
What role does the N-terminus play for the activity of separase and its 
inhibition by securin? To address this question, I now analysed the separase 
deletion mutants for protease activity against Scc1. After overexpression in
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yeast, only full-length separase was capable of cleaving Scc1 while removing 
the first 155 amino acids completely abolished its protease activity (Fig.2.15-A). 
This shows that the separase N-terminus plays an essential role in the 
proteolytic activity of the protein.
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Figure 2.15: The separase N-terminus is required for catalytic activity
(A) Separase and N-terminal deletion mutants were overexpressed in yeast, and 
separase activity in the extracts was measured using yeast chromatin as the substrate 
as described [35]. The arrows in the left panel indicate the migration of the individual 
separase fragments. (B) A catalytically inactive version of full-length separase and the 
deletion mutants together with Scc1 were co-overexpressed in yeast. Association of 
Scc1 with separase was measured after binding separase to chitin beads.
It might be that separase lacking the N-terminus can no longer interact 
with its substrate Scc1. Alternatively the N-terminus might be required for the C- 
terminus to adopt a proteolytically active conformation. To distinguish between 
these possibilities I first analysed the ability of the N-terminal separase deletion 
mutants to interact with Scc1 (Fig.2.15-B). All of the deletion mutants interacted
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with Scc1. Indeed the interaction was reproducibly enhanced when only the C- 
terminal protease domain of separase, 1390C, was expressed (Fig.2.15-B). 
This demonstrates that the separase N-terminus is not required for interaction 
with the substrate Scc1. N-terminal sequences might be even involved in 
loosening the protease substrate interaction to facilitate turnover of processed 
substrate.
I then analysed the binding of the peptide inhibitor Bio-SVEQGR-amk to 
the separase deletion mutants which all interacted with Scc1. If the protease 
domain is in an active state, one would expect the cleavage site peptide 
inhibitor to be able to bind to these fragments as well. Instead, while full-length 
separase efficiently bound the peptide inhibitor, binding was strongly reduced in 
any N-terminal deletion (Fig.2.16).
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Figure 2.16: The separase N-terminus is required for binding of the cleavage site 
peptide
Wild-type separase and separase deletion mutants were immobilised on chitin beads 
and incubated with the cleavage site peptide inhibitor Bio-SVEQGR-amk. Binding of 
the inhibitor was analysed by probing the Western blot against the biotin moiety of the 
inhibitor.
This shows that while the N-terminus is not required for overall interaction of 
separase with its substrate Scc1, it is required for the C-terminal protease active 
site to react with the peptide inhibitor. The separase N-terminus might be 
required to stabilise an active conformation of the protease active site. Only the
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active conformation would allow access of the cleavage site peptide to the 
active site groove or its attack by the active site cysteine residue. To achieve 
this, the N-terminus might have an allosteric effect on the active site. 
Alternatively, the N-terminus might become itself part of the active site.
2.2.5 Separase N- and C-termini bind each other
The dependence of separase activity on its own N-terminus predicts that 
separase N- and C-termini may interact. To test whether there might be a direct 
physical association, I co-overexpressed fragments from both ends of separase 
in yeast. The C-terminal fragments were purified via the attached chitin binding 
domain and association with the N-terminal fragments was analysed by 
Western blotting against the flag epitopes present on both fragments (Fig.2.17- 
A and B).
I first expressed the entire separase sequence in two parts, the C-terminal 
separase domain (1196C), together with the N-terminus (N1195). These two 
fragments of separase associated with each other in stoichiometric amounts, 
indicating a stable interaction between them (Fig.2.17-B, lane 3). The 
interaction was not diminished when only the shorter C-terminal protease 
domain, 1390C, was expressed (Fig.2.17-B, lane 4), indicating that the contact 
of the N-terminus may occur at the protease domain. When a shorter N-terminal 
fragment comprising residues 1-370 was expressed, this N370 fragment also 
interacted with the C-terminal separase domain, although with somewhat 
reduced efficiency (Fig.2.17-B, lane 5). Therefore, while N370 makes contact 
with the separase C-terminus, more central parts of the protein may also be 
involved.
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Figure 2.17: The N- and C-termini of separase interact with eachother
(A) Scheme of the separase fragments expressed in the experiment. The strains 
expressing these fragments were 1 Y538 {MATa, GAL1-flag-ESP1(N370)), 2 Y490 
{MATa, GAL1 -flag-ESP1 (N 1195)), 3 Y533 {MATa/MATa, GAL1-flag-ESP1(N1195), 
G A L1-flag -E S P 1 ( 1 196C )-C B D ), 4 Y532 {MATa/MATa, GAL1-flag-ESP1(N1195), 
GAL1-f!ag-ESP1(1390C)-CBD), 5 Y541 {MATa/MATa, GAL1-flag-ESP1(N370), GAL1- 
flag-ESP1 (1196C)-CBD), 6 Y561 {MATa/MATa, GAL1-flag-ESP1(N155), GAL1-flag- 
ESP1(1390C)-CBD). (B) Extracts from these strains were prepared and interactions 
between N- and C-terminal pairs were analysed after binding of the C-terminal 
fragments to chitin beads. The numbers correspond to the combinations of fragments 
as indicated in (A).
2.2.6 Securin disrupts the separase N/C-terminal interaction
How could the presence of securin influence the interaction between 
separases’ N- and C-termini? To address the question, I expressed 155 N- 
terminal amino acids (N155) together with the C-terminal protease domain 
(Fig.2.17-A, raw 6). Expression of the N155 fragment from the GAL1 promoter
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consistently yielded poor expression levels compared to other separase 
fragments. Nevertheless a clear interaction of this fragment with the C-terminal 
protease domain (Fig.2.18) was detectable. When securin was co­
overexpressed in the same cells, the interaction between the N155 fragment 
and the protease domain was markedly reduced. Instead, securin now bound to 
the protease domain. This indicates that securin is capable of displacing the 
separase N-terminus from the C-terminus. The low levels of N155 still bound to 
the separase domain in the presence of securin could mean that the 
displacement was not complete under the experimental conditions. Alternatively 
it might stem from a trimeric complex in which securin might bind separase N- 
and C-termini simultaneously. The recovery of a trimeric complex is expected to 
be poor because of the relatively weak interaction of securin with the separase 
C-terminus. This demonstrates that securin can interrupt interactions between 
the separase N- and C-terminus. Therefore securin has the potential to disrupt 
contacts within separase that may be crucial for the activation of the protease 
active site.
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Figure 2.18: The interaction between the separase N- and C-termini is disrupted 
by securin
As described in Figure 2.16, but securin was co-overexpressed in addition to the 
separase fragments using strain Y682 (M A T a /M A T a , GAL1-PDS1, GAL1-flag- 
ESP1 (N 155), GAL 1-flag-ESP1(1390C)-CBD).
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2.2.1 Separase activation is intramolecular
Securin could prevent separases’ proteolytic activity in two ways: either 
by preventing an intramolecular activating interaction between separases’ Isl­
and C-termini or by interfering with an intermolecular interaction of two 
separase polypeptides. To investigate if separase forms dimeric or multimeric 
complexes, I myc-epitope tagged endogenous separase and introduced in the 
same cell a further HA-epitope tagged separase copy under its endogenous 
promoter. As in budding yeast separase is active from anaphase throughout 
G1-phase, I arrested cells in G1 by pheromone treatment to follow a possible 
oligomerisation of separase during its proteolytic active phase. 
Immunoprecipitaion with either tag was performed, but did not lead to a pull 
down of the second separase polypeptide (Fig.2.19). This indicates that 
separase does not form dimers or multimers, but that it most likely activates 
itself via an intramolecular interaction between its N-and C-terminus.
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Figure 2.19: Separase activation is intramolecular
Extracts from strains Y1244 {MATa, ESP1-HA6), Y1316 {MATa, ESP1-myc18), Y1243 
{MATa, ESP1-myc18, Esp1 promoter-ESP1 -HA6) were prepared after alpha factor 
arrest and interactions between the two separase polypeptides were analysed after 
binding to protein A beads.
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Chapter 3
Differential cleavage of chromatin-bound and soluble cohesin
An aspect of cohesin cleavage that has so far received little attention is 
the apparent ability of separase to discriminate between cohesin bound to 
chromosomes and soluble cohesin inside cells in mitosis. In vertebrates a large 
fraction of cohesin is removed from chromosomes already in prophase by a 
mechanism that does not involve Scc1 cleavage [106, 125]. This 'prophase 
pathway' of cohesin removal is thought to facilitate individualisation and 
condensation of chromosome arms as cells enter mitosis. Only a relatively 
small fraction of cohesin is still bound to chromosomes in metaphase, providing 
crucial cohesion at centromeres and between condensed sister arms. At 
anaphase onset, only a similarly small fraction of the total cellular cohesin is 
cleaved by separase [106], and this fraction therefore most likely corresponds to 
still chromatin-bound cohesin. During fission yeast anaphase an equally small 
fraction of the cellular cohesin appears to be cleaved [71]. Targeted cleavage of 
only chromatin-bound cohesin would make the best use of separase activity to 
promptly separate sister chromatids at anaphase onset. Furthermore, in both 
fission yeast and vertebrates cohesin reassociates with chromosomes soon 
after anaphase. For this it may be important to maintain the soluble pool of 
cohesin intact and uncleaved during anaphase.
In budding yeast metaphase approximately two thirds of the total cohesin 
is bound to chromatin, while one third is found in a soluble cellular fraction [52, 
126]. In contrast to higher eukaryotes, budding yeast chromosomes condense 
only slightly in mitosis [127], which may allow a relatively large fraction of 
cohesin to remain chromatin-bound. Consistently, in anaphase the majority of, 
but not all, Scc1 is cleaved by separase [38]. It is not known whether budding 
yeast separase differentiates cleavage of chromosomal and soluble cohesin.
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3.1 Separase preferentially cleaves chromatin-bound Scc1 in vitro
3.1.1 Chromatin-bound Scc1 is cleaved faster than soluble Scc1
To address whether chromatin-bound budding yeast cohesin might be 
preferentially cleaved by separase over cohesin in the soluble cellular fraction, I 
established an in vitro assay to compare the cleavage rates of Scc1 in these 
two pools of cohesin. Chromatin and soluble fractions were prepared from two 
metaphase arrested cultures of budding yeast cells in which endogenous Scc1 
was fused to an HA- or myc-epitope tag, respectively. Chromatin and soluble 
fractions containing reciprocal Scc1 epitope tags were mixed. This resulted in 
two reactions, one containing chromatin bound Scc1-HA and soluble Scc1-myc, 
and one with chromatin bound Scc1-myc and soluble Scc1-HA (Fig. 3.1).
Scc1-HA Scc1-myc
30% Sucrose
soluble Scc1-myc soluble Scc1-H,
chromatin-bound Scc1-HA chromatin-bound Scc1-myc
|  + SeParase |
Reaction 1 Reaction 2
timecourse: 0, 1, 2, . . .  8 min
Figure 3.1: Experimental outline to compare the rates of Scc1 cleavage in 
chromatin-bound versus soluble cohesin
Whole cell extracts of nocodazole arrested cells were fractionated by centrifugation 
through a 30% sucrose cushion into chromatin-bound and soluble proteins. Chromatin 
and soluble fractions containing differentially tagged Scc1 were mixed and cell extract 
containing overexpressed separase was added. The two reciprocal reactions were 
incubated at 25°C and aliquots retrieved at 1 min intervals for analysis by quantitative 
Western blotting.
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Scc1 cleavage in the mixtures was induced by adding cell extracts containing 
overexpressed separase and placing the reactions at 25°C. Samples of the 
cleavage reaction were taken every minute to follow Scc1 cleavage. This 
allowed cleavage of chromatin-bound and soluble cohesin to be compared 
within one reaction, distinguished by their differential epitope tags.
The amount of remaining full-length Scc1 with either epitope tag at each 
time point was analysed by quantitative Western blotting (Fig.3.2). Scc1 
cleavage over time adhered closely to the characteristics of a first order 
reaction, consistent with a bimolecular reaction in which Scc1 is turned over by 
a constant concentration of separase (Fig.3.3).
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Figure 3.2: Scc1 in chromosomal cohesin is cleaved at faster rate than Scc1 in 
soluble cohesin
Western blot analysis of the two Scc1 cleavage reactions described in Figure 1. 
Reaction 1 compares cleavage of chromatin-bound Scc1-HA with soluble Scc1-myc, 
and reaction 2 compares cleavage of chromatin-bound Scc1-myc with soluble Scc1- 
HA. The strains were Y58 (MATa, SCC1-myc18), and K8869 (MATa, SCC1-HA6). 
Separase overexpression was in strain Y334 (MATa, GAL-flag-ESP1-CBD).
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Figure 3.3: Quantification of remaining full-length Scc1 in the chromatin-bound 
(cb) and soluble (sol) fraction over time
Bands on the Western blot in Figure 3.2 were quantified using an IRDye800 coupled 
secondary antibody and an Odyssey fluorescence scanner (LI-COR). The graph was 
fitted with a first order reaction (bold line), and the first order rate constant ki was 
derived.
Comparison of the derived first order rate constants for Scc1 cleavage in 
each reaction showed that chromatin-bound Scc1 was cleaved significantly 
faster than soluble Scc1. Chromatin-bound Scc1-HA was cleaved 6 times faster 
than soluble Scc1-myc, and chromatin-bound Scc1-myc was cleaved about 1.5 
times faster than soluble Scc1-HA. Therefore, in both reactions chromatin- 
bound cohesin was preferentially cleaved by separase. The discrepancy as to 
the extent of the difference was most likely caused by the differential epitope 
tags. When compared side by side, cleavage of Scc1-myc occured consistently 
at reduced rate compared to corresponding fractions containing Scc1-HA 
(Fig.3.4). This could be due to steric hindrance of cleavage by the myc epitope 
tag. Together this suggests that the chromatin context enables Scc1 to be 
cleaved faster as compared to Scc1 in soluble cohesin.
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Figure 3.4: Cleavage rates of HA and myc epitope-tagged Scc1 in direct comparison
Cleavage rates of chromatin-bound and soluble Scc1-HA and Scc1-myc were 
determined as in Figure 3.3, but the reactions compared either chromatin-bound Scc1- 
HA and chromatin-bound Sccl-myc, or soluble Scc1-HA and soluble Scc1-myc.
3.1.2 Preferred cleavage of chromatin-bound Scc1 is maintained after its 
solubilisation
The faster cleavage of chromosomal Scc1 could be due to preferential 
separase targeting by the chromatin environment. Alternatively, chromatin- 
bound cohesin may aquire a property that facilitates its cleavage independently 
of the chromosomal context. To distinguish between these possibilities, I 
solubilised cohesin from chromatin by DNase I treatment. After DNase I digest, 
no DNA was detectable in the solubilised fraction and the released cohesin was 
found in a complex indistinguishable in size from soluble cohesin (Fig.3.5, and 
[52]).
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Figure 3.5: Chromatin release of cohesin by DNase I digest
Fractions during the release of cohesin from chromatin were analysed by Western 
blotting against Scc1. Aliquots were analysed after phenol/chloroform extraction and 
RNase treatment by TAE/agarose gel electrophoresis, followed by staining with 
ethidium bromide, to visualise DNA. The starting chromatin-bound (cb) and soluble 
(sol) fractions are shown, as well as the remaining insoluble material after DNase I 
treatment (pel) and the released, soluble fraction after DNase I digest (rel).
The rate of cleavage of chromatin-released cohesin was analysed as in 
the above assay. I compared cleavage of chromatin-released HA-epitope 
tagged Scc1 with either chromatin-bound or soluble myc-epitope tagged Scc1. 
Chromatin-released Scc1-HA was still 4 times faster cleaved than Scc1-myc 
from the soluble cellular fraction. It was also somewhat faster cleaved than 
Scc1-myc in chromatin-bound cohesin, but the latter difference was not 
significantly different from the effect of the differential epitope tags (Fig.3.6-A). 
This suggests that chromatin-released cohesin is cleaved with similar rate to 
chromatin-bound cohesin. I also compared cleavage of chromatin-released 
myc-epitope tagged Scc1 with either chromatin-bound or soluble HA-epitope 
tagged Scc1. Chromatin-released Scc1-myc was now cleaved with similar rate 
as soluble Scc1-HA, and 2-fold slower than chromatin bound Scc1-HA (Fig.3.6- 
B). Taking into account that the myc epitope tag by itself slows cleavage, this is 
consistent with the idea that cohesin released from chromatin is still cleaved at 
a faster rate than cohesin found in the soluble cellular fraction.
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Figure 3.6: Scc1 in cohesin that was released from chromatin by DNase I 
treatment is cleaved at a similar rate to chromosomal Scc1
(A) Cleavage of chromatin-released Scc1-HA (rel) was compared in the same reaction 
with soluble (sol) or chromatin-bound (cb) Scc1-myc. (B) Cleavage of chromatin- 
released Scc1-myc was compared with soluble and chromatin-bound Scc1-HA.
The experiments so far compared cleavage of differentially epitope 
tagged Scc1 within the same reaction mix. While providing a direct internal 
comparison, this method suffered from the differential effect of the two epitope 
tags. Throughout our experiments, I found that cleavage rates between different 
reactions were highly reproducible, in particular when the source of separase 
were aliquots of the same separase-enriched cell extract (compare e.g. Fig.3.3 
and 3.6). I therefore compared the cleavage rates of chromatin-bound,
cb-myc
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time(min)
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chromatin-released, and soluble cohesin containing the same Scc1 epitope tag 
in parallel reactions. Figure 3.7 shows that both Scc1-HA and Scc1-myc in 
chromatin-released cohesin are cleaved 2.5 times faster than Scc1 with the 
same epitope tag in cohesin from the soluble cellular fraction. The cleavage of 
chromatin-released cohesin was comparable to chromatin-bound cohesin, but 
somewhat less efficient in the case of Sccl-myc. This suggests that the 
chromatin context may play some role in facilitating separase cleavage, but 
mainly that chromatin-bound cohesin has acquired an intrinsic property, maybe 
a post-translational modification, that allows its efficient cleavage even after 
chromatin-release.
-0.4-
-0.3-
- 0 . 1-
sol
sol
See 1-HA Scc1 -myc
Figure 3.7: Summary of rate constants obtained in parallel reactions for cleavage 
of Scc1 in chromosomal, chromatin-released, and soluble cohesin
Average rate constants are given together with error bars indicating the standard 
deviation (n=3 for chromatin-bound and soluble Scc1-HA and Scc1-myc, n=2 for 
chromatin-released Scc1)
3.2 The preferential cleavage of chromatin-bound Scc1 depends on its 
phosphorylation status
3.2.1 Chromatin-bound Scc1 is hyperphosphorylated compared to soluble Scc1
Phosphorylation of Scc1, dependent on Polo-like kinase, has been 
shown to contribute to its efficient cleavage [35, 102]. I therefore analysed
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whether chromatin-bound Scc1 may be preferentially phosphorylated. Most 
Scc1 from chromatin-bound cohesin in metaphase shows slow migration during 
electrophoresis, indicative of phosphorylation ([102] and Fig.3.10). In contrast, a 
significant fraction of Scc1 in soluble cohesin migrated faster, suggesting it was 
less phosphorylated (Fig.3.10, compare lane 1 and 4). It therefore appears that 
Scc1 in chromatin-bound cohesin is preferentially phosphorylated.
Mass spectroscopy has identified ten serine residues in Scc1 that can be 
directly phosphorylated by Polo ([102] and Fig.3.8). In order to address the role 
of Scc1 phosphorylation in preferential cleavage of chromatin-bound cohesin, I 
mutated these ten serines to alanine, individually and in combination. All mutant 
proteins were expressed under control of the endogenous SCC1 promoter and 
were able to complement for the deletion of the essential wild-type SCC1 gene. 
Individual mutations showed only a minor effect, but mutation of all 10 serines 
(10xS-*A) lead to a significant shift in electrophoretic mobility of Scc1 (Fig.3.9, 
Fig.3.10). A mutant changing two serines near the two separase cleavage sites 
was described before (S175,263A) [102], and showed an intermediate mobility 
pattern (Fig.3.10). Slower migrating bands, even though largely reduced, were 
still evident in the 10xS->A mutant Scc1. These were due to residual 
phosphorylation as they could be removed by phosphatase treatment 
(Fig.3.10). In all mutants, as with the wild-type protein, chromatin-bound Scc1 
showed a pattern of slower mobility as compared to soluble Scc1. This indicates 
that Scc1 is preferentially phosphorylated when bound to chromatin, and that 
phosphorylation can occur at over ten different sites within the protein.
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Figure 3.8: Schematic representation of the 10 known Polo phosphorylation sites 
in Scc1
The two separase cleavage sites are indicated by arrows.
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Figure 3.9: Effect of mutations replacing polo phosphorylated serines to alanines
Migration of Scc1 containing different serine to alanine mutations. Whole cell extracts 
from strains Y1287 (MATa, GAL-SCC1-myc18, SCC1promoter-SCC1-HA3), Y1296 
(MATa, GAL-SCC1 -mycl 8, SCC1promoter-SCC1 (S175,263A)-HA3), Y1633 (M ATa, 
GAL-SCC1 -m yc l8, SCC1promoter-SCC1 (S183,194,273,276,325A)-HA3), Y1634 
( M A T a ,  GAL-SCC1 -m yc l8, SCC1promoter-SCC1 (S374,389,497A)-HA3), Y1635 
( M AT a ,  GAL-SCC1 -m ycl8, SCC1promoter-SCC1 (S 183,194,,273,276,325,374,389, 
497A)-HA3) and Y1288 (MATa, GAL-SCC1-myc18, SCC1promoter-SCC1 (S175, 183, 
194, 263, 273,276, 325, 374, 389, 497A) -HA3) were analysed by Western blotting.
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Figure 3.10: Scc1 in chromatin-bound cohesin is hyperphosphorylated compared 
to Scc1 in soluble cohesin
Migration of chromatin-bound (cb) and soluble (sol) Scc1, and the effect of mutations 
replacing serines S175 and S263 (S175.263A), or all 10 potential phospho-serine 
residues to alanine (10xS->A). Chromatin-bound and soluble fractions of nocodazole 
arrested strains Y1287 (MATa, GAL-SCC1-myc18, SCC1 promoter-SCC1 -HA3), Y1296 
( M A T a ,  GAL-SCC1 -m yc l8, SCC1promoter-SCC1(S175,263A)-HA3), and Y1288  
(MATa,  GAL-SCC1-myc18 SCC1promoter-SCC1(S175,183,194,263,273,276,325,374, 
389,497A)-HA3) were analysed by Western blotting. Remaining slow migration of the 
chromatin-bound 10xS-»A mutant was resolved after treatment with X-phosphatase. 
An HA cross-reacting band in the soluble fractions is denoted by a star.
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3.2.2 The cleavage rate of chromatin-bound Scc1 is regulated by 
phosphorylation
To find out whether differential phosphorylation accounts for preferred 
cleavage of chromatin-bound cohesin, I compared the rates of cleavage of the 
phosphorylation site mutants. In two sets of experiments cleavage of wild-type, 
mutant, and phosphatase-treated wild-type cohesin was compared, either 
chromatin-bound or soluble. Scc1 was tagged with HA epitopes in all cases, 
and the rates of cleavage were determined in parallel reactions. Myc epitope- 
tagged wild-type Scc1 was included as an internal control in each reaction and 
was found cleaved at the same rate in each reaction (data not shown). Figure 
3.11 therefore directly compares cleavage of the HA-epitope tagged cohesin 
variants.
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Figure 3.11: Response of the Scc1 cleavage rate to phospho-site mutations and 
to dephosphorylation by X-phosphatase
Scc1-HA cleavage was analysed in parallel reactions using chromatin-bound or soluble 
cohesin preparations.
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The efficient cleavage of chromosomal Scc1-HA was reduced by 15% 
due to the S175.263A mutation, and was down by nearly half as a consequence 
of the 10xS->A mutation. The reduction in cleavage was most likely due to the 
absence of phosphorylation, rather than another adverse effect of the 
mutations, because phosphatase treatment of wild-type chromosomal cohesin 
also caused a drastic reduction of cleavage. After phosphatase treatment, 
cleavage was a further two-fold slower than cleavage of the 10xS-»A mutant. 
This is consistent with the possibility that remaining phosphorylation even on 
the 10xS-»A mutant facilitates cleavage to some degree.
Scc1 in soluble wild-type cohesin was cleaved at a rate comparable to 
the chromatin bound 10xS-*A mutant, and any phosphorylation site mutations 
reduced cleavage to rates similar of phosphatase treated cohesin (Fig.3.11). 
Together, these results suggest that the phosphorylation status of Scc1 is an 
important determinant of its rate of cleavage, and that the higher 
phosphorylation levels of Scc1 in chromatin-bound cohesin might be 
responsible for its faster cleavage.
3.2.3 Hyperphosphorylation of soluble Scc1 increases its cleavage
If the difference in the rate of cleavage was indeed due to preferential 
phosphorylation of chromatin-bound Scc1 over soluble Scc1, then enhancing 
Polo phosphorylation of soluble Scc1 should make it a likewise susceptible 
cleavage target. To test this I used cells in which, in addition to endogenous 
Polo, levels of the kinase could be increased under control of the galactose- 
inducible GAL promoter. One hour after Polo induction in metaphase arrested 
cells, the migration of soluble Scc1 had changed to a pattern similar to 
chromatin-bound Scc1, indicating increased phosphorylation (Fig.3.12-A). I then 
compared the cleavage rates of soluble and chromatin bound Scc1 before and 
after Polo induction. Scc1 was again tagged with HA epitopes, and cleavage 
rates were obtained in parallel reactions. Similar cleavage rates of Scc1-myc, 
contained in the reactions as internal standard, confirmed that separase activity 
was the same in all reactions. Cleavage of soluble cohesin was 2.5 times
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accelerated after Polo induction, reaching 80% of the rate of chromatin-bound 
cohesin (Fig.3.12-B).
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Figure 3.12: Phosphorylation of soluble Scc1 by overexpressed Polo makes its 
cleavage comparable to chromatin-bound Scc1
(A) Hyperphosphorylation of soluble Scc1 in strain Y1585 {MATa, SCC1-HA3, GAL- 
CDC5) after induction of Polo (encoded by CDC5) in metaphase arrested cells. (B) 
Soluble and chromatin-bound cohesin was prepared 1 hour after Polo induction, and its 
cleavage was compared to soluble and chromatin-bound cohesin from uninduced cells.
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The cleavage rate of chromatin-bound cohesin increased only 
marginally, in keeping with its pattern of phosphorylation that did not noticeably 
change after Polo induction. This suggests that the relative under­
phosphorylation of soluble cohesin is limiting its rate of cleavage. It also 
suggests that Polo phosphorylation of chromosomal cohesin is close to its 
maximum possible level in metaphase cells, thus facilitating its fast cleavage
3.2.4 Scc1 phosphorylation enhances both recognition and cleavage by 
separase
I next addressed the mechanism responsible for preferential separase 
cleavage of phosphorylated Scc1. Separase might show enhanced affinity for 
phosphorylated Scc1, or phosphorylation might in another way facilitate the 
cleavage reaction. To investigate these possibilities, I first measured cleavage 
of recombinant phosphorylated Scc1 by purified separase. Recombinant Scc1 
can be isolated in a mitotically phosphorylated form after overexpression in 
insect cells that have been treated with the phosphatase inhibitor okadaic acid 
[35]. I compared cleavage of mitotically phosphorylated recombinant Scc1 to 
cleavage of the same protein after dephosphorylation with lambda 
phosphatase. Separase was purified from yeast via chitin affinity 
chromatography [41]. Saturating amounts of Scc1 were added to the reaction, 
and quantitative Western blotting revealed that after 10 minutes at 25°C, 
separase had cleaved 8 times more mitotically phosphorylated Scc1 as 
compared to phosphatase treated Scc1. The difference was due to the 
phosphorylation status of Scc1, rather than an effect of the phosphatase on 
separase activity, because preincubation of separase with lambda phosphatase 
did not change its activity (Fig.3.13-A). This result is consistent with previous 
qualitative experiments that demonstrated a requirement of okadaic acid- 
induced or Polo-mediated phosphorylation for cleavage of recombinant Scc1 
[35, 102].
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Figure 3.13: Fast cleavage of recombinant, phosphorylated Scc1 is not due to 
higher affinity for separase
(A) Phosphorylated recombinant Scc1 (Scc1-P) is cleaved faster than phosphatase- 
treated Scc1 (Scc1). Recombinant Scc1 was incubated with separase, purified by chitin 
affinity chromatography from strain Y334. Cleavage was analysed by quantitative 
Western blotting and relative amounts of the cleavage product in each reaction is 
given. In one reaction, separase was phosphatase treated, denoted by *, before 
incubation with Scc1. (B) Separase binding to Scc1. Phosphorylated and phosphatase- 
treated recombinant Scc1 was bound to catalytically inactive separase (C1531A) that 
was affinity purified on chitin beads. Bound protein was analysed by quantitative 
Western blotting, binding is indicated relative to the respective input. A reaction in 
which separase was phosphatase treated is also included, denoted by *.
To analyse whether separase has a higher binding affinity for 
phosphorylated versus unphosphorylated Scc1, I repeated the experiment, but 
this time purified a proteolytically inactive separase protein containing a point 
mutation in the active site cysteine residue (C1531A). This prevented Scc1 
cleavage in the reaction and thus enabled the examination of substrate binding.
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C1531A mutated separase was bound to chitin beads, similar amounts of 
mitotically phosphorylated or phosphatase treated recombinant Scc1 were 
added, and bound Scc1 quantified. Both phosphorylated and phosphatase 
treated Scc1 associated with separase, but 1.8 times more phosphorylated 
Scc1 was recovered (Fig.3.13-B).
This indicates that separase possesses higher affinity for 
phosphorylated Scc1. However, discrimination against binding to 
unphosphorylated Scc1 did not appear large enough to explain the 8-fold 
difference in the efficiency of cleavage. Scc1 phosphorylation, in addition to 
increasing affinity to separase, might therefore facilitate cleavage more directly, 
maybe by providing substrate induced catalysis.
3.3 Phosphorylation-dependent preferential cleavage of chromatin-bound 
Scc1 in vivo is important for chromosomal stability
3.3.1 In vivo chromatin-bound Scc1 is preferentially cleaved depending on its 
phosphorylation
The above data show that chromatin-bound cohesin is preferentially 
cleaved over soluble cohesin by separase in vitro, and that Scc1 
phosphorylation is likely to play a role in determining this difference. I next 
addressed whether preferred cleavage of chromatin-bound cohesin would take 
place during budding yeast anaphase in vivo. I arrested cells in metaphase by 
depletion of the APC activator Cdc20 under control of the galactose inducible 
GAL promoter, and released cells into synchronous anaphase by reinduction of 
Cdc20 [38]. Anaphase at the normal growth temperature of 25°C occurs very 
rapidly, therefore release was performed at 16°C to slow mitotic progression 
and facilitate analysis. Samples were taken every 5 minutes, soluble and 
chromatin-bound fractions separated, and levels of remaining full-length Scc1 
over time were analysed by quantitative Western blotting. Full-length Scc1 
started to disappear from the chromatin fraction 15 min after release into 
anaphase, but a reduction in the soluble fraction only became obvious after 25 
min (Fig.3.14). Therefore chromatin-bound cohesin appears to be preferentially
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cleaved during budding yeast anaphase. This may aid the rapid resolution of 
sister chromatid cohesion at anaphase onset.
To investigate whether preferred cleavage of chromosomal cohesin in 
vivo depended on its phosphorylation, I repeated the experiment with a strain 
containing the Scc1 10xS^A mutant as the sole source of Scc1. Cleavage of 
chromatin-bound cohesin was now delayed until 25 minutes after release into 
anaphase, and both chromatin-bound and soluble full-length Scc1 disappeared 
with similar kinetics. This suggests that the preferential cleavage of chromatin- 
bound cohesin in vivo depends on its phosphorylation.
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Figure 3.14: Phosphorylation accelerates cleavage of chromosomal Scc1 in vivo
Faster cleavage of chromatin-bound Scc1 in vivo depends on phospho-serine residues. 
Strains Y1447 [MATa,  GAL-CDC20, PDS1-myc18, SCC1 promoter-SCC1 -HA3) and 
Y1449 {MATa, GAL-CDC20, PDS1-myc18, SCC1promoter-SCC1(S175,183,194,263, 
273,276,325,374,389,497A)-HA3) were arrested in metaphase by depleting Cdc20 and 
released into synchronous anaphase at 16°C. Soluble and chromatin-bound Scc1 was 
separated in samples taken at the indicated time points, and full-length Scc1 quantified. 
Note that cleaved cohesin is released from chromatin, thus the Scc1 cleavage product 
in the soluble fraction originates partly from chromatin.
75
Chapter 3: Regulation of cohesin cleavage
I also analysed whether the subcellular distribution of separase could 
help the preferential cleavage of chromatin-bound versus soluble cohesin. 
Approximately two thirds of separase was found in the soluble cellular fraction 
and one third was chromatin-associated (Fig.3.15). Therefore, a pool of 
separase exists on chromatin, but in contrast to cohesin most separase is found 
in the soluble cellular fraction.
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Figure 3.15: Separase distribution between soluble and chromatin-bound 
fractions
Strain Y1215 {MATa,  GAL-CDC20, ESP1-myc18, SCC1-HA6) was arrested in 
metaphase by depletion of Cdc20 (time point 0), and released into synchronous 
anaphase at 16°C (compare Fig.3.14). Chromatin and soluble fractions were prepared 
at the indicated times, and levels of separase were compared by quantitative Western 
blotting against the myc epitope tag fused to separase. Note that twice the comparable 
amount of the soluble fraction has been loaded on the blot shown above, but that the 
levels have been normalised to the same cell equivalent in the quantification below.
3.3.2 Delayed cleavage of chromatin-bound cohesin slows anaphase 
progression and causes chromosomal instability
Does delayed cleavage of chromatin-bound cohesin due to the Scc1 
10xS-^A mutation has consequences for the faithful progression of mitosis?
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Previously, the Scc1 S175,263A mutation has been shown to cause lethality 
and delay cohesin cleavage by about 30 minutes in cells lacking securin [102], 
a situation in which separase is mislocalised and shows reduced activity [41]. 
The Scc1 10xS->A mutation introduced a 10 minutes delay to cleavage of 
chromatin-bound cohesin in wild-type cells progressing through anaphase at 
16°C. When analysing chromosome segregation in these cells, compared to 
cells containing wild-type Scc1, I found a corresponding delay in the 
dissociation of cohesin from chromosomes, and of anaphase spindle elongation 
(Fig.3.16). The time difference was small, but reproducible. I confirmed that 
separase activation occurred at the exact same time in both strains as judged 
from the disappearance of nuclear securin.
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Figure 3.16: 10xS-*A mutant Scc1 dissociates from chromatin later and delays 
elongation of the anaphase spindle
As in Figure 3.14, but degradation of securin and spindle elongation were analysed by 
indirect immunofluorescence, and Scc1 binding to chromatin was visualised on 
chromosome spreads.
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Cells containing Scc1 10xS-*A as the sole source of Scc1 were viable 
and, apart from a delay, anaphase progression appeared normal. To more 
rigorously test the effect of this mutation on chromosome segregation, I 
analysed the rate of chromosome loss using a sensitive colony sectoring assay 
[128]. This assay indicated that a marker chromosome was lost with twice the 
frequency of that observed in wild-type strains, suggesting that efficient 
cleavage of chromatin-bound cohesin at anaphase onset is important for faithful 
chromosome segregation (Fig.3.17).
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Figure 3.17:10xS-*A mutant Scc1 confers increased chromosome loss
Strains Y1305 (MATa, CFIII (CEN3.L.YPH278), URASUP11, SCC1promoter-SCC1- 
HA3) and Y1306 (MATa, CFIII (CEN3.L.YPH278), URASUP11, SCC1promoter-SCC1- 
S175,183,194,263,273,276,325,374,389,497A)-HA3) were grown in medium lacking 
uracil to maintain a marker chromosome, and plated on rich medium. Half red sectored 
colonies were counted, indicative of chromosome loss in the first division after plating. 
Chromosome loss in the strain containing 10xS->A Scc1 is greater than in wild-type 
with a confidence level greater than 93.75%.
3.4 Polo kinase co-localises with Scc1 on chromatin
The finding that Scc1 is higher phosphorylated when bound to 
chromosomes offers a plausible explanation for why chromatin-bound cohesin 
is preferentially cleaved by separase. But how is chromatin-bound Scc1 
preferentially phosphorylated in a Polo-dependent manner? To address this, I 
analysed whether Polo may co-localise with cohesin on chromosomes. In a 
subcellular fractionation experiment, a significant part of Polo, close to half of 
the total cellular pool, was found associated with a Triton-insoluble chromatin 
fraction (Fig.3.18-A).
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Figure 3.18: Chromatin provides a Polo-rich environment
(A) Polo in the chromatin-bound fraction. Whole extract (we), chromosomal (cb), and 
soluble (sol) cellular fractions were prepared from strain Y1570 {MATa, SCC1-HA6, 
CDC5-myc18), Scc1 and Polo were detected by Western blotting. (B) Polo associates 
with chromatin independently of cohesin. Scc1 was depleted from strain Y1571 {MATa, 
GAL-SCC1-myc18, CDC5-HA6) and cells arrested in metaphase by nocodazole 
treatment. Chromatin binding of Scc1 and Polo were analysed by chromosome 
spreading, and levels of both proteins in soluble and chromatin-bound fractions 
confirmed by Western blotting. (C) Cohesin binds chromatin independently of Polo. 
Cells were arrested by nocodazole treatment after depletion of Polo in strain Y8646 
{MATa, GAL-CDC5, SCC1-HA6). Polo depletion was confirmed by the fast mobility of 
hypophosphorylated Scc1. Cohesin binding to chromosomes was analysed by 
chromosome spreading and cellular fractionation.
The chromosome association of Polo could be confirmed by 
immunostaining on mitotic chromosome spreads. Interestingly, the staining of
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Polo on mitotic chromosomes overlapped the staining of cohesin (Fig.3.18-B). 
Both proteins were enriched in two foci that most likely correspond to the two 
clusters of centromeres in mitosis where cohesin is known to accumulate [108]. 
Polo may associate with chromosomes as a consequence of binding and 
phosphorylating cohesin. If this was the case, chromosomal cohesin would not 
be in any advantage over soluble cellular cohesin with which the soluble pool of 
Polo could likewise associate. I therefore tested whether binding of Polo to 
chromosomes depended on cohesin. Scc1 was depleted from cells under 
control of the repressible GAL promoter, conditions under which none of 
cohesin's subunits binds to chromatin [52, 126], but the amount and pattern of 
Polo association with mitotic chromosomes was unaltered (Fig.3.18-B). This 
suggests that Polo binds chromosomes independently of cohesin. I also tested 
whether cohesin binding to chromatin depended on Polo. After Polo-depletion 
under control of the repressed GAL promoter, the phosphorylation-dependent 
mobility shift in Scc1 was abolished, but the levels of chromatin-bound Scc1 
remained unchanged (Fig.3.18-C). Therefore Polo and cohesin bind to 
chromosomes in a similar pattern, but independently from each other. The pool 
of chromosomal Polo may thus provide an environment for preferential 
phosphorylation of cohesin that binds within its vicinity.
80
Chapter 4: Discussion
Chapter 4
Discussion
4.1 Separase regulation by securin in the yeast Saccharomyces cerevisiae
4.1.1 Securin is a positive regulator of separase
The first interaction studies between separase and securin have been 
performed in the yeast Schizosaccharomyces pombe [30]. In this organism, 
complex formation between Cut1/separase and Cut2/securin is needed for the 
loading of Cut1/separase to the spindle in prophase. After securin degradation 
in metaphase, central and C-terminal regions of Cut1 are needed for its 
association with the anaphase spindle and the spindle pole bodies [40]. While I 
performed these studies, a securin dependent nuclear localisation and spindle 
association of separase has been shown in budding yeast using over­
expressed GFP-tagged Esp1 [34]. The here presented study addressed the 
nuclear localisation of Esp1 under more natural conditions by virtue of myc 
epitopes that were added to the genomic copy of the ESP1  gene. This 
confirmed a dependency of separase nuclear localisation on securin. It also 
shows a separase concentration on the anaphase spindle, mainly the spindle 
midzone and the spindle pole bodies. Interestingly, securin deletion mutants still 
show a reduced chromatin and spindle association of separase in metaphase. 
In anaphase, this association is limited to the spindle pole region. The 
association of low levels of separase with chromatin and the mitotic spindle in 
the absence of securin indicates that separase can enter the nucleus 
independently of securin, consistent with the fact that securin deleted budding 
yeast cells are viable. Monitoring the nuclear localisation of separase and 
securin during one cell cycle revealed a 20-minute delay of separases’ nuclear 
accumulation compared to securin. The above observations led to the model 
that separase can enter the nucleus independently of securin but that securin
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helps separase to accumulate in the nucleus by preventing its nuclear export, 
possibly by blocking nuclear export sequences within separase. As blocking the 
nuclear export receptor Crm1/Xpo1 does not prevent separase from leaving the 
nucleus, these export sequences might be recognised by a mechanism different 
from the Crm1/Xpo1-mediated nuclear export.
4.1.2 Securin is a direct inhibitor of separase
I analysed the functional relationship between securin and separase, by 
producing a series of deletion mutants of both proteins. The analysis of 
separase and securin domains and their interactions shows interesting features. 
It revealed that securin is a direct inhibitor of separase protease activity. 
Interestingly, a C-terminal fragment of securin spanning aminoacids 256 to 359 
out of the total 373 aminoacids is sufficient to bind and inhibit separases’ 
proteolytic activity. This is in line with studies in fission yeast that show that the 
C-terminus of Cut2/securin is necessary for binding to separase [40] and 
studies in Drosophila that show that the C-terminal residues 115-199 out of 199 
aminoacids are sufficient for binding to THR, the N-terminal domain of separase 
[39]. N-terminal regions of securin contain the destruction boxes needed for the 
cell cycle regulated degradation of securin [32,129].
Studies in fission yeast also showed that the first 300 aminoacids out of 
the 1828 aminoacid long Cut1/separase polypeptide are sufficient for an 
interaction with securin [40]. Deletion analysis of separase in this study revealed 
that the first 156 aminoacids of Esp1/separase are necessary for a tight 
interaction with the C-terminus of securin. However full-length Pds1/securin is 
able to interact with C-terminal regions of separase although this interaction is 
much weaker (aa1390-1630). Similarly, in fission yeast more central regions of 
securin (aa128-161) are needed for an interaction with separase [30].
If securin binds tightly to the N-terminus of separase, how can it 
efficiently inhibit the proteolytic activity located at the very C-terminus of the 
protein separated by over 1500 aminoacids? The presented results suggest that 
securin competes with Scc1 for binding to separase. The definition of a 
competitive inhibitor is that it interferes with substrate binding. This study clearly
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shows that securin not only hinders binding of the substrate Scc1, but that it is 
also able to displace separase-bound Scc1, indicative for a competitive 
inhibition. However a competitive inhibitor usually competes for the active site. 
This was puzzling as the active site is located at separases’ C-terminus and 
although Scc1 has a strong binding affinity for this C-terminal region, securin’s 
strongest affinity is the very N-terminus of separase. In addition, Scci binding 
happens outside the catalytic side and more N-terminal regions of separase 
seem to influence the binding of the substrate, weakening the interaction and 
thereby possibly increasing the turnover of the substrate.
Allosteric inhibitors inhibit enzymes by acting on a site different 
(allosteric) from the substrate binding site. Interestingly, securin, by binding to 
the N-terminus of separase, can prevent binding of the small peptide inhibitor 
that recognises the active site, indicating an allosteric effect of securin on 
separases’ catalytic site. However, it cannot be excluded that securin hinders 
the binding of the small peptide inhibitor by preventing access to the active site. 
Indeed, and as discussed above, securin is also able to interact with the C- 
terminus of separase, although much less efficiently.
A possible answer to this puzzle came through the observation that the 
N-terminus of separase itself is necessary for its proteolytic activity. An N- 
terminal deletion of the first 156 aminoacids of separase is unable to bind the 
small peptide inhibitor, suggesting that these aminoacids are needed to 
establish the correct configuration of the active site of separase. Securin could 
therefore act in the following way: it competes with Scc1 for binding to separase 
and in the same time interferes with an activating interaction between 
separases’ N-and C-termini (Fig.4.1). Indeed N- and C-terminal fragments of 
separase do interact when co-expressed.
Co-expression of securin with short N-and C-terminal fragments of 
separase lead to the formation of a trimeric complex with securin in the centre 
further sustaining the idea that securin interferes with an activating interaction 
between the N- an the C-terminus of separase. This model also offers a 
possible explanation for securin’s proposed chaperone function. By bridging 
separases’ N-and C-termini, which are separated from each other by over 1500 
aminoacids, securin might bring them in juxtaposition, preparing them for 
interaction upon securin destruction (Fig.4.1).
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Figure 4.1: Model of separase and its inhibition by securin
Securin binds to both separase N- and C-terminus. Thereby securin may separate 
these two parts of the protein, acting as a molecular wedge. After securin degradation 
via ubiquitylation by the anaphase promoting complex (APC) the separase N-terminus 
is free to interact with the protein's C-terminus. Securin might promote the interaction 
by pre-positioning the separase termini. The interaction within separase might induce 
an activating conformational change at the protease active site at the separase C- 
terminus. Securin, while bound to separase, also prevents access of Scc1 to separase.
The above observations also go some way in explaining why separases 
are such large proteins. Sequences very close to the N-terminus of the protein 
are required for protease activity at the protein's C-terminus. What about the 
sequences in between? The co-expressed fragments from the N- and C-termini 
of separase efficiently formed complexes, but were unable to reconstitute 
protease activity. This indicates that the intactness of the middle portion of 
separase is also important for the function of the protease. Consistent with this, 
when 10 temperature sensitive alleles of the fission yeast separase Cut1 were 
sequenced, 8 were found to encode single amino acid changes in the middle of 
the protein [30]. Therefore this region might also contribute to the proteolytic 
activity of separase.
The presented model would predict a possible binding competition of 
securin and the C-terminus of separase to N-terminal regions of separase. 
Interestingly, a search for sequence homologies between Pds1 /securin and 
separases from different species revealed the following Prosite profile: N-
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X(15,16)-{RK}-{IL}-X(8,10)-R-L-P-L-X(12,14)-F-X(15)-{QE}. This consensus 
sequence located in the C-terminal half of separase, is also present in budding 
yeast securin and is conserved in the phylogenetic group of the different fungi 
S.cerevisiae, S.pombe, C.albicans and E.nidulans (Fig.4.2).
E.nidulans 
S.cerevisiae 
C.albicans 
S.pombe 
S.cerevisiae 
consensus
E.nidulans 
S.cerevisiae 
C.albicans 
S.pombe 
S.cerevisiae 
consensus
NVLSLSLSADRAEFWSRLHRG-CSPFLLRLPLRRGNSE 
NVITIDFCPITGNLLLSKLEPRRKRRTHLRLPLIRSNSR 
.LVTLDICQNTGDLLISKLTKGSPNPIFMRLPLLRFPS. 
NWSITINNSGEDLFISKIRKG. HSPLIFRLPLORHNSR 
N ..TLKYIQGGKEVSPTKRLHT.HAQQQGRLPLAAKDNN
DEE.EQFTFEDGRDEMKEL.IRLANE (Separase) 
DLDEVHLSFPEATKKLLSI.INESNQ (Separase)
 SLGFQQLMQNFEKI.IDDSN. (Separase)
DADEEILVFTKAQTELFRI.ISKSNQ (Separase) 
RSK..SFIFPETSNQSKDADLPQL.Q (Securin)
Figure 4.2: The C-terminus of separase and the N-terminus of securin share a 
specific profile
The C-terminal regions of separases from the fungi S.cerevisiae (aa1167-1230), 
S.pombe (aa1375-1437), C.albicans (aa1095-1138) and E.nidulans (aa1601-1662) 
share the following common sequence profile with budding yeast securin (aa59-117): 
N-X(15,16)-{RK}-{IL}-X(8,10)-R-L-P-L-X(12,14)-F-X(15)-{QE}.
Given the poor overall sequence homology between separase and 
securin molecules of different species, this alignment could indeed reinforce the 
model of a trimeric complex. As the consensus sequence in securin is located in 
the N-terminal half, the C-terminus of securin could be, like in fission yeast, 
necessary but not sufficient for the interaction with separase. Also, in 
Drosophila a mutational analysis of aminoacids located in PIM/securin revealed 
two mutations at the very N-terminus of the protein that were able to abolish the 
interaction with THR, the N-terminal domain of separase [46]. Although in their 
analysis most mutations affecting this interaction were located in the C-terminus 
of securin, the PIM-THR interaction appears to be less dependent on defined 
residues. Altogether, it is likely that securin form multiple interactions with 
separase, the N-terminus being the strongest.
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Securin prevents separases’ proteolytic activity by preventing an 
intramolecular activating interaction between separases’ N- and C-termini. This 
is in contrast to other members of the CD clan of proteins, the caspases. The 
initiator caspases 8 and 9 both need to form dimers in order to be active [130]. 
Dimer formation is achieved by a process of induced proximity and mediated by 
adaptor molecules like Apaf-1 in the apoptosome or FADD in the DISC (death 
inducing signaling complex). In both cases the interaction of the prodomains of 
the caspases with an oligomerised adaptor molecule increases the local 
caspase concentration and induces the activation of the protease.
Will this model of separase inhibition and activation also be applicable to 
other organisms? N-terminal regions within PIM/securin (aa 88-114) are 
particularly important for binding with SSE, the separase domain containing the 
catalytic site. Additionally, the THR protein in Drosophila is required for 
separase activity [39]. The pattern of interactions of THR with separase and the 
Drosophila securin PIM is reminiscent of the interactions of the budding yeast 
separase N-terminus with its catalytic C-terminus and securin [39]. Therefore 
the presented results on the activation of separase's protease activity and its 
inhibition by securin might be applicable to Drosophila as well, supporting a 
model in which THR activates separase by an interaction that is prevented by 
PIM (Fig.4.3) [39].
Xenopus and human securin must be degraded for separase activation 
[33, 106] and human securin promotes inhibition of human separase in vitro 
[37]. A distinct feature of human separase is that, after its activation by securin 
degradation, separase cleaves itself into two halves at a position upstream of 
separases’ active site [37]. Processed separase is still active to cleave cohesin. 
Consistent with the idea that the N-terminus might be required for proteolytic 
activity, is the observation that the resulting polypeptides stay associated with 
eachother after cleavage. Taken together, the here proposed interaction 
between separase and securin appear to be very similar in higher eukaryotes 
(Fig.4.3).
Another level of regulation of human separase is its inhibition by CDK 
(CDC2)-dependent phosphorylation. This inhibition is effective even after 
securin is degraded. The phosphorylation takes place in the centre of separase, 
and it would be interesting to see whether it influences an interaction between
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N- and C-termini or inhibits separase by an alternative mechanism. In budding 
yeast there is no evidence for self-cleavage and CDK-dependent inhibition of 
separase. Sister separation proceeds in the presence of high kinase activity and 
securin destruction is sufficient to promote anaphase onset [31, 102].
Yeast APCt © Securin
Human Securin
Three Rows
Drosophila
Separase
APCt Securin
Figure 4.3: Separase regulation at the metaphase to anaphase transition 
In budding yeast, securin prevents an interaction of the separase amino terminus with 
the protease active site at the carboxyl terminus. Securin is degraded at anaphase 
onset after ubiquitylation by the anaphase promoting complex (APC). This allows an 
intramolecular interaction within separase that may activate protease activity. Human 
separase is inactivated by phosphorylation in metaphase. The phosphate has to be 
removed in anaphase, when cyclin-dependent kinase activity decreases. During 
anaphase, separase cleaves itself and the carboxy-terminal separase fragment, which 
contains the protease active site, is rendered unstable (asterisk). In Drosophila, 
separase consists of two polypeptides, called Three Rows and separase. After securin 
destruction, separase cleaves its own Three Rows component. The carboxy-terminal 
Three Rows fragment, probably required for separase activity, is thereby destabilised 
(asterisk) (adapted from F.Uhlmann, Current Biology, Volume 13, 4.2.2003).
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Apart from the highly conserved C-termini, separases from different 
eukaryotes show very little sequence homology (see appendix). Moreover, 
sequence similarity among securin proteins is restricted to signals that promote 
the mitotic degradation required for separase activation.
This study and studies in Drosophila and humans indicate a very similar 
tertiary structure of separases and their interactions with securin, despite their 
low primary sequence similarity. Interestingly, N-terminal regions of human 
separase are able to interact with the C-terminus of PIM and human 
securin/PTTG is able to interact with Drosophila THR and separase/SSE [46]. 
The fact that heterologous interactions between Drosophila and human 
separase and securin proteins occur, even though significant primary sequence 
similarities are missing, raised the possibility that these domains might 
nevertheless adopt a related tertiary structure. Tertiary structure predictions on 
THR in Drosophila indicate an alpha-alpha superhelical structure similar to 
ARM/HEAT repeat-containing domains. A secondary structure query on the N- 
termini of Esp1 and Cut1 shows a helical rich structure (Fig.4.4-A).
Secondary structure alignment of Esp1 and Cut1:
Espl:MMVKQEEPLNEI-SPNTPMTSKSYLLNDTLSKVHHSGQTRPLTSVLSG-DASSN 
Cut1:MSTRSIVTSKVSWTPEKFISALSYPEHCSITLVKRLKASVKLKDLKQNISRDAP 
CCCCCCCCHHHC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCHHHHHCC-CCCCC 
CCCCCCCCHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCHHHHHCCCCCCCCE
Espl:SIGILAMHNNIIRDFTKIASNNIDLAIEDITTVDHSLNSIYSLLKSHHMWGHIN 
Cutl:SWTFEHLFVAFKCAVSNLAKQWAELSTTDKEKTRRMFCTPSRLNTAHRPEVFYL 
CEEEEEECHHHHHHHHHHCCCCCCEEEEEHHHHHHHHHHHHHHHHHHCCCCCCH 
EEEEECHHHHHHHHHHCCCCCCEEEEEHHHHHHHHHHHHHHHHHHCCCCCCHHH
Espl:STVKQHLMIIVKLINNNALGLASSEIIFLFNETNLFQAHSLKNILLADFSTWND 
Cut1:LECCTYILEQMQWTKNTSHLYDC-IRSGVSICNRLLDMEIFEPAISLLMKTHK 
HHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCEEEHHCCCCEEEECCCCCCC 
HHHHHHHHHHHHCCCCCCCCCCCE-EEEECCCCEEEHHCCCCEEEECCCCCCCC
Espl:YYLSNLKILALQIILKRKLVDEYLPHILELFSHDKRYLLK 
Cutl:NLIILLTYRDHDAIPTATLLNPTL-DVSEIQLESCLFVPM 
CHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCEEECC 
HHCCHHHHHHHHHHHHHHHHHHHH-HHHHHHCCCCEEECC
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Secondary structure alignment of Espl and D12:
Espl:MMVKQEEPLNEISPNTPMTSKSYLLNDTLSKVHHSGQTRPLTSVLSGDASSNSI 
D12 :MDEIVKNIREGTHVLLPFYETLPELNLSLGKSPLPSLEYGANYFLQISRVNDLN 
CCCCCCCCHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCHHHHHCCCCCCCCE 
CCCCCCCCHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCHHHHHCCCCCCCCE
Espl:GILAMHNNIIRDFTKIASNNIDLAIE— DITTVDHSLNSIYSLLKSHHMWGHIN 
D12 :RMPTDMLKLFTHDIMLPESDLDKVYEILKINSVKYYGRSTKADAWADLSARNK 
EEEEECHHHHHHHHHHCCCCCCEEEE— EHHHHHHHHHHHHHHHHHHCCCCCCH 
EEEEECHHHHHHHHHHCCCCCCEEEEEHHHHHHHHHHHHHHHHHHCCCCCCHHH
Espl:STVKQHLMIIVK-LINNNALGLASSEIIFLFNETNLFQAHSLKNILLADFSTWN 
D12 LFKRERDAIKSNNHLTENNLYISDYKMLTFDVFRPLFDFVNEKYCIIKLPTLFG 
HHHHHHHHHHHH-HHCCCCCCCCCCCEEEEECCCCEEEHHCCCCEEEECCCCCC 
HHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCEEEHHCCCCEEEECCCCCCCCH
Espl:DYYLSNLKI---LALQIILKRKLVDEYLPHILELFSHDKRYLLK
D12 RGVIDTMRIYCSLFKNVRLLKCVSDSWLKDSAIMVASD------
CCHHCCHHH HHHHHHHHHHHHHHHHHHHHHHHCCCCEEECC
HCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCEEECC------
Figure 4.4: Secondary structure alignment of Espl (S.cerevisiae), Cutl (S.pombe) 
and the D12 subunit of the vaccinia virus mRNA capping enzyme
The secondary structure alignment was performed using the 3D-JIGSAW software.
HEAT repeats in invertebrate and mammalian orthologues average only 13% 
sequence identity [131]. Thus, the structural features rather than primary 
sequences are conserved in these cases. In those structures, where the 
HEAT/ARM-repeat containing proteins have been co-crystallised with a binding 
partner, the HEAT/ARM-repeat region is involved in protein-protein interactions 
[131], It is thus conceivable that the predicted alpha-alpha superhelical domains 
in THR and separases mediate binding to PIM/SSE and securin/C-terminal 
separase domains, respectively [46].
Functional instead of structural studies on the N-terminus of Espl 
revealed an unexpected link to the mRNA machinery [132]. The N-terminus of 
Espl is able to complement a temperature-sensitive mutation in the CEG1 gene 
encoding the mRNA guanylyltransferase (capping enzyme). The 52-kDa protein 
resembles that of the vaccinia virus guanylyltransferase. In both cases, GTP 
reacts with the enzyme-GMP intermediate with concomitant release of 
pyrophosphate. The enzyme then donates the GMP to a 5’ diphosphate-
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terminated RNA [133]. Mechanistic similarities between the cellular and viral 
capping enzyme are echoed at the structural level by regional amino acid 
sequence conservation. The vaccinia virus mRNA capping enzyme is a 
heterodimer of D1 (95kDa) and D12 (33kDa) subunits that catalyse all three 
steps in cap synthesis [133]. The RNA triphosphatase and RNA 
guanylyltransferase activities reside within the 60kDa N-terminal region of the 
D1 subunit. The 287 aminoacid D12 subunit, together with the C-terminal 305 
aminoacid portion of the D1 subunit, catalyse the cap methylation reaction.
The N-terminus of Espl that rescues Ceg1 function and the D12 subunit of the 
vaccinia virus mRNA capping enzyme show four fragments of sequence 
similarity arrayed in a collinear fashion in both polypeptides ([132], Fig.4.5).
The last 700 amino acids of Espl/separase containing the catalytic side are 
dispensable for the complementation of Ceg1. The D12 protein itself, although 
essential, has no catalytic activity. Rather it interacts tightly with the D1 subunit 
and stimulates its RNA-methyltransferase activity by 50- to 100 fold [132].
: *  * *  : * :  : *  : * *
D12 49:VNDLNRMPTDMLKLFTHDIMLPESDLDKVYEILK:83
Espl 63:IRDFTKIASNNIDLAIEDITTVDHSLNSIYSLLK:97
D12 1 2 3 :TENNLYISDYKMLTFDV:14 0
Espl 1 5 6 :TWNDYYLSNLKILALQI:17 3
D12 171:YCSLFKNVRLL-KCVS:18 6
Espl 316:YCNMSEN-RLLWSCIS:331
*  ★ * • * * * ★
D12 2 4 1 :INKFLEFSN:2 5 0
Espl 5 2 3:ITKFIEFSN:532
Figure 4.5: Regions of similarity between the N-terminus of Espl (S.cerevisiae) 
and the D12 subunit of the vaccinia virus capping enzyme
Amino acid identity is indicated by a star, similarity is denoted by 2 dots (adapted from 
B.Schwerand S.Shuman, Gene Expression, Volume 5, 1996).
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These mechanistic features seem to be very similar to the proposed 
activation of separase through its own N-terminus. Interestingly, a secondary 
structure query in D12 showed a similar helix-coiled-helix distribution as found 
in the N-termini of Espl and Cutl (Fig.4.4-B). Furthermore a tertiary structure 
model of D1 shows a similar array of five beta strands as that of gingipain 
containing the catalytic dyad, the structure predicted for the C-terminus of 
separase (Fig.4.6).
What role could the N-terminus of Espl play in mRNA capping? It is 
possible that in the screen increased dosage of Espl drove a physical 
interaction with Ceg1, the effect of which is to either stabilise Ceg1 against 
denaturation or proteolysis at the non-permissive temperature or else to 
enhance its catalytic activity above a threshold level required for viability. It is 
conceivable that gene duplication led to the development of two different 
enzymes using very similar activation mechanisms.
gingipain
Figure 4.6: The D1 subunit of the vaccinia virus capping enzyme and the
Cysteine Proteinase Gingipain (Porphyromonas gingivalis) show a similar 
tertiary structure
Crystal Structure Of The Arginine Specific Cysteine Proteinase Gingipain 
(Porphyromonas gingivalis) (Eichinger, A., Embo J., Volume 18, 1999) and the the D1 
subunit of the vaccinia virus capping enzyme (Mao, X., et al., Biochemistry, Volume 35, 
1996)
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4.2 Regulation of cohesion cleavage
Anaphase onset is triggered when the Scc1 subunit of the chromosomal 
cohesin complex is cleaved by the protease separase. Only part of the total 
cellular cohesin is bound to chromosomes in metaphase, and it has been 
suspected separase may specifically recognise and cleave only this fraction to 
separate sister chromatids, while leaving cohesin in the soluble cellular fraction 
intact. Direct evidence for preferential cleavage of chromosomal cohesin or 
suggestions as to a possible targeting mechanism have not been available. The 
presented study shows that the rate of separase cleavage of chromosomal 
cohesin in budding yeast is indeed significantly greater when compared to 
cleavage of cohesin in the soluble cellular fraction, and that this is most likely 
due to preferential phosphorylation of chromatin-bound cohesin by Polo kinase. 
In budding yeast, two thirds of cohesin are chromatin-bound in metaphase, and 
accordingly a relatively large fraction of cohesin is cleaved at anaphase onset. If 
budding yeast is arrested in G1, or small daughter cells are isolated, little or no 
uncleaved Scc1 remains detectable in these cells [134, 135]. This suggests that 
in the course of mitotic progression most budding yeast Scc1, also in the 
soluble fraction, is cleaved. Nevertheless, preferential cleavage of chromosomal 
cohesin at anaphase onset will increase the promptness of sister chromatid 
separation. Some Scc1 may remain uncleaved and can be reused as large 
mother cells enter the subsequent S-phase soon after mitosis. The origin of 
cohesin that is unbound to chromosomes in the soluble cellular fraction in 
budding yeast metaphase is unclear. Not all cohesin may ever bind to 
chromosomes, and a soluble fraction of cohesin can be detected even during S 
and G2 phase [52]. In higher eukaryotes, a large fraction of cohesin dissociates 
from chromatin during chromosome condensation in prophase, leading to a 
substantial pool of soluble cohesin in metaphase [106]. Whether a fraction of 
chromatin-bound cohesin becomes soluble during budding yeast chromosome 
condensation is not known.
In vertebrates, it has been estimated that the amount of cohesin left on 
chromosomes after condensation is only about 5% of the total [125]. The 
amount of cohesin cleaved at anaphase onset appears similarly small [106], but 
it has not been formally shown that the cleaved cohesin in fact corresponds to
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chromosomal cohesin. This seems likely to be the case though, because 
cohesin only promotes sister chromatid cohesion when bound to chromosomes, 
and cleavage of human cohesin is required for sister chromatid separation [36, 
50]. To achieve preferential cleavage, the discrimination of human separase for 
chromatin-bound cohesin is likely to be greater than the 2-3 fold faster cleavage 
of chromosomal cohesin observed in budding yeast. The same is probably true 
in fission yeast, where a relatively small fraction of the total cohesin is cleaved 
to trigger anaphase [71, 119, 136]. Preferential cleavage of chromatin-bound 
cohesin in budding yeast depends on its phosphorylation, probably by a high 
local concentration of chromosome-associated Polo kinase. An alternative 
explanation for preferential phosphorylation might be that chromatin-bound 
cohesin is in a distinct conformational state that assists recognition by the 
kinase. This appears less likely, as overexpression of Polo led to 
hyperphosphorylation mainly of soluble rather than chromosomal cohesin. This 
study suggests that preferential modification of chromatin-bound cohesin is due 
to a high local concentration of a chromosome-associated enzyme. Such a 
mechanism might also contribute to distinguish chromosomal from soluble 
cohesin in other organisms.
Could Polo-like kinase be involved in determining preferential cleavage of 
chromosomal cohesin also in vertebrates? There, Polo promotes separase- 
independent cohesin removal from chromosomes during condensation [119, 
136]. It seems at first sight counterintuitive that Polo could induce cleavage- 
independent cohesin dissociation, and at the same time mark persisting 
chromosomal cohesin for preferential separase cleavage. Another 
chromosomal kinase or enzymatic activity could therefore facilitate cohesin 
cleavage in vertebrates. Then again, Polo may in fact provide a generic mark 
for all chromosomal cohesin. Polo may not be specifying cohesin for one of the 
two pathways of removal from chromosomes, but it may identify all 
chromosomal cohesin as ‘still chromosome-bound’. Such a mark could help 
both the prophase pathway, as well as cohesin cleavage by separase. Once 
released from chromosomes, phosphorylation may no longer be maintained. 
This would ensure that both mechanisms to remove cohesin from 
chromosomes are specifically targeted at remaining chromosomal cohesin.
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In vertebrate, as well as Drosophila and fission yeast cells, cohesin 
reassociates with chromosomes very soon after mitosis, as chromosomes 
decondense in telophase [106,120, 125]. Whether cohesin plays a specific role 
on chromosomes in telophase and the following G1 phase, before cohesion 
between sister chromatids must be again established in the next round of DNA 
replication, is not known. Nevertheless, maintenance of a pool of intact soluble 
cohesin throughout mitosis is clearly required to enable cohesin’s fast 
reassociation with chromosomes when these cells exit from mitosis.
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Chapter 5
Materials and methods
This chapter details the experimental methods used throughout this thesis. It 
also gives details of the contents of buffers and the derivation of strains used.
5.1 Solutions, buffers and media
All media and commonly used solution were provided by Cancer Research UK 
central services.
Media
L-Broth (LB) 170mM NaCI, 0.5%w/v yeast extract, 1 % w/v bactotryptone
Ampicilin was added to a final concentration of 100pig/ml.
YEP-D 1.1%w/v yeast extract, 2.2%w/v bacto-peptone, 2%w/v D-
glucose, 0.0055%w/v adenine 
YEP-Raff/Gal 1.1%w/v yeast extract, 2.2%w/v bacto-peptone, 2%w/v
raffinose, 2%w/v galactose, 0.0055%w/v adenine 
YNB 0.32% Yeast Nitrogen Base
For plates 2%w/v agar was added.
Sectoring plates 1%w/v yeast extract, 2%w/v bacto-peptone, 4%w/v D-
glucose, 2%w/v agar 
Sporulation plates 0.33% Sodium acetate, 0.048% Sodium chloride, 0.076%
potassium chloride, 0.014% Magnesium sulphate, 2%w/v 
agar
PBSA 170mM NaCI, 3mM KCI, 10mM Na2HP04, 2mM KH2P 04
Gibco™ Graces Insect Cell Culture Medium (Invitrogen) containing 3.33 mg/l 
lactalbumin hydrolysate, 3.33 mg/l yeastolate, 1.5% L-glutamine, 10% foetal calf 
serum and 0.01 mg/ml gentamycin.
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Molecular biology
TE
10XDNA loading
buffer
TAE
10xTaq Buffer
10mM TrisHCI pH7.0, 0.1M EDTA 
60%w/v sucrose, 0.1%w/v bromophenol blue
SCE
40mM Tris-acetate, 1mM EDTA
200mM TrisHCI pH6.8, 100mM KCI, 30mM MgS04, (0.5% 
Triton X-100)
1M sorbitol, 0.1M sodium citrate pH7.0, 60mM EDTA 
SCE/ME/zymolase 1M sorbitol, 0.1 M sodium citrate pH7.0, 60mM EDTA,
8^ xl/ml p-mercaptoethanol, 2mg/ml zymolyase T-20 
100mM TrisHCI pH9.0, 50mM EDTA, 2% SDS 
100mM TrisHCI pH7.5, 1mM EDTA, 1M Lithium acetate 
100^1 10xTEL, 100pi I H20 ,  800pi I 50% PEG
(polyethylenglycol 3350 or 4000)
SDS-solution 
10xTEL 
TELP
Protein Biochemistry
2X SDS-PAGE- loading buffer 100mM TrisHCI pH6.8, 20% glycerol, 4%
SDS, 0.2% Bromophenol blue, 100mM DTT 
10x Running buffer 250mM TrisHCI, 2.5M glycine pH8, 1% SDS
Transfer buffer 144g/l glycine, 30g/l Tris base, 10% methanol
Stripping buffer 2% SDS, 50mM DTT, 50mM Tris base pH7
4x Stacking gel buffer 0.5M TrisHCI pH6.8, 0.4% SDS
4x Separating gel buffer 1.5M TrisHCI pH8.8, 0.4% SDS
Wash buffer (protein extractioSpmM HEPES/KOH pH7.5, 100mM KCI,
2.5mM MgCb,
Extraction buffer (protein extraction) 50mM HEPES/KOH pH7.5, 100mM
KCI, 2.5mM MgCb, 1mM DTT, 2mM 
benzamidine, 0.2mg/ml bacitracin, 20mg/ml 
leupeptine, 2p,g/ml aprotinin, 2^g/ml 
pepstatinA, 1mM PMSF 
Wash buffer (chromatin preparation) 50mMHEPES/KOH pH7.5, 100mMKCI,
2.5mM MgCb, 0.4M sorbitol
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EB (chromatin preparation)
EBX (chromatin preparation)
50mM HEPES/KOH pH7.5, 100mM KCI, 
2.5mM MgCI2> ImMDTT, 2mM benzamidine, 
0.2mg/ml bacitracin, 20mg/ml leupeptine, 
2pg/ml aprotinin, 2p,g/ml pepstatinA, 1mM 
PMSF (fresh)
EB + 0.25% Triton X-100
EBX-S (chromatin preparation) EBX + 30% sucrose
Protein purification from insect cells:
Wash buffer
H200
H500
Elution buffer
50mM HEPES/KOH pH7.5, 10mM KCI, 1.5mM 
MgCI2, 2mM benzamidine, 0.2mg/ml bacitracin, 
20mg/ml leupeptine, 2p,g/ml aprotinin, 2pg/ml 
pepstatinA
50mM HEPES/KOH pH7.5, 200mM NaCI, 1.5mM
MgCI2, 0.01% Nonidet P-40
50mM HEPES/KOH pH7.5, 500mM NaCI, 1.5mM
MgCI2, 0.01% Nonidet P-40
50mM HEPES/KOH pH7.5, 200mM NaCI, 1.5mM
MgCI2, 0.01% Nonidet P-40, 2mM benzamidine,
0.2mg/ml bacitracin, 20mg/ml leupeptine, 2pg/ml
aprotinin, 2^g/ml pepstatinA, 50mM DTT
Microscopy
Formaldehyde buffer
Wash buffer 
Spheroplasting buffer
Blocking buffer
5011
5012
100mM KH2P 04 pH6.4, 0.5mM MgCI2, 3.7%  
formaldehyde
100mM KH2P 04pH7.4, 0.5mM MgCI2, 1.2M sorbitol 
100mM KH2P 04 pH7.4, 0.5mM MgCI2, 1.2M sorbitol, 
0.2% p-mercaptoethanol, 0.04% zymolase T-100 
1% BSA (bovine serum albumin) in PBS 
100mM KH2P 04 pH7.4, 0.5mM MgCI2, 1.2M sorbitol 
0.1 M MES (2-(N-morpholino) ethane sulfonic acid), 
1mM EDTA, 0.5mM MgCI2, 1M sorbitol pH6.4
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Fixative 4% paraformaldehyde (dissolved in water at 60-80°C
(minute amounts of NaOH are eventually added to 
dissolve), 3.4% sucrose (kept in dark at 4°C)
Blocking buffer 0.5% BSA, 0.5% gelatine in PBS (warmed up in a
microwave oven to dissolve gelatine)
5.2 Molecular Biological techniques
Molecular biological techniques were used as described (Maniatis, 1982) 
including growth and transformation of bacterial cells, gel electrophoresis of 
DNA in TAE buffer, restriction enzyme digests, minipreps and preparation of 
competent bacteria.
Nucleic Acid preparation and manipulation
Yeast genomic DNA for PCR genotyping was prepared from fresh patches of 
the strain of interest. A toothpick of cells was incubated in 200pl 
SC/ME/zymolase for 45min at 37°C on a shaking thermomixer. 200pl SDS- 
solution was added and the mix was heated up for 5min at 65°C. 200pl 5M KAc 
was added at room temperature. After 10min centrifugation at 12000rpm the 
supernatant was treated with 800pl EtOH. After a further centrifugation at 
6000rpm for 2min, the pellet was washed with 70% EtOH and dissolved in 
200|xl H2O. For PCR, 0.5-1 pi of the genomic DNA was used.
Enzymatic digestion of DNA with restriction enzymes was carried out as 
recommended by the suppliers (New England Biolabs).
DNA fragments were examined on 1%, 1.5% and occasionally, where 
fragments were very small, 2% (w/v) agarose in 1XTAE buffer. Gels were run at 
100V in 1XTAE buffer in Anachem electrophoresis cells.
Polymerase Chain Reaction:
Non Mutagenic PCR
Normal PCR reactions were carried out using Vent (New England Biolabs) or 
Expand High Fidelity (Roche) polymerases with buffers supplied by the
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manufacturers. dNTPs were supplied at 0.2mM in reaction volumes of 50 or 
100|il. A reaction volume of 100pJ contained 5 units of enzyme.
For colony PCR, samples were prepared in a similar manner. A toothpick full of 
yeast colony was suspended in the reaction mix heated to 95°C for 5 minutes. 
Subsequently enzyme was added and PCR started.
All PCRs were performed in a Peltier Thermal Cycler-200. Reactions were 
checked on DNA agarose gels for product size and precipitated in 1/10 volume 
of NaAc and 2.5 volumes of EtOH for further use.
PCR based site directed mutagenesis
Generation of site specific mutated DNA fragments was performed by PCR 
using overlap extension mutagenesis with Expand High Fidelity polymerase. 
For a first round of PCR (15 cycles: 5 cycles with an annealing temperature of 
at 56°C, 10 cycles with an annealing temperature of 60°C) 100ng template was 
used. Two sets of primers were used for two parallel reactions. The two sets 
contained the forward and reverse primers carrying the site specific mutation 
and a downstream reverse primer and an upstream forward primer respectively, 
needed for cloning. The two resulting PCR fragments were purified after running 
on an agarose gel using the Qiagen gel extraction kit. Equal amounts of PCR 
product (total amount 100ng) were used as templates for a second round of 
PCR (15 cycles: 5 cycles with an annealing temperature of 56°C, 10 cycles with 
an annealing temperature of 60°C) using only the outside primers. The resulting 
PCR fragment was either purified after running on an agarose gel or 
precipitated in 1/10 volume of NaAc and 2.5 volumes of EtOH. The 
mutagenesis was checked by sequencing.
Gene Disruption
All genes were disrupted using PCR generated fragments [137]. A marker gene 
( L E U 2, URA3, HIS3, TRP1) was amplified with flanking sequences 
corresponding to the 5’ and 3’ ends of the relevant genes. Fragments were 
transformed into a strain lacking the selective marker. Colonies were selected 
on plates lacking the selective marker. The marker genes came from
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heterologous sources (K.lactis, S.pombe) to prevent gene conversion of the 
mutant marker in S.cerevisiae.
Overexpression and C-terminal epitope tagging of genes in their 
chromosomal location
Glucose repressible promoters were integrated into the genome in front of the 
initiator ATG codon of genes by a PCR-based gene targeting method [137]. C 
terminal tagging of genes with HA, Myc or GFP eptiopes was also carried out 
using PCR generated fragments as described [137], All tagging was confirmed 
by western blotting with specific antibodies.
Transformation and isolation of plasmid DNA in E. coli
Competent E. coli stored at -70°C were thawed on ice and incubated 20 
minutes with 10ng of plasmid DNA. Cells were heat shocked at 42°C for 90s 
after which 1ml of LB media was added. The cells were allowed to recover at 
37°C for 30 minutes to 1 hour before being plated onto LB plates containing the 
selective marker carried by the plasmid.
Chromosome loss assay
The assay to determine the frequency of chromosome loss was adapted from 
Spencer et al 1990 [128]. Strains were grown on medium lacking uracil and 
plated on rich medium. Half red sectored colonies were counted as they lost the 
extra chromosome in the first mitotic division.
5.3 Protein Biochemistry
Western blot analysis
Budding yeast protein extract were either prepared using glass beads disruption 
or NaOH lysis. For glass bead disruption between 106—108 cells were 
resuspended in protein extraction buffer and boiled in 250^1 2xSDS-loading 
buffer. Cells were then broken on a IKA Vibrax shaker for 10min. Following lysis 
with glass beads the extract was boiled again for 5 min, then clarified by 
centrifugation, and the protein concentration measured using the Bradford
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Assay (BioRad). 5-10^1 (20ng) of protein extracts were boiled in 2xSDS-loading 
buffer for 5 minutes and then run on 8% or 10% SDS-polyacrylamide gels.
For NaOH lysis of yeast cells between 106 -1 0 8 cells were used per sample. 
Cells were harvested by centrifugation and washed once with water. 10Opil of 
chilled water and 100^1 of 0.2M NaOH were then added to the cells, which were 
incubated at room temperature for 5 minutes before centrifugation. The 
supernatant was discarded and cell pellet resuspended in 50p,l of 2xSDS- 
loading buffer. After boiling for 5 minutes, 5-10pJ of protein extract was run on 
an SDS-polyacrylamide gel as above.
Blotting of gels was carried out as follows. Proteins were first transferred onto 
Protran (Schleicher and Schuell) transfer membrane. Semidry transfer was 
used for 3 hours at 1.2mA/cm2 gel. After blocking for 1 hr in 5% Milk PBSA 
solution with 0.01% Tween, antibodies were added in the same solution. 
Membranes were incubated for 1-2h (for quantitative western blots overnight at 
4°C), washed and secondary antibody of Horseradish peroxidase conjugated 
goat anti-rabbit or goat anti-mouse IgG were incubated with the blot. A 
chemiluminescence system (ECL) was used to detect the bound antibodies.
Chromatin preparation
A crude Triton X-100-insoluble chromatin preparation was adapted from Liang & 
Stillman, 1997 [138].
200 ml of yeast cultures were grown in YEP-D medium at 25°C to a density of
0
1x10 cells/ml. Cells were pelleted by centrifugation and resuspended in 6 ml 
100 mM PIPES/KOH (pH 9.3), 10 mM dithiothreitol, and 0.1% sodium azide, 
and incubated at room temperature for 10 min. Cell were collected again by 
centrifugation and resuspended in 4 ml of 50 mM potassium phosphate (pH 
7.5), 0.6 M sorbitol, 0.5 mM MgCI2, and 10 mM dithiothreitol. Zymolase T-100 
(ICN Biochemicals) was added to a final concentration of 40p,g/ml and 
spheroplasting was at 37°C for 10 min. Cells were collected again, washed in 
wash buffer, and resuspended in 350jaI buffer EB. Spheroplasts were lysed by 
the addition of 0.25% Trition X-100 for 3 min on ice. This whole cell extract was 
layed on 100^1 EBX-S and centrifuged 10min at 12000rpm. The upper phase of 
the supernatant containing the soluble material was removed carefully and
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stored at -80°C  for further analysis. The sucrose was removed by aspiration 
and the chromatin pellet resuspended in 100pJ EBX. For storage at -80°C, 10% 
glycerol was added to the chromatin pellet.
In vitro assay for Esp1 activity
The Esp1 activity assay was adapted from Uhlmann et al. [35]. 200 ml of yeast 
cultures containing the ESP1 gene under the inducible galactose promoter were 
grown in YEP medium with 2% raffinose as carbon source at 25°C. At a density
of 2.5 x 10 cells/ml, the GAL promoter was induced by the addition of 2% 
galactose for 3 h before cells were harvested. As overexpression of Esp1 from 
the GAL promoter is toxic to cells, extracts with overproduced Esp1 were 
prepared 3 h after induction with galactose. One culture was left uninduced as a 
control for the purification. Cells were resuspended in 6 ml 100 mM PIPES/KOH 
(pH 9.3), 10 mM dithiothreitol, and 0.1% sodium azide, and incubated at room 
temperature for 10 min. Cell were collected again by centrifugation and 
resuspended in 4 ml of 50 mM potassium phosphate (pH 7.5), 0.6 M sorbitol, 
0.5 mM MgCI2, and 10 mM dithiothreitol. Zymolase T-100 (ICN Biochemicals) 
was added to a final concentration of 40ng/ml and spheroplasting was at 37°C 
for 10 min. Cells were collected again, washed in wash buffer, and resuspended 
in 350jaI buffer EB. Spheroplasts were lysed by the addition of 0.25% Trition X- 
100 for 3 min on ice.
A crude Triton X-100-insoluble chromatin preparation was obtained from yeast 
cells containing epitope tagged Scc1 as described above. The pelleted 
chromatin was resuspended in the above extracts containing overexpressed 
Esp1. Reactions were incubated for 10 min at 25°C with gentle shaking, and 
stopped on ice. The chromatin fraction was separated again from the 
supernatant by centrifugation, and resuspended in buffer EBX. Equivalent 
aliquots of supernatant and chromatin pellet were analysed by SDS-PAGE and 
western blotting. HA-tagged Scc1 was detected using monoclonal antibody 
16B12, myc-tagged Scc1 with monoclonal antibody 9E10.
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Purification of Scc1 Expressed in Baculovirus Infected Insect Cells
Purification of Scc1 from baculovirus infected insect cells was adapted from 
Uhlmann et al 2000. The Scc1 coding sequence was cloned into the 
baculovirus transfer vector pFastBad (Gibco Life Technologies). At the C 
terminus, a Flag and HA epitope tag was added followed by a cassette 
containing the yeast VMA intein and a chitin binding domain (New England 
Biolabs). Recombinant baculoviruses were obtained according to the 
manufacturer’s instructions, and HiFive insect cells (Invitrogen) grown in 
monolayers to confluency were infected at a multiplicity of infection of 2. To 
obtain metaphase-like phosphorylation, 0.1 pM Okadaic acid was added 40 hr 
after infection. 43 hours after infection, cells were harvested. Cytoplasmic and 
nuclear extracts were obtained as described [139]. When Scc1 was purified 
after treatment of the cells with Okadaic acid, 5 mM NaF and 5 mM sodium 
pyrophosphate was added to the extraction buffer. Combined cytoplasmic and 
nuclear extracts from cells in 10 T250 flasks (8 ml, 100 mg protein) were loaded 
onto 1 ml bead volume of chitin beads (New England Biolabs), equilibrated in 
buffer H200. Loading was for 2 hr by rocking at 4°C. The chitin resin was then 
washed in a column with 20 column volumes each of buffer H500 and H200 
(index indicates the concentration of NaCI). The column was then flushed with 3 
column volumes of buffer H200 containing 50mM dithiothreitol and closed for 
cleavage of the intein overnight. The eluate containing Scc1 released from the 
column was directly loaded onto a MonoQ HR 5/5 column (Amersham 
Pharmacia), and the column was developed with a gradient from H200 to 
H1000 in 10 ml. Fractions containing Scc1 were detected by SDS-PAGE 
followed by Coomassie staining and Western blotting against the Flag epitope 
or the HA epitope. Pooled fractions were diluted to 200 mM NaCI by adding 
buffer H 0, and chromatography on the MonoQ column was repeated. This step 
was necessary to remove traces of a contaminating protein that copurified with 
Scc1 and was identified as Hsp70 from the insect host cells by mass 
spectrometry. The final eluate was dialyzed against buffer H 100 and 
concentrated by ultrafiltration. This protocol yielded 25 |xg of purified Scc1 or 
purified metaphase-like phosphorylated Scc1.
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Overexpression and Purification of Esp1 from Yeast Cells
200 ml of yeast culture were grown in YEP medium with 2% raffinose as carbon
g
source at 25°C. At a density of 2.5 x 10 cells/ml, the GAL promoter was 
induced by the addition of 2% galactose for 5 hr before cells were harvested. 
One culture was left uninduced as a control for the purification. Cells were 
resuspended in 6 ml 100 mM PIPES/KOH (pH 9.3), 10 mM dithiothreitol, and 
0.1% sodium azide, and incubated at room temperature for 10 min. Cell were 
collected again by centrifugation and resuspended in 4 ml of 50 mM potassium 
phosphate (pH 7.5), 0.6 M sorbitol, 0.5 mM MgCI2, and 10 mM dithiothreitol. 
Zymolase T-100 (ICN Biochemicals) was added to a final concentration of 40 
pg/ml and spheroplasting was at 37°C for 10 min. Cells were collected again, 
washed in 2 ml of 50 mM HEPES/KOH (pH 7.5), 100 mM KCI, 2.5 mM MgCI2, 
and 0.4 M Sorbitol, and resuspended in 350 pi buffer FB (50 mM HEPES/KOH 
(pH 7.5), 250 mM NaCI, 1 mM MgCh, 1 mM CaCb, and 1 mM dithiothreitol, plus 
protease inhibitors as described [138]. Cells were lysed by the addition of 
0.25% Trition X-100 for 3 min on ice, and the lysate was cleared by 
centrifugation. The extracts were loaded onto 50pl bead volume of chitin beads 
and equilibrated in buffer FBX (FB plus 0.05% Triton X-100) for 2 hr on a 
rotating wheel. Beads were transferred into a chromatography column and 
washed with 5 ml each of FBX1000, and FBX100, containing 1 M and 100 mM 
NaCI, respectively. Beads were then resuspended in a total volume of 100 pi 
FBX100 and 20 pi aliquots of the suspension were distributed. Beads were 
sedimented by gravity and 10 pi supernatant was retrieved and discarded. For 
detection of purified Esp1, 10 pi of SDS-PAGE loading buffer was added to the 
beads, boiled for 5 min, and 10 pi of the SDS eluate was loaded for SDS- 
PAGE.
For immunoprecipitations of Esp1, Pds1 and Scc1 the same protocol was 
followed up to the cell lysis. Buffer EB was used instead of buffer FB. Protein A 
beads were used for binding of myc- and HA-epitope tagged protein, chitin 
beads for binding of CBD epitope tagged protein. Antibodies were added at the 
concentrations listed below.
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Cleavage of Purified Scc1 in Yeast Extracts
Scc1 cleavage-competent yeast extracts after overexpression of Esp1 and 
control extracts were obtained as described above. 6 pil (20 ng/pJ) purified Scc1 
or Scc1-P in H200 was added to 12 jxl of control or Esp1 containing extracts, or 
to mixtures at different ratios between these extracts. Incubation was for 10 min 
at 25°C. The reaction was stopped by adding SDS-PAGE loading buffer, and 
aliquots were analysed by SDS-PAGE and Western blotting against the Flag 
and HA-epitope [35].
Scc1 Cleavage by Esp1 Bound to Chitin Affinity Beads
10 pil (20 ng/pJ) of purified Scc1 or Scc1-P in FBX100 supplemented with 0.1 
mg/ml BSA was added to 10pil of Esp1-bound chitin beads obtained as 
described above. The reaction was incubated for 15 min at 25°C with 
continuous shaking. Beads were sedimented by brief centrifugation and 10 pJ 
supernatant was retrieved and loaded for SDS-PAGE. In experiments where the 
peptide inhibitor was used, 10pil of a 20piM dilution of the small protease 
inhibitor Bio-SVEQGR-amk (uhlmann cell 2000) was added to 10 pil of chitin 
beads and incubated 10 min at 25°C. Then, 10pl of supernatant was retrieved 
again, and Scc1 was added and incubated as above. To detect the proteins on 
the beads labeled by the inhibitor, the beads were boiled with 10pil of SDS- 
PAGE loading buffer and the eluate was loaded for SDS-PAGE. After 
electrophoresis, the gel was transferred to a nitrocellulose membrane and 
biotinylated proteins were detected as described [140].
To investigate the effect of securin on Scc1 cleavage by Esp1, amino acids 
256-359 of securin were cloned into the bacterial expression vector pGEX-KG 
[141] by PCR using genomic DNA as the template. The binding of the GST- 
securin fragment to Esp1 was analysed incubating 1 pig of GST-securin with 20 
pJ of chitin beads, to which Esp1 had been bound as above, in a reaction 
volume of 25 pil of FBX buffer. Incubation was for 10 min on ice with agitation, 
after which the beads were washed and the bound protein eluted in SDS-PAGE 
loading buffer. To analyse the binding of recombinant Scc1 to separase, 0.2 pig 
Scc1 was added to the separase-containing beads for 10 min at 25°C. For 
binding of Scc1 to separase deletion mutants, both proteins were co­
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overexpressed in the same strain. To detect interactions between N- and C- 
terminal fragments of separase the fragments in question were co­
overexpressed in a diploid strain obtained by crossing strains expressing the 
individual fragments.
Analysis of Scc1 cleavage kinetics
Exponentially growing cells were arrested in metaphase by addition of 5 ng/ml 
nocodazole. Soluble and chromatin fractions were prepared after spheroplast 
lysis as previously described. The Scc1 in vitro cleavage assay was modified as 
follows [142]: chromatin-bound and soluble fractions containing equivalent 
amounts of reciprocally tagged Scc1 were mixed, ensuring chromatin was 
thoroughly resuspended. Chromatin-released cohesin was also included that 
was obtained as described, and phosphatase treatment of chromosomal 
cohesin was as described [35]. An aliquot of this mix was taken as the time 
point 0. Then extract containing overexpressed separase was added and the 
mix was incubated at 25°C with light agitation. Aliquots were taken every minute 
and the reaction stopped by injecting the samples directly into preheated SDS- 
PAGE loading buffer. Samples were subjected to quantitative Western blotting: 
After Western transfer, membranes were blocked with Odyssey buffer (Ll- 
COR):PBS (1:1), and incubated with 12CA5 and 9E10 mouse monoclonal 
antibodies against the HA and myc epitope, respectively, and a goat anti-mouse 
IRDye800 coupled secondary antibody (LI-COR). The fluorescent signal was 
quantified using the Odyssey infrared imager (LI-COR) and Infrared Imaging 
System software. Scc1 at time point 0 was set to 100% and remaining full- 
length Scc1 was plotted over time. Scc1 cleavage by separase adhered closely 
to the characteristics of a first order reaction, and graphs were fitted with 
exponential regression (R2 typically > 0.9) using Excel software.
Dephosphorylation of Scc1 on Chromatin
Chromatin obtained from 50p,l cell lysate was resuspended in 200^1 
phosphatase buffer (50 mM Tris/HCI pH 7.5, 100 mM KCI, 0.1 mM EDTA, 2 mM 
MnCh, 5 mM dithiothreitol, 0.1% Triton X-100), and 2000 units lambda protein 
phosphatase (New England Biolabs) was added. Incubation was for 12 min at
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30°C, then the chromatin was recovered by centrifugation and washed once 
before it was used for the Scc1 cleavage assay [38]. To exclude that the effect 
observed after phosphatase treatment of the chromatin was due to residual 
amounts of phosphatase carried into the subsequent cleavage reaction, a 
control reaction was carried out in which 200 units of lambda phosphatase were 
added to the cel! extract. This had no effect on the efficiency of Scc1 cleavage 
in the assay.
Hyperphosphorylation by Polo of Scc1 in soluble cohesin
Cells containing an extra copy of the CDC5 gene, encoding Polo kinase, under 
control of the galactose inducible GAL promoter, were grown in raffinose and 
arrested in metaphase by addition of 5 ng/ml nocodazole for 2.5 hours. During 
this period, Polo expression was induced by adding 2% galactose 2h, 1h or 
0.5h before the final arrest point.
Phosphorylation shift assay
Strains containing phosphorylation site mutation were assayed for a 
phosphorylation band shift. Extracts were prepared using the glass bead 
method described above and run on a specialised 10% SDS-polyacrylamide gel 
containing an increased concentration of acrylamide to bis-acrylamide, which 
allowed greater separtation of proteins.
The ratio of acrylamide was increased from 29:1 to 200:1 by the addition of pure 
30% acrylamide solution to the gel mixture before pouring.
In vivo cleavage of chromatin-bound versus soluble Scc1
Arrest in metaphase and release into synchronous anaphase using CDC20 
under GAL promoter control was as described [38], but cultures were cooled to 
16°C before release. Aliquots of 5x108 cells were harvested in 5 min intervals 
and resuspended in ice-cold wash buffer. After completion of the time course, 
cells were resuspended in 200pJ EB buffer, added to 500\i\ glass beads and 
broken on an IKA-Vibrax shaker for 10 min. The crude cell extract was retrieved 
and separated into chromatin-enriched and supernatant fractions by 
centrifugation at 12,000 x g for 10 min. Small chromatin fragments in the soluble
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fraction were removed by a second round of centrifugation at 100,000 x g for 10 
min. The chromatin pellet was washed in EB buffer supplemented with 0.25% 
Triton X-100 to remove detergent soluble material, and resuspended in 200 \i\ 
of the same buffer for analysis by quantitative Western blotting as above.
Separase binding and cleavage of recombinant Scc1
Purification of phosphorylated Scc1 after overexpression in baculovirus infected 
insect cells, treated with Okadaic acid, was as described above. 
Dephosphorylation of purified Scc1 was performed using X-phosphatase (New 
England Biolabs). Separase and separase (C1531A) was purified after 
overexpression in yeast by chitin affinity chromatography as described [41]. 
Scc1 was added to separase decorated chitin beads, and cleavage or binding 
was analysed after 10 minutes at 25°C. SDS-PAGE loading buffer was directly 
added to stop the cleavage reaction, while the beads were washed extensively 
with EB buffer containing 0.25% Triton X-100 before bound Scc1 was analysed 
in SDS-PAGE loading buffer.
5.4 Microscopy
In situ immunofluorescence
In situ immunofluorescence was adapted from Michaelis et al. [134]. 1x105 cells 
were resuspended in 1 ml icecold formaldehyde buffer and either fixed over 
night at 4°C or immediately for 1h at 30°C. After washing in washing buffer the 
fixed cells were incubated at 30°C for 30min for spheroplastation in 
spheroplasting buffer. Cells were washed again and resuspended in 100-200|xl 
of wash buffer. For immunostaining 5-1 O^ il of cells were pipetted on 15 well 
slides pretreated with 0.1% polylysine. Cells were left to adhere for 5min, then 
excess cells and liquid were removed, plunged into icecold methanol for 3min, 
and then transferred to icecold acetone for 10sec. Slides were blocked in 
blocking buffer in a moist chamber for 20min. Incubation of the first and 
secondary antibody (concentrations are listed below) were for 1 hour interrupted 
by 3x washing with blocking buffer. After the secondary antibody incubation,
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slides were washed 4x in blocking buffer and 0.1ng/ml DAPI in antifade 
mounting medium was added to each well. The slides were covered with a 
cover slip and sealed with nail polish.
Immunofluorescence images were viewed with a Zeiss Co, Axioplan 2 imaging 
microscope attached to a Princeton Instrument cooled CCD digital camera. A 
laser scanning confocal microscope LSM510 (Zeiss Co.) was also used. 
Images were processed using IPlab software and Adobe ® Photoshop versions 
6 or 7.
Chromosome spreads
Yeast chromosome spreading was adapted from Michaelis et al. [134]. 1x106 
cells were resuspended in 1ml of Soli, then incubated for 5-10min at 37°C in 
SoM adding 20(xl 1M DTT and 14 1^ 10mg/ml zymolase T-100. The reaction was 
stopped by adding 1ml icecold Sol2. Cells were resuspended in 100-200^1 Sol2. 
Menzel SuperFrost slides were used for spreading. 20pJ of cell suspension was 
pipetted onto the slide, followed by 40^1 of fixative, 80\l\ of 1% lipsol and 
another 80pJ of fixative. The drop was distributed over the slide by moving a 
glass rod gently parallel to the slide. The slides were dried over night. After 
drying, the slides were washed in PBS, blocked in blocking buffer and incubated 
with first and second antibody (concentrations are listed below) for 2 hours 
interrupted by 10min washing in PBS. After the second antibody incubation, the 
slides were washed in PBS for 10min and 0.1 ng/ml DAPI in antifade mounting 
medium was added to each well. The slides were covered with a cover slip and 
sealed with nail polish.
Immunofluorescence images were viewed with a Zeiss Co, Axioplan 2 imaging 
microscope attached to a Princeton COOL CCD digital camera. Images were 
processed using IPlab software and Adobe ® Photoshop versions 6 or 7.
5.5 Antibodies used in Western blot, Immunoprecipitation (IP) analysis 
and Immunohistochemistry (in situ)
C-Myc9E10 mouse mono Babco 1/2000 western
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1/1000 IP
1/1000 in situ
C-Myc rabbit poly Gramsch 1/100 in situ
HA12CA5 mouse mono CRUK 1/5000 western 
1/1000 IP
HA16B12 mouse mono CRUK 1/15000 western 
1/1000 IP 
1/1000 in situ
FLAG-M2 mouse mono Sigma 1/1000 western 
1/100 IP
GST mouse mono Sigma 1/3000 western
Scc1 rabbit mono Dr.A.Strunikow 
NIH Bethesda
1/3000 western 
1/100 IP
Sc Pds1 rabbit mono Santa Cruz 1/200 western
GFP rabbit mono MBL, Japan 1/500 in situ
a-tubulin rat mono Serotec 1/200 in situ
Peroxidase mouse mono Sigma 1/2000 western
Mouse IgG goat Rockland via Tebu 1/5000 western
(For Odyssey Infrared Imaging System) Biosiences
Mouse IgG goat FluoroLink Cy2 1/200 in situ
Amersham Pharmacia Biotech
Mouse IgG goat FluoroLink Cy3 1/1000 in situ
Amersham Pharmacia Biotech
Mouse IgG sheep Amersham 1/5000 western
(For ECL detection) Pharmacia Biotech
Rabbit IgG goat FluoroLink Cy2 1/200 in situ
Amersham Pharmacia Biotech
Rabbit IgG goat FluoroLink Cy3 1/1000 in situ
Amersham Pharmacia Biotech
Rabbit IgG donkey Amersham 1/5000 western
(For ECL detection) Pharmacia Biotech
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5.6 Yeast physiology 
Budding yeast nomenclature
The gene names of budding yeast are typically shown as 3 upper italicised case 
letters and a number e.g. PDS1, a mutant allele is italicised and shown lower 
case letters e.g. pdsl .  Temperature sensitive mutant alleles of a gene are 
indicated by a suffix of ts in superscript. Proteins are named using the same 
three letters indicative of the gene but are not written in italics. Gene deletions 
which have been achieved using a specific marker are shown by the gene 
name followed by :: and the replacement marker gene name. E.g. pds1::URA3. 
A gene deletion can also be annotated by a A symbol.
Strain growth and maintenance
S. cerevisiae  cells were grown in either liquid media or on agar plates 
containing 2% agar. The contents of different media are shown above. Stocks 
of yeast strains were stored in 15% glycerol and maintained at -8 0  °C.
Insect cells were grown in Gibco™ Graces Insect Cell Culture Medium 
(Invitrogen).
Bacteria were grown in LB-medium containing 100p,g/ml ampicillin. 
Transformation of budding yeast
Transformations of plasmid DNA into yeast cells were carried out using Lithium 
Acetate and Poly Ethylene Glycol (PEG) as previously described (ref: Ito, 1983). 
50-100^1 cells (1x108) grown to mid logphase were spun down, washed in 
water, then washed in 1xTEL and resuspended in 100^1 1xTEL. Approximately 
1 \xg of plasmid DNA or PCR product was used for integrative transformations. 
0.05mg/ml denaturised salmon sperm DNA was added together with the 
plasmid or PCR DNA to 50^1 of cell suspension in TEL. 300pil TELP was added 
followed by a short vortex. After an incubation of 2-4 hours at 25°C, the 
transformations were heat shocked for 15 min at 42°C and plated on selective 
medium. Selective markers used in plasmid and integrant transformations were 
LEU2, URA3, HIS3, TRP1.
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Synchronous cultures:
G1 synchrony
Cells were grown to mid log phase in rich media, diluted to 1x106 cells/ml and 
1pg/ml of the pheromone a-factor was added. After 1 and 2 hours another 
0.5pg/ml were added. G1 synchrony was checked under the microscope 
(budding index). To release cells form the arrest, cells were filtered and washed 
with YEP media, then resuspended in rich media. Synchrony was measured by 
flow cytometric analysis (FACS).
Flow cytometry
106-107 cells/ml from relevant cultures were fixed in 70% ethanol. Cells were 
pelleted and rehydrated in 3ml 50mM Na3Citrate and then resuspended in 1ml 
50mM Na3Citrate containing 0.1 mg RNase A, 2p,g/ml propidium iodide and 
incubated for 4hrs at 37°C. Before analysis cells were sonicated for 30s at 
setting 5 (soniprep 150 sonicator MSE). Flow cytometry was performed as 
described previously [143] using a Becton-Dickinson FAC Scan with an 
excitation wavelength of 488nm and a detection wavelength of 510-550nm. 
Data analysis used the CELL QUEST software package.
S-phase arrest
Cells were grown to mid log phase in rich media (1x108/ml). 100mM 
hydroxyurea (HU) was added and large budded cells, indicating an S-phase 
arrest, were scored under the microscope after 2 hours.
G2 synchrony
Cells were grown to mid log phase in rich media (1x108/ml). 5pg/ml nocodazole 
(sigma) with 1% DMSO was added and large budded cells, indicating a 
metaphase arrest, were scored under the microscope after 2 hours.
Strains expressing Cdc20 from the GAL1-10 promoter were grown in complete 
medium containing 2% raffinose as carbon source. The GAL1-10 promoter was 
induced by adding 2% galactose. Metaphase arrest due to Cdc20 depletion was 
obtained in cells with CDC20 under control of the GAL1-10 promoter by shifting 
to medium containing raffinose only. For release from the arrest, 2% galactose
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was added back to the culture.
5.7 Budding yeast strains
Name Description Derivation
699 MATa, ade2-1, can1-100, trp1-1, Ieu2-3,112, his3-11,15, 
ura3, GAL, psi+,
Kim
Nasmyth
700 MATalpha, ade2-1, can1-100, trp1-1, Ieu2-3,112, his3- 
11,15, ura3, GAL, psi+,
Kim
Nasmyth
58 MATa, Scc1-myc18::TRP, ura3::URA3 tetOs, leu2::LEU2 
his::HIStetR-GFP, leu2-3, 112
Frank
Uhlmann
157 MATa, ade2-101, CAN+, Iys2-801, trp1-1, leu2D1,112, 
his3D200, CFIII (CEN3.L.YPH278) URA3SUP11
P.Hieter/
Christine
192 MATa, ura3::3xURA3 teto112, his::HIStetR-GFP Attila Toth
189 MATa, Esp1-myc18::TRP, ade2-1, can1-100, Ieu2-3,112, 
his3-11,15, ura3, GAL, psi+,
Rafal Ciosk
8869 MATa, ade2-1, can1-100, trp1-1, Ieu2-3,112, Scc1- 
HA6::HIS, ura3, GAL, psi+,
Gabriela
Alexandru
8646 MATa, ade2-1, can1-100, trp1-1, Ieu2-3,112, 
GALCDC5::HIS3, Scc1-HA6::HIS, cdc5::URA3, GAL, psi+,
Gabriela
Alexandru
291 MATa, pds1::URA3, Scc1-HA3::TRP, ura3::URA3 tetOs, 
leu2::LEU2 tetR-GFP, Esp1-myc18::HIS3
this study
292 MATa, tetR-GFP:LEU2, TetOx200:URA3, Esp1myc18::HIS3 this study
334 MATa, tetR-GFP:LEU2, TetOx200: GAL-Flag-Esp1- 
CBD::TRP1 ,his::HIStetR-GFP
this study
335 MATa, pds1::URA3, ura3::URA3 tetOs, leu2::LEU2, GAL- 
Flag-Esp1 -CBD:TRP1
this study
336 MATa, GAL-Flag-ESP1 (1391 -1630)-CBD, tetR-GFP:LEU2, 
TetOx200:URA3, TRP1
this study
358 MATa, ESP1-myc18::TRP1, GAL1-PDS1-mdb on pRS305 
LEU2
this study
363 MATa, ade2-1, can1-100, leu2-3, 112, his3-11,15, ura3, 
GAL, psi+, pep4::URA3, bar1::hisG, GAL-Flag-Esp1- 
CBD::TRP1
this study
364 MATa, ade2-1, can1-100, Ieu2-3,112, his3-11,15, ura3, 
GAL, psi+, pep4::URA3, bar1::hisG, GAL-Flag- 
Esp1(H1505A)-CBD::TRP1
this study
367 MATa, GAL-Flag-ESP1 (1196-1630)-CBD, tetR-GFP:LEU2, 
TetOx200:URA3, TRP1
this study
373 MATalpha, GAL-Flag-ESP1(156-1630)-CBD, esp1-1, 
ura3::URA3 tetOs, leu2::LEU2 tetR-GFP, his3-11, TRP1
this study
455 MATa, tetR-GFP:LEU2, TetOx200:URA3, Esp1- 
myc18::HIS3, Pds1-HA3::TRP
this study
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456 Mat a, clb1 del, clb3::TRP1, clb4::HIS3, clb2-VI rt 37 C, 
Esp1-myc18:URA
this study
463 MATa, ade2-1, can1-100, Ieu2-3,112, GAL-Esp1(1390- 
1630)::TRP, his3-11,15, ura3, GAL, psi+
this study
465 MATa, ade2-1, can1-100, Ieu2-3,112, GAL-Esp1(1196- 
1630)::TRP, his3-11,15, ura3, GAL, psi+
this study
467 MATa, ade2-1, can1-100, Ieu2-3,112, GAL-Esp1(156- 
1630)::TRP, his3-11,15, ura3, GAL, psi+
this study
480 MATa, ade2-1, can1-100, his3-11,15, ura3, GAL, psi+, 
pep4::URA3, bar1::hisG, GAL-Flag-Esp1-CBD::TRP1, GAL- 
SCC1-HA3::LEU2
this study
483 MATa, ade2-1, can1-100, his3-11,15, ura3, GAL, psi+, 
pep4::URA3, bar1::hisG, GAL-Flag-Esp1(H1505A)- 
CBD::TRP1, GAL-SCC1-HA3::LEU2
this study
487 MATa, ade2-1, can1-100, Ieu2-3,112, ura3, GAL, psi+, 
pep4::URA3, bar1::hisG, GAL-Flag-Esp1(H1505A)- 
CBD):TRP1, Scc1-HA6::HIS5
this study
488 MATa, ade2-1, trp1-1, can1-100, Ieu2-3,112, his3-11,15, 
GAL, psi+, Esp1-myc18::URA3
this study
490 MATalpha,ade2-1,trp1-1,can1-100, his3-11,15, ura3, GAL, 
psi+, GAL-Flag-ESP1 (1-1195)::LEU2
this study
491 MATa, ade2-1, can1-100, Ieu2-3,112, Esp1(156- 
1630)::TRP, his3-11,15, ura3, GAL, psi+
this study
492 MATa, ade2-1, can1-100, GAL-Flag-Esp1(1390- 
1630)::TRP, his3-11,15, ura3, GAL, psi+, GAL-SCC1-HA3 
(LEU2)
this study
494 MATa, ade2-1, can1-100, GAL-Flag-Esp1(1196- 
1630)::TRP, his3-11,15, ura3, GAL, psi+ , GAL-SCC1-HA3 
(LEU2)
this study
496 MATa, ade2-1, can1-100, GAL-Flag-Esp1(156-1630)::TRP, 
his3-11,15, ura3, GAL, psi+, GAL-SCC1-HA3 (LEU2)
this study
498 MATa, Crm1T539C, ade2-1, trp1-1, can1-100, Ieu2-3,112, 
his3-11,15, ura3, GAL, psi+
this study
499 MATa, Crm1T539C, ade2-1, trp1-1, can1-100, Ieu2-3,112, 
ura3, GAL, psi+, Esp1myc18::HIS
this study
532 MATa/Matalpha, ade2-1/ade2-1, can1-100/can1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1390- 
1630)::TRP1/trp1-1, GAL-Flag-ESP1(1-1195)::LEU2/leu2- 
3,112, GAL/GAL, psi+/psi+
this study
533 MATa/Matalpha, ade2-1/ade2-1, can1-100/can1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1196- 
1630)::TRP1/trp1 -1, GAL-Flag-ESP1(1-1195)::LEU2/leu2- 
3,112, GAL/GAL, psi+/psi+
this study
538 MATalpha,GAL-Flag-ESP1(1-370)::LEU,ade2-1,trp1-1, 
can1-100, his3-11,15,ura3,GAL,psi+
this study
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539 MATalpha,GAL-Flag-ESP1 (1 -175)::LEU,ade2-1 ,trp1 -1, 
can1 -100, his3-11,15,ura3,GAL,psi+
this study
540 MATa/Matalpha, ade2-1/ade2-1, can 1-100/can 1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1390- 
1630)::TRP1/trp1-1, GAL-Flag-ESP1(1-370)::LEU2/leu2- 
3,112, GAL/GAL, psi+/psi+
this study
541 MATa/Matalpha, ade2-1/ade2-1, can 1-100/can 1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1196- 
1630)::TRP1/trp1-1, GAL-Flag-ESP1(1-370)::LEU2/leu2- 
3,112, GAL/GAL, psi+/psi+
this study
542 MATa, Crm1T539C, ade2-1, trp1-1, can1-100, Ieu2-3,112, 
GAL, psi+ , Esp1myc18::HIS, deltapds1::URA
this study
543 MATa, ESP1-myc18::TRP1, pds1::URA this study
561 MATa/Matalpha, ade2-1/ade2-1, can 1-100/can 1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1390- 
1630)::TRP1/trp1-1, GAL-Flag-ESP1(1-175)::LEU2/leu2- 
3,112, GAL/GAL, psi+/psi+
this study
562 MATa/Matalpha, ade2-1/ade2-1, can 1-100/can 1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1196- 
1630)::TRP1/trp1 -1, GAL-Flag-ESP1(1-175)::LEU2/leu2- 
3,112, GAL/GAL, psi+/psi+
this study
576 MATa, ESP1-myc18::TRP1, GAL1-PDS1-mdb on pRS305 
LEU2, pds1::URA3
this study
610 MATalpha,Ylp128 GAL-Flag-ESP1 (156-1195), ade2-1, trpl- 
1,can1-100,his3-11,15,ura3,GAL, psi+
this study
611 MATa/Matalpha, ade2-1/ade2-1, can1-100/can1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1390- 
1630)::TRP1/trp1-1, GAL-Flag-ESP1(156- 
1195)::LEU2/leu2-3,112, GAL/GAL, psi+/psi+
this study
612 MATa/Matalpha, ade2-1/ade2-1, can1-100/can1-100, his3- 
11,15/his3-11,15, ura3/ura3, GAL-Flag-ESP1(1196- 
1630)::TRP1/trp1-1, GAL-Flag-ESP1(156- 
1195)::LEU2/leu2-3,112, GAL/GAL, psi+/psi+
this study
644 MATa, tetR-GFP:LEU2, TetOx200:URA3, GAL-Flag- 
ESP1 (K809N)(K810N)(K811 N)-HA6:TRP
this study
646 MATa, pds1::URA3, ura3::URA3 tetOs, leu2::LEU2 tetR- 
GFP, GAL-Flag-ESP1 (K809N)(K810N)(K811 N)-HA6:TRP
this study
682 MATa, ade2-1, can1-100, ura3, GAL-Flag-ESP1(1390- 
1630)::TRP 1 /trp 1-1, GAL-Flag-ESP1 (156- 
1195)::LEU2/leu2-3, HIS/ his3-11,15 GAL-Pds1::LEU/leu2- 
3,112, GAL, psi+
this study
717 Mat alpha, ade2-1, ura3-1, his3-11,15, Ieu2-3,112, canl- 
100, xpol ::LEU2(pKW457-xpo1 -1-HIS3), Esp1myc18::TRP
this study
718 Mat alpha, ade2-1, his3-11,15, Ieu2-3,112, can1-100, 
xpo1::LEU2(pKW457-xpo1-1-HIS3), Esp1myc18::TRP, 
pds1::URA
this study
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727 MATalpha,GAL-Flag-ESP1 (1-175): :LEU ,ade2-1, trp1 -1, 
can1-100, ura3, HIS, GAL, psi+
this study
730 Mata, ade2-1, his3-11,15, can1-100, xpo1::LEU2(pKW457- 
xpo1-1-HIS3), Esp1myc18::TRP, tetR-GFP:LEU2, 
TetOx200:URA3
this study
759 MATa, tetR-GFP:LEU2, TetOx200:URA3, GAL-Flag- 
ESP1 (L163A,L166A.L169A)-CBD::TRP
this study
760 MATa, pds1::URA3, ura3::URA3 tetOs, leu2::LEU2 tetR- 
GFP, GAL-Flag-ESP1 (L163A,L166A,L169A)-CBD::TRP
this study
761 MATa, ade2-1, can1-100, Esp1 (1196-1630)::TRP, GAL1- 
PDS1-mdb on pRS305::LEU2, his3-11,15, ura3, GAL, psi+
this study
762 MATa, ade2-1, can1-100, Esp1(156-1630)::TRP, GAL1- 
PDS1-mdb on pRS305::LEU2, his3-11,15, ura3, GAL, psi+
this study
763 MATa, GAL-PDS1-mdb::LEU, GAL-Flag-ESP1-CBD::TRP, 
ade2-1, can1-100, his3-11,15, ura3, GAL, psi+
this study
764 MATa, ade2-1, GAL-SCC1-HA3::TRP1, can1-100, Ieu2- 
3,112, his3-11,15, ura3, GAL, psi+
this study
765 MATa, ade2-1, GAL-SCC1 -HA3::TRP1 ,GAL1 -PDS1 -mdb 
on pRS305::LEU2, can1-100, his3-11,15, ura3, GAL, psi+
this study
1134 MATa, Scc1myc18::HIS3, Gal-Scc1-HA3::TRP, tetR- 
GFP:LEU2, TetOx200:URA3
this study
1135 MATa, Scc1myc18::HIS3, Gal-Scc1(S183A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
1136 MATa, Scc1myc18::HIS3, Gal-Scc1(S194A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
1137 MATa, Scc1myc18::HIS3, Gal-Scc1(S273A,S276A)- 
HA3::TRP, tetR-GFP:LEU2, TetOx200:URA3
this study
1138 MATa, Scc1myc18::HIS3, Gal-Scc1(S325A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
1139 MATa, Scc1myc18::HIS3, Gal-Scc1(S374A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
1140 MATa, Scc1myc18::HIS3, Gal-Scc1(S389A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
1141 MATa, Scc1myc18::HIS3, Gal-Scc1(S497A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
1142 MATa, Scc1myc18::HIS3, Gal-
Scc1 (S183A,S273A,S276A,S325A)-HA3::TRP, tetR-
GFP:LEU2, TetOx200:URA3
this study
1143 MATa, Scc1myc18::HIS3, Gal-Scc1(S374,S389A)- 
HA3::TRP, tetR-GFP:LEU2, TetOx200:URA3
this study
1144 MATa, Scc1myc18::HIS3, Gal-Scc1(S374,S389A,S497A)- 
HA3::TRP, tetR-GFP:LEU2, TetOx200:URA3
this study
1145 MATa, Scc1myc18::HIS3, Gal-Scc1(S183A,374A,S389A)- 
HA3::TRP, tetR-GFP:LEU2, TetOx200:URA3
this study
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1146 MATa, Scc1myc18::HIS3, Gal- 
Scc1(S183AI374A,S389A,S497A)-HA3::TRP, tetR- 
GFP:LEU2, TetOx200:URA3
this study
1147 MATa, Scc1myc18::HIS3, Gal-
Scc1 (S273A,S276A,S374A,S389A)-HA3::TRP, tetR-
GFP:LEU2, TetOx200:URA3
this study
1148 MATa, Scc1myc18::HIS3, Gal-Scc1(S273A,S276A,S374A, 
S389A,S497A)-HA3::TRP, tetR-GFP:LEU2, 
TetOx200:URA3
this study
1149 MATa, Scc1 mycl8::HIS3, Gal-Scc1 (S183A,S273A,S276A, 
S325A,S374A,S389A)-HA3::TRP, tetR-GFP:LEU2, 
TetOx200:URA3
this study
1150 MATa, Scc1myc18::HIS3, Gal-Scc1(S183A,S273A,S276A, 
S325A,S374A,S389A)-HA3::TRP, tetR-GFP:LEU2, 
TetOx200:URA3
this study
1151 MATa, Scc1myc18::HIS3, Gal-Scc1(S183A,S273A,S276A, 
S325A,S374A,S389A,S497A)-HA3::TRP, tetR-GFP:LEU2, 
TetOx200:URA3
this study
1186 MATa, Scc1myc18::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, Scc1promoterScc1-HA3 ::TRP
this study
1187 MATa, Scc1myc18::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, Scc1promoterScc1(S183A)-HA3 ::TRP
this study
1188 MATa, Scc1myc18::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, Scc1promoterScc1(S194A)-HA3 ::TRP
this study
1189 MATa, Scc1myc18::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, Scc1 promoterScd (S273A,S276A)-HA3 
::TRP
this study
1190 MATa, Scc1myc18::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, Scc1 promoterScd (S325A)-HA3 ::TRP
this study
1191 MATa, Scc1myc18::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, S cd  promoterScd (S374A)-HA3 ::TRP
this study
1192 MATa, Scd mycl 8::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, Scd promoterScd (S389A)-HA3 ::TRP
this study
1193 MATa, Scd mycl 8::HIS3, tetR-GFP:LEU2, 
TetOx200:URA3, S cd  promoterScd (S497A)-HA3 ::TRP
this study
1215 MATa, ade2-1, can1-100, Ieu2-3,112, psi+, Esp1- 
myc18::URA3, GAL1-CDC20::TRP, Scc1-HA6::HIS
this study
1216 MATa, Scd mycl 8::HIS3, Gal-Scc1(S183A,S194A,S263A, 
S273A,S276A,S325A,S374A,S389A)-HA3::TRP, tetR- 
GFP:LEU2, TetOx200:URA3
this study
1217 MATa, Scd mycl 8::HIS3, Gal-Scc1(S175A,S183A,S194A, 
S263A,S273A,S276A,S325A,S374A,S389A)-HA3::TRP, 
tetR-GFP:LEU2, TetOx200:URA3
this study
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1218 MATa, Scc1myc18::HIS3, GalScc1(S175A,S183A,S194A, 
S263A,S273AIS276A,S325A,S374AJS389A, S497A)- 
HA3::TRP, tetR-GFP:LEU2, TetOx200:URA3
this study
1243 MATa, ade2-1, trp1-1, can1-100, his3-11,15, GAL, psi+, 
Esp1-myc18::URA3, Esp1promoter-Esp1-HA6::LEU
this study
1244 MATa, ade2-1, trp1-1, can1-100, leu2-3, Esp1-HA6::HIS, 
ura3, GAL, psi+
this study
1287 MATa, ade2-1, can1-100, Ieu2-3,112, his3-11,15, GAL, 
psi+, bar-, Scc1promoter-Scc1-HA3::TRP,GAL- 
SCC1myc18, scc1::URA3
this study
1288 MATa, ade2-1, can1-100, Ieu2-3,112, his3-11,15, GAL, 
psi+, bar-, Scc1promoter-Scc1(S175A,S183A, 
A194A,S263A,
S273A,S276A,S325A,S374A,S389A,S497A)-HA3::TRP, 
GAL-SCC1myc18, scc1::URA3
this study
1295 MATa, ura3-52, Iys2-801, ade2-101, CAN+, his3A200, 
leu2A1, CFIII (CEN3.L.YPH278) URA3SUP11, 
Scc1promoter-SCC1-HA3::TRP
this study
1296 MATa, ade2-1, can1-100, trp1-1, his3-11,15, GAL, psi+, 
bar-, Scc1promoter-Scc1(S175A,S263A)-HA3::LEU, GAL- 
SCC1myc18, scc1::URA3
this study
1297 MATa, ura3-52, Iys2-801, ade2-101, CAN+, his3A200, 
leu2A1, CFIII (CEN3.L.YPH278) URA3SUP11,
Scc1 promoter SCC1 (S175A,S183A.A194A,S263A,S273A, 
S276A, S325A,S374A,S389A,S497A)-HA3::TRP
this study
1306 MATa, ura3-52, Iys2-801, ade2-101, CAN+, his3A200, 
leu2A1, CFIII (CEN3.L.YPH278) URA3SUP11,
Scc1 promoter-SCC1 (S175A,S183A,A194A,S263A,S273A, 
S276A, S325A, S374A,S389A,S497A)-HA3::TRP, 
AScc1::HIS
this study
1316 MATa, ade2-1, ura3, can1-100, leu2-3, his3-11,15, GAL, 
psi+, Esp1-myc18::TRP
this study
1444 MATa, ade2-1, can1-100, his3-11,15, Pds1-myc18::URA, 
GAL-CDC20::TRP, S cd  promoterScd (S175A,S263A)-HA3 
(LEU2), psi+
this study
1445 MATa, ade2-1, can1-100, Pds1-myc18::URA, GAL- 
CDC20::TRP, S cd  promoterScd (S175A,S263A)-HA3 
(LEU2),scc1::HIS, psi+
this study
1446 MATa, ade2-1, can1-100, his3-11,15, Pds1-myc18::URA, 
GAL-CDC20::LEU, Scd promoterScd-HA3 (TRP), psi+
this study
1447 MATa, ade2-1, can1-100, Pds1-myc18::URA, GAL- 
CDC20::LEU, S cd  promoterScd-HA3 (TRP), scc1::HIS, 
psi+
this study
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1448 MATa, ade2-1, can1-100, his3-11,15, Pds1-myc18::URA, 
GAL-CDC20::LEU, Scd promoter- 
SCC1 (S175A.S183A.A194A,S263A,S273AJS276A,S325A> 
S374A,S389A,S497A)-HA3 (TRP1), psi+
this study
1449 MATa, ade2-1, can1-100, Pds1-myc18::URA, GAL- 
CDC20::LEU, Scc1 promoter-SCC1 (S175A.S183A, 
S194A,S263A,S273A,S276A,S325A,S374A,S389A,S497A)- 
HA3::TRP1, scc1::HIS, psi+
this study
1540 MATa, SCC1-HA6::HIS3, Gal-Cdc5::URA this study
1569 MATa, ade2-1, can1-100, leu2-3, his3-11,15, ura3, GAL, 
psi+, Scc1-HA3::TRP
this study
1570 MATa, SCC1-HA6::HIS3, CDC5-myc18::URA this study
1571 MATa, ade2-1, trp1-1, can1-100, Ieu2-3,112, GAL, psi+, 
bar-, GAL-SCC1myc18, scc1::URA3, CDC5 HA6::HIS
this study
1572 MAT alpha,ade2-1 ,can1 -100,leu2-3,112,his3-
11,15,ura3,GAL,psi+, Scd promoter-
SCC1 (S175A,S183A,A194A,S263A,S273A,S276A,S325A,S
374A,S389A,S497A)-HA3::TRP1
this study
1576 MATalpha,ade2-1,can1-100,leu2-3,112,ura3,GAL,psi+, 
S cd promoter-SCC1 (S175A,S183A,A194A,S263A,S273A, 
S276A,S325A,S374A,S389A,S497A)-HA3::TRP1, 
AScc1::HIS
this study
1585 MATa, ade2-1, can1-100, Ieu2-3,112, his3-11,15, GAL, 
psi+, Scc1-HA3::TRP, GAL-CDC5::URA
this study
1633 MATa, Scd mycl 8::HIS3,
S cd  promoterScd (S183A.S194A,S273A,S276A,S325A)- 
HA3::TRP, tetR-GFP:LEU2, TetOx200:URA3
this study
1634 MATa, Scd mycl 8::HIS3,
S cd  promoterScd (S374A,S389A,S497A)-HA3::TRP, tetR- 
GFP:LEU2, TetOx200:URA3
this study
1635 MATa, Scd mycl 8::HIS3,
S cd  promoterScd (S183A,S194A,S273A,S276A,S325A,S3 
74A,S389A,S497A)-HA3::TRP, tetR-GFP:LEU2, 
TetOx200:URA3
this study
5.8 Plasmids
Name Description Derivation
1 Ylplac128 LEU2 based integrative vector (see Gietz and Sugino 1988, Gene 74, p. 527)
Gietz and 
Sugino
2 Ylplac204 TRP1 based integrative vector Gietz and
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(see Gietz and Sugino 1988, Gene 74, p. 527) Sugino
3 Ylplac211 URA3 based integrative vector (see Gietz and Sugino 1988, Gene 74, p. 527)
Gietz and 
Sugino
9 pRS303 HIS3 based integrative vector(see Sikorski and Hieter 1989, Genetics 122, p. 19)
Sikorski and 
Hieter
13
Ylp128GAL GAL1-10 promoter between EcoRI and 
BamHI of Ylp128
(towards BamHI is the GAL1 side; both EcoRI and 
BamHI are still available)
Frank
Uhlmann
14
Ylp204GAL GAL1-10 promoter between EcoRI and 
BamHI of Ylp204
(towards BamHI is the GAL1 side; both EcoRI and 
BamHI are still available)
Frank
Uhlmann
15
Ylp211GAL GAL1-10 promoter between EcoRI and 
BamHI of Ylp211
(towards BamHI is the GAL1 side; both EcoRI and 
BamHI are still available)
Frank
Uhlmann
17 pGEX-KG cloning vector for bacterial expression, adding a GST-tag plus a glycine linker and thrombin site
Neil
McDonald
22 pFastBad Baculovirus transfer cloning vector GIBCO
29 pTYB2 Bacterial expression vector, introducing an Intein- Chitin binding domain tag.
New England 
Biolabs
33 myc9-KITRP1 in pl)C19 for one step tagging WolfgangZachariae
34 myc18-KITRP1 in pUC19 for one step tagging WolfgangZachariae
35 HA3-KITRP1 in pUC19 for one step tagging WolfgangZachariae
36 HA6-SpHIS5 in pl)C19 for one step tagging (SpHIS5 complements ScHIS3)
Gustav
Ammerer
37 HA3-SpHIS5 in pUC19 for one step tagging (SpHIS5 complements ScHIS3)
Wolfgang
Zachariae
38 myc18-SpHIS5 in pUC19 for one step tagging (SpHIS5 complements ScHIS3)
Wolfgang
Zachariae
39
myc18-KIURA3 in pUC19 for one step tagging 
derived from 34: TRP1 cut out with Bglll + Stul and 
replaced by K. lactis URA3 as a Bglll, Stul PCR fragment
Frank
Uhlmann
40
HA3-KIURA3 in pUC19 for one step tagging 
derived from 35: TRP1 cut out with Bglll + Stul and 
replaced by K. lactis URA3 as a Bglll, Stul PCR fragment
Frank
Uhlmann
68 Ylp204 GAL-SCC1myc9 (TRP1) Spe1 myc9 cassette in 67
Frank
Uhlmann
69
Ylp128 GAL-SCC1-Notl (LEU2)
Xbal-Sphl PCR fragment of entire Scc1 with Notl before 
Stop in 13. Xbal in frame with start (TCT AGA ATG ...), 
Notl before Stop is (.GC GGC CGC TAA).
Frank
Uhlmann
70
Ylp128 GAL-SCC1-HA3 (LEU2)
Notl HA3 cassette in 69
cut with EcoRV for integration at LEU2
Frank
Uhlmann
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86
Ylp128 Scc1 promoterScd-HA3 (LEU2)
EcoRI-Xbal promoter fragment from 77 and Xbal-Sphl 
Scc1-HA3 fragment from 70 in Ylp128
Frank
Uhlmann
90 Ylp128 Scc1 promoterScd (S175A,S263A)-HA3 (LEU2) S175A.S263A mutations in 86
Frank
Uhlmann
91 Ylp204 GAL-SCC1-HA3 (TRP1)Xbal-Sphl fragment containing S cd-H A3 from 70 into 14
Frank
Uhlmann
94 Ylp204 GAL-SCC1 (S175A,S263A)-HA3 (TRP1) S175A.S263A double mutation in 91
Frank
Uhlmann
98
pFastBac Scd-FLAG-lnteinCBD 
Xbal-Xhol fragment of 76 cloned into Spel-Xhol of pFB1 
(22)
Frank
Uhlmann
135
Ylp204 GAL-ESP1-Flag
C-terminal Flag tag by linker insertion into the BstEII site 
close to the end of ESP1 in 133
Frank
Uhlmann
136
Ylp204 GAL-Flag-ESP1 -Xhol
Xhol site introduced into ESPI before Stop by linker
insertion into the BstEII site close to the end of ESP1 in
134
Frank
Uhlmann
140
Ylp204 GAL-Flag-ESP1 -CBD 
CBD amplified from pTYB2 (29) without the intein. Xhol 
introduced 5' of CBD and Sail after Stop. Placed into 
Xhol in 136.
Linearise with BstXI for integration at TRP1
Frank
Uhlmann
141
Ylp204 GAL-Flag-ESP1 -CBD 
CBD amplified from pTYB2 (29) without the intein. Xhol 
introduced 5' of CBD and Sail after Stop. Placed into 
Xhol in 136.
(two amino acids in the linker between Esp1 and the 
CBD changed through PCR mutation. Fully functional.)
Frank
Uhlmann
142
Ylp204 GAL-Flag-ESP1 (H1505A)-CBD
H1505A mutation in 141, by exchanging a Ncol (ESP1),
Xhol (end of ESP1) fragment.
Frank
Uhlmann
143
Ylp204 GAL-Flag-ESP1(C1531A)-CBD
C1531A mutation in 141, by exchanging a Ncol (ESP1),
Xhol (end of ESP1) fragment.
Frank
Uhlmann
193 Ylp204GAL-Flag-ESP1 (1391 -1630)-CBD Xba/Xho1 This study
194 Ylp204GAL-Flag-ESP1 (1196-1630)-CBD Xba/Xho1 This study
197 Ylp204GAL-Flag-ESP1 (156-1630)-CBD Xba/Xho1 This study
220
Ylplac211 (URA3 based integrative vector), Crm1 (Pvull 
cut) is cloned into the Pvull site of this vector This study
233 Ylp128 GAL-Flag-ESP1 (1-370), Xbal-flag-ESP1-Xho1- TAA-Hindlll This study
234 Ylp128 GAL-Flag-ESP1 (1-175), Xbal-flag-ESP1-Xho1- TAA-Hindlll This study
243 Ylp204,GAL-Flag-ESP1 -HA6 This study
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HA6 cloned in Xhol site of 136
244
Ylp204 GAL-Flag-ESP1 (K809N)(K810N)(K811N)- 
HA6NLS mutated and Xhol site used to put in HA6-tag This study
311 Ylp128 GAL-Flag-ESP1 (156-1195), Xbal-flag-ESP1- TAA-Hindlll This study
330
Ylp204 GAL-Flag-ESP1 (L163A,L166A,L169A)-CBD 
putative NES mutation that is proteolytically inactive, but 
did not lead to nuclear accumulation This study
331 Ylp204 GAL-Flag-ESP1 (K526A,E529A,S531 A)-CBD This study
332 Ylp204 GAL-Flag-ESP1 (S1144A.E1148A,R1151 A)-CBD This study
387
Ylp204 Scc1 promoterScd-HA3 (TRP)
EcoRI-Xbal promoter fragment and Xbal-Sphl Scc1-HA3 
fragment from 86 in Ylp204
This study
404 Ylp204 S cd  promoterScd (S183A)-Notl-STOP (TRP) This study
405 Ylp204 Scd promoterScd (S194A)-Notl-STOP (TRP) This study
406
Ylp204 S cd  promoterScd (S273A,S276A)-Notl-STOP 
(TRP) This study
407 Ylp204 S cd  promoterScd (S325A)-Notl-STOP (TRP) This study
408
Ylp204
S cd promoterScd (S183A.S194A,S273A,S276A,S325A) 
-HA3-STOP (TRP) This study
409 Ylp204 S cd  promoterScd (S389A)-Notl-STOP (TRP) This study
410 Ylp204 S cd  promoterScd (S497A)-Notl-STOP (TRP) This study
411
Ylp204 Scd promoterScd (S183A)-HA3-STOP (TRP) 
HA3 casette into Notl of 404 This study
412
Ylp204 S cd  promoterScd (S194A)-HA3-STOP (TRP) 
HA3-casette into Notl of 405 This study
413
Ylp204 S cd  promoterScd (S273A,S276A)-HA3-STOP 
(TRP) HA3-casette into Notl of 406 This study
414 Ylp204 S cd  promoterScd (S325A)-HA3-STOP (TRP) HA3-casette into Notl of 407 This study
415
Ylp204 S cd  promoterScd (S374A)-HA3-STOP (TRP) 
HA3-casette into Notl of 408 This study
416
Ylp204 S cd  promoterScd (S389A)-HA3-STOP (TRP) 
HA3-casette into Notl of 409 This study
417 Ylp204 Scd promoterScd (S497A)-HA3-STOP (TRP) This study
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HA3-casette into Notl of 410
418
Ylp204 GAL-SCC1 (S183A)-HA3 (TRP1) Hindlll fragment 
from 411 into 67 This study
419
Ylp204 GAL-SCC1 (S194A)-HA3 (TRP1) 
Hindlll fragment from 412 into 67 This study
420
Ylp204 GAL-SCC1 (S273A,S276A)-HA3 (TRP1) 
Hindlll fragment from 413 into 67 This study
421
Ylp204 GAL-SCC1 (S325A)-HA3 (TRP1) 
Hindlll fragment from 414 into 67 This study
422
Ylp204 GAL-SCC1 (S374A)-HA3 (TRP1) 
Hindlll fragment from 415 into 67 This study
423
Ylp204 GAL-SCC1 (S389A)-HA3 (TRP1) 
Hindlll fragment from 416 into 67 This study
424
Ylp204 GAL-SCC1 (S497A)-HA3 (TRP1) 
Hindlll fragment from 417 into 67 This study
463
Ylp204 GAL-SCC1 (S183AIS273A,S276A,S325A)-HA3 
(TRP1) This study
464 Ylp204 GAL-SCC1 (S374A,S389A)-HA3 (TRP1) This study
465 Ylp204 GAL-SCC1 (S374A,S389A,S497A)-HA3 (TRP1) This study
467 Ylp204 GAL-SCC1 (S183A,S374A,S389A)-HA3 (TRP1) This study
468
Ylp204 GAL-SCC1 (S183A,S374A,S389A>S497A)-HA3 
(TRP1) This study
469
Ylp204 GAL-SCC1 (S273A,S276A,S374A,S389A)-HA3 
(TRP1) This study
471
Ylp204 GAL-
SCC1 (S183A>S273A>S276A,S325A,S374A,S389A)-HA3 
(TRP1) This study
472
Ylp204 GAL-
SCC1 (S183A>S273A>S276A,S325A,S374AJS389A>S497 
A)-HA3 (TRP1) This study
485
Ylp204 GAL-
SCC1 (S175A.S183AIS273A>S276A,S325AJS374A>S389 
A,S497A)-HA3 (TRP1)
Acc1 fragment from 94(S175A) into 472
This study
487 Ylp204 GAL- This study
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SCC1 (S183A.S194A>S273A,S276A,S325A)-HA3 (TRP1)
488
Ylp204 GAL-
SCC1 (S175A.S183A,S194AJS273A,S276A>S325A)-HA3 
(TRP1) This study
489
Ylp204 GAL-
SCC1(S183AJS194A,S273AJS276A>S325A>S374A,S389 
A)-HA3 (TRP1) This study
490
Ylp204 GAL-
SCC1 (S175A.S183A,S194A,S273A,S276A,S325A,S374 
A,S389A)-HA3 (TRP1) This study
491
Ylp204 Scc1 promoterScd (S374A,S389A,S497A)-HA3 
(TRP1) This study
492
Ylp204
S cd  promoterScd (S183A,S194A,S273A>S276A,S325A, 
S374A>S389A,S497A)-HA3 (TRP1) This study
493
Ylp128 GAL-
SCC1 (S175A.S183A.A194A,S263A,S273A,S276A,S325 
A,S374A>S389A,S497A)-HA3 (LEU)
Xba/Sph1 fragment form 505 into 70
This study
496
Ylp204 GAL-
SCC1 (S183A,S194AJS263AJS273A,S276AIS325A,S374 
A,S389A)-HA3 (TRP1) This study
502
Ylp204 GAL-
SCC1(S175A>S183A,S194A,S263A,S273A>S276A,S325 
A,S374A>S389A)-HA3 (TRP1) This study
505
Ylp204 GAL-
SCC1 (S175A,S183A,A194A,S263AIS273A>S276A>S325 
A,S374A,S389A,S497A)-HA3 (TRP1) This study
509
Ylplad28-Esp1 promoter-ESP1 -HA6 (wt)
430 was Xhol cut and the proteinA-tag was replaced by 
the HA-tag of 243
This study
524
Ylp204 Scdpromoter-
SCC1 (S175A.S183A.S194A,S263A,S273A,S276A>S325 
AJS374A,S389A)-HA3 (TRP1)
Hindlll fragment from 502 into 387
This study
525
Ylp204 Scdpromoter-
SCC1 (S175A,S183A.A194A,S263A,S273A,S276A,S325 
A,S374A>S389A,S497A)-HA3 (TRP1) Hindlll-fragment 
from 505 into387
This study
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